Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Rachel M Temple
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Junjia Zhu
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Lynn Budgeon
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Neil David Christensen
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Craig Meyers
Efficient replication of Epstein-Barr virus in stratified epithelium in vitro,2014,Clare E Sample
Age dependence of excitatory-inhibitory balance following stroke,2011,Silvio Schmidt
Age dependence of excitatory-inhibitory balance following stroke,2011,Claus Bruehl
Age dependence of excitatory-inhibitory balance following stroke,2011,Christiane Frahm
Age dependence of excitatory-inhibitory balance following stroke,2011,Christoph Redecker
Age dependence of excitatory-inhibitory balance following stroke,2011,Otto W Witte
Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood,2014,Michele D'Alto
Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood,2014,Giuseppe Santoro
Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood,2014,Maria T Palladino
Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood,2014,Francesco Parisi
Patent ductus arteriosus stenting for palliation of severe pulmonary arterial hypertension in childhood,2014,Maria G Russo
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,A Chacko
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,A C Bedard
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,D J Marks
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,N Feirsen
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,J Z Uderman
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,A Chimiklis
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,E Rajwan
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,M Cornwell
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,L Anderson
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,A Zwilling
A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: a replication in a diverse sample using a control condition,2013,M Ramon
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis,2014,Christopher J Michaud
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis,2014,Heather M Bockheim
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis,2014,Muhammad Nabeel
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis,2014,Timothy E Daum
Oral potentially malignant disorders: is malignant transformation predictable and preventable?,2014,Isaäc van der Waal
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Paul Nankivell
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Hazel Williams
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Keith Webster
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,David Pearson
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Alec High
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Kenneth MacLennan
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Burcu Senguven
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Christopher McConkey
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Pamela Rabbitts
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia,2013,Hisham Mehanna
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Hiroyuki Terawaki
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Masaaki Nakayama
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Koichi Asahi
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Takeyasu Kakamu
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Takehito Hayakawa
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Kunitoshi Iseki
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Kenjiro Kimura
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Toshiki Moriyama
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Kunihiro Yamagata
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Ichiei Narita
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Shouichi Fujimoto
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Kazuhiko Tsuruya
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Tsuneo Konta
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Masahide Kondo
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Issei Kurahashi
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Yasuo Ohashi
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Tetsuhito Fukushima
Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation,2014,Tsuyoshi Watanabe
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective,2013,Stephanie A Fernandes
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective,2013,Andrew G L Douglas
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective,2013,Miguel A Varela
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective,2013,Matthew J A Wood
Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective,2013,Yoshitsugu Aoki
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Farren B S Briggs
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Brigid S Acuña
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Ling Shen
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Kalliope H Bellesis
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Patricia P Ramsay
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Hong Quach
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Allan Bernstein
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Catherine Schaefer
Adverse socioeconomic position during the life course is associated with multiple sclerosis,2014,Lisa F Barcellos
A triadic neurocognitive approach to addiction for clinical interventions,2013,Xavier Noël
A triadic neurocognitive approach to addiction for clinical interventions,2013,Damien Brevers
A triadic neurocognitive approach to addiction for clinical interventions,2013,Antoine Bechara
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Yang Li
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,David Elashoff
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Myungshin Oh
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Uttam Sinha
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Maie A R St John
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Xiaofeng Zhou
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,Elliot Abemayor
Serum circulating human mRNA profiling and its utility for oral cancer detection,2006,David T Wong
Idiopathic intracranial hypertension caused by dietary hypervitaminosis A,2014,G R Aispuru
Idiopathic intracranial hypertension caused by dietary hypervitaminosis A,2014,E E Pascual-Pablo
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Yoshio Ota
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Toshio Imai
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Mai Hasumura
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Young-Man Cho
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Shigeaki Takami
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Toshifumi Oyamada
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Masao Hirose
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Akiyoshi Nishikawa
Prostaglandin synthases influence thyroid follicular cell proliferation but not carcinogenesis in rats initiated with N-bis(2-hydroxypropyl)nitrosamine,2012,Kumiko Ogawa
Alterations in neuromuscular function and perceptual responses following acute eccentric cycling exercise,2010,Steven J Elmer
Alterations in neuromuscular function and perceptual responses following acute eccentric cycling exercise,2010,John McDaniel
Alterations in neuromuscular function and perceptual responses following acute eccentric cycling exercise,2010,James C Martin
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,M Dolores Perea
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Gemma Castaño-Vinyals
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Jone M Altzibar
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Nieves Ascunce
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Víctor Moreno
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Adonina Tardon
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Marina Pollán
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,Maria Sala
Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study],2012,[Collective Name] MCC-Spain
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,Aç Aykan
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,A Güler
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,I Gül
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,Cy Karabay
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,E Alizade
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,T Gökdeniz
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,E Kalaycıoğlu
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,M Cetin
Management and outcomes of coronary artery perforations during percutaneous treatment of acute coronary syndromes,2014,M Yıldız
Food allergy training event for restaurant staff; a pilot evaluation,2014,Samuel Bailey
Food allergy training event for restaurant staff; a pilot evaluation,2014,Tiffany Billmeier Kindratt
Food allergy training event for restaurant staff; a pilot evaluation,2014,Helen Smith
Food allergy training event for restaurant staff; a pilot evaluation,2014,David Reading
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Anxin Wang
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Jie Tao
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Xiuhua Guo
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Xuemei Liu
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Yanxia Luo
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Xiurong Liu
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Zhe Huang
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Shuohua Chen
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Xingquan Zhao
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Jost B Jonas
The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity,2014,Shouling Wu
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Satoshi Honda
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Yasuhide Asaumi
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Takafumi Yamane
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Toshiyuki Nagai
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Tadayoshi Miyagi
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Teruo Noguchi
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Toshihisa Anzai
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Yoichi Goto
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Masaharu Ishihara
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Kunihiro Nishimura
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Hisao Ogawa
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Hatsue Ishibashi-Ueda
Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years,2014,Satoshi Yasuda
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,A M M Sonnenschein-van der Voort
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,V W V Jaddoe
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,R J P van der Valk
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,S P Willemsen
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,A Hofman
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,H A Moll
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,J C de Jongste
Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms,2011,L Duijts
Renal denervation as a friend of catheter ablation in patients with atrial fibrillation and hypertension,2014,Meng Zhang
Renal denervation as a friend of catheter ablation in patients with atrial fibrillation and hypertension,2014,Hui Tao
Renal denervation as a friend of catheter ablation in patients with atrial fibrillation and hypertension,2014,Kai-Hu Shi
The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis,2014,Y Cui
The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis,2014,H Zong
The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis,2014,H Yan
The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis,2014,Y Zhang
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,Yong Wang
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,Di Zhang
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,YiXiang Liu
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,Dan Wang
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,Jia Liu
The protective effects of berry-derived anthocyanins against visible light-induced damage in human retinal pigment epithelial cells,2014,BaoPing Ji
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Chien-Cheng Huang
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Min-Hsien Chung
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Shih-Feng Weng
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Chih-Chiang Chien
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Shio-Jean Lin
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Hung-Jung Lin
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,How-Ran Guo
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Shih-Bin Su
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Chien-Chin Hsu
Long-term prognosis of patients with carbon monoxide poisoning: a nationwide cohort study,2014,Chi-Wen Juan
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Arnon P Kater
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Marjolein Spiering
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Roberto D Liu
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,G Doreen Te Raa
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,E Slinger
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Sanne H Tonino
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Marielle M Beckers
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Simon Daenen
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Jeanette K Doorduijn
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Nienke A G Lankheet
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Dieuwertje M Luijks
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Eric Eldering
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study,2013,Marinus H J van Oers
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Ssu-Hsueh Tseng
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Cheng-Chieh Yang
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,En-Hao Yu
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Christine Chang
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Yong-Syu Lee
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Chung-Ji Liu
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Kuo-Wei Chang
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression,2014,Shu-Chun Lin
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Carlo Catassi
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Julio C Bai
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Bruno Bonaz
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Gerd Bouma
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Antonio Calabrò
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Antonio Carroccio
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Gemma Castillejo
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Carolina Ciacci
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Fernanda Cristofori
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Jernej Dolinsek
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Ruggiero Francavilla
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Luca Elli
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Peter Green
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Wolfgang Holtmeier
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Peter Koehler
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Sibylle Koletzko
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Christof Meinhold
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,David Sanders
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Michael Schumann
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Detlef Schuppan
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Reiner Ullrich
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Andreas Vécsei
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Umberto Volta
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Victor Zevallos
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Anna Sapone
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders,2013,Alessio Fasano
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,A Vitale
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,A Cucchetti
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,G L Qiao
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,M Cescon
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,J Li
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,R Ramirez Morales
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,A C Frigo
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,Y Xia
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,F Tuci
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,F Shen
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,U Cillo
"Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on ""number of patients needed to transplant"" as measure of transplant benefit",2014,A D Pinna
Colon cancer: a civilization disorder,2011,Alastair J M Watson
Colon cancer: a civilization disorder,2011,Paul D Collins
Changes in surface EMG assessed by discrete wavelet transform during maximal isometric voluntary contractions following supramaximal cycling,2012,Luis Peñailillo
Changes in surface EMG assessed by discrete wavelet transform during maximal isometric voluntary contractions following supramaximal cycling,2012,Rony Silvestre
Changes in surface EMG assessed by discrete wavelet transform during maximal isometric voluntary contractions following supramaximal cycling,2012,Kazunori Nosaka
Flap selection and functional outcomes in total glossectomy with laryngeal preservation,2013,Jordan Rihani
Flap selection and functional outcomes in total glossectomy with laryngeal preservation,2013,Michael R Lee
Flap selection and functional outcomes in total glossectomy with laryngeal preservation,2013,Thomas Lee
Flap selection and functional outcomes in total glossectomy with laryngeal preservation,2013,Yadranko Ducic
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,I Florath
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,S Brandt
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,M N Weck
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,A Moss
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,P Gottmann
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,D Rothenbacher
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,M Wabitsch
Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference,2014,H Brenner
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Saulo J A Felizola
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Takashi Maekawa
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Yasuhiro Nakamura
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Fumitoshi Satoh
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Yoshikiyo Ono
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Kumi Kikuchi
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Shizuka Aritomi
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Keiichi Ikeda
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Michihiro Yoshimura
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Katsuyoshi Tojo
Voltage-gated calcium channels in the human adrenal and primary aldosteronism,2014,Hironobu Sasano
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,G Manin
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,A Pons
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,P Baltzinger
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,F Moreau
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,C Iamandi
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,J M Wilhelm
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,P Lenoble
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,L Kessler
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications,2014,R Kessler
Developments in renal pharmacogenomics and applications in chronic kidney disease,2014,Ariadna Padullés
Developments in renal pharmacogenomics and applications in chronic kidney disease,2014,Inés Rama
Developments in renal pharmacogenomics and applications in chronic kidney disease,2014,Inés Llaudó
Developments in renal pharmacogenomics and applications in chronic kidney disease,2014,Núria Lloberas
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Cheng-Chi Chang
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Yu-Jen Yang
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Yue-Ju Li
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Szu-Ta Chen
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Been-Ren Lin
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Tai-Sheng Wu
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Sze-Kwen Lin
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Mark Yen-Ping Kuo
MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma,2013,Ching-Ting Tan
Effectiveness of web-based tailored smoking cessation advice reports (iQuit): a randomized trial,2012,Dan Mason
Effectiveness of web-based tailored smoking cessation advice reports (iQuit): a randomized trial,2012,Hazel Gilbert
Effectiveness of web-based tailored smoking cessation advice reports (iQuit): a randomized trial,2012,Stephen Sutton
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,L Cervenka
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,J Bíbová
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,Z Husková
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,Z Vaňourková
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,H J Kramer
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,J Herget
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,S Jíchová
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,J Sadowski
Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia,2014,V Hampl
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Thomas Schmitz
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Stefanie Endesfelder
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Marie-Christine Reinert
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Florian Klinker
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Susanne Müller
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,Christoph Bührer
Adolescent hyperactivity and impaired coordination after neonatal hyperoxia,2012,David Liebetanz
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Rui Liu
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Jingyi Li
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Tao Zhang
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Linzhi Zou
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Yi Chen
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Kui Wang
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Yunlong Lei
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Kefei Yuan
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Yi Li
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Jiang Lan
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Lin Cheng
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Na Xie
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Rong Xiang
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Edouard C Nice
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Canhua Huang
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking,2014,Yuquan Wei
Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain,2013,Rajneet K Oberoi
Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain,2013,Rajendar K Mittapalli
Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain,2013,William F Elmquist
Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein,2012,Adam Pickard
Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein,2012,Ann-Christin Cichon
Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein,2012,Craig Menges
Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein,2012,Daksha Patel
Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein,2012,Dennis J McCance
Predicting intrinsic brain activity,2013,R Cameron Craddock
Predicting intrinsic brain activity,2013,Michael P Milham
Predicting intrinsic brain activity,2013,Stephen M LaConte
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Tanya Elizabeth Benjamin
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Jewel Elias Crasta
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Ann Patricia Catherine Suresh
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Merlin Jemi Thanka Alwinesh
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Gomathi Kanniappan
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Sanjeev M Padankatti
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,M K C Nair
Sensory Profile Caregiver Questionnaire: A Measure for Sensory Impairment Among Children with Developmental Disabilities in India,2014,Paul Swamidhas Sudhakar Russell
Synergy of BMI and family history on diabetes: the Humboldt Study,2009,Yue Chen
Synergy of BMI and family history on diabetes: the Humboldt Study,2009,Donna C Rennie
Synergy of BMI and family history on diabetes: the Humboldt Study,2009,James A Dosman
Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy,2010,Zenichiro Kato
Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy,2010,Masahiro Morimoto
Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy,2010,Kenji E Orii
Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy,2010,Tomomi Kato
Developmental changes of radiological findings in Fukuyama-type congenital muscular dystrophy,2010,Naomi Kondo
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,Ying Jiang
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,Yue Chen
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,Douglas Manuel
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,Howard Morrison
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,Yang Mao
Quantifying the impact of obesity category on major chronic diseases in Canada,2007,[Collective Name] Obesity Working Group
Would it be ethical to use motivational interviewing to increase family consent to deceased solid organ donation?,2013,Isra Black
Would it be ethical to use motivational interviewing to increase family consent to deceased solid organ donation?,2013,Lisa Forsberg
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Linda Marklund
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Anders Näsman
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Torbjörn Ramqvist
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Tina Dalianis
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Eva Munck-Wikland
Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer,2012,Lalle Hammarstedt
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Hye-Jung Yoon
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Ji-Soo Hong
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Wui-Jung Shin
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Yoo-Jin Lee
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Kyoung-Ok Hong
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Jae-Il Lee
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Sam-Pyo Hong
The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma,2011,Seong-Doo Hong
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Valentina Nardi
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Peter M Sadow
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Dejan Juric
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Dave Zhao
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Arjola K Cosper
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Kristin Bergethon
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Vanessa L Scialabba
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Julie M Batten
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Darrell R Borger
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Anthony John Iafrate
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Rebecca S Heist
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Donald P Lawrence
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Keith T Flaherty
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Johanna C Bendell
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Daniel Deschler
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Yi Li
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Lori J Wirth
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment,2012,Dora Dias-Santagata
Alternative models for estimating the radiotherapy retreatment dose for the spinal cord,2014,Bleddyn Jones
Alternative models for estimating the radiotherapy retreatment dose for the spinal cord,2014,John W Hopewell
Microalbuminuria in adult outpatients not receiving nephrological care and with risk factors for chronic kidney disease in Peruvian nephrology departments,2012,[Collective Name] National Campaign of World Kidney Day 2010
Microalbuminuria in adult outpatients not receiving nephrological care and with risk factors for chronic kidney disease in Peruvian nephrology departments,2012,[Collective Name] Peruvian Society of Nephrology
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Yumiao Zhang
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Mansik Jeon
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Laurie J Rich
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Hao Hong
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Jumin Geng
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Yin Zhang
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Sixiang Shi
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Todd E Barnhart
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Paschalis Alexandridis
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Jan D Huizinga
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Mukund Seshadri
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Weibo Cai
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Chulhong Kim
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines,2014,Jonathan F Lovell
Analyzing task-dependent brain network changes by whole-brain psychophysiological interactions: A comparison to conventional analysis,2014,Martin Fungisai Gerchen
Analyzing task-dependent brain network changes by whole-brain psychophysiological interactions: A comparison to conventional analysis,2014,David Bernal-Casas
Analyzing task-dependent brain network changes by whole-brain psychophysiological interactions: A comparison to conventional analysis,2014,Peter Kirsch
Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation,2013,Ana M Puga
Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation,2013,Ana Catarina Lima
Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation,2013,Joao F Mano
Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation,2013,Angel Concheiro
Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation,2013,Carmen Alvarez-Lorenzo
Stability of oxyhemoglobin affinity in patients with obstructive sleep apnea-hypopnea syndrome without daytime hypoxemia,2008,Didier Clause
Stability of oxyhemoglobin affinity in patients with obstructive sleep apnea-hypopnea syndrome without daytime hypoxemia,2008,Bruno Detry
Stability of oxyhemoglobin affinity in patients with obstructive sleep apnea-hypopnea syndrome without daytime hypoxemia,2008,Daniel Rodenstein
Stability of oxyhemoglobin affinity in patients with obstructive sleep apnea-hypopnea syndrome without daytime hypoxemia,2008,Giuseppe Liistro
Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia,2014,Bs Ganavi
Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia,2014,Shankargouda Patil
Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia,2014,Roopa S Rao
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis,2014,Le-Gang Huang
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis,2014,Dong-Bo Liu
Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis,2014,Hai-Qing Wang
Bacteriology of normal frontal sinuses,2013,Silviu Albu
Bacteriology of normal frontal sinuses,2013,Ioan S Florian
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Mitchell E Tyler
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Kurt A Kaczmarek
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Kathy L Rust
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Alla M Subbotin
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Kimberly L Skinner
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial,2014,Yuri P Danilov
Are perceptuo-motor decisions really more optimal than cognitive decisions?,2014,Andreas Jarvstad
Are perceptuo-motor decisions really more optimal than cognitive decisions?,2014,Ulrike Hahn
Are perceptuo-motor decisions really more optimal than cognitive decisions?,2014,Paul A Warren
Are perceptuo-motor decisions really more optimal than cognitive decisions?,2014,Simon K Rushton
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Hsueh-Sheng Chiang
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Raksha A Mudar
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Jeffrey S Spence
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Athula Pudhiyidath
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Justin Eroh
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Bambi DeLaRosa
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,Michael A Kraut
Age-related changes in feature-based object memory retrieval as measured by event-related potentials,2014,John Hart
Fundamental Technical Elements of Freeze-fracture/Freeze-etch in Biological Electron Microscopy,2014,Johnny L Carson
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Rodrigo Modolo
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Ana Paula de Faria
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Maria O Paganelli
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Andréa R Sabbatini
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Natália R Barbaro
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Beatriz B Nascimento
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Celso D Ramos
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Vanessa Fontana
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,David A Calhoun
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients,2014,Heitor Moreno
Confounding in association studies: month of birth and multiple sclerosis,2014,Barnaby Fiddes
Confounding in association studies: month of birth and multiple sclerosis,2014,James Wason
Confounding in association studies: month of birth and multiple sclerosis,2014,Stephen Sawcer
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Yi-Shing Lisa Cheng
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Lee Jordan
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Terry Rees
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Huey-Shys Chen
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Lance Oxford
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,Ole Brinkmann
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients,2013,David Wong
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Ataur Rahman Khan
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Zaki Naser Al Abdul Lateef
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Shaheen Fatima
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Sana Abdullah Ahmad Al Yousuf
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Syed Zakaullah Khan Afghan
Prevalence of Chronic Complication among Type 2 Diabetics Attending Primary Health Care Centers of Al Ahsa District of Saudi Arabia: A Cross Sectional Survey,2014,Salah Al Marghani
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation,2014,Atsushi Satake
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation,2014,Amanda M Schmidt
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation,2014,Shosaku Nomura
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation,2014,Taku Kambayashi
Infarct volume predicts critical care needs in stroke patients treated with intravenous thrombolysis,2014,Roland Faigle
Infarct volume predicts critical care needs in stroke patients treated with intravenous thrombolysis,2014,Amy W Wozniak
Infarct volume predicts critical care needs in stroke patients treated with intravenous thrombolysis,2014,Elisabeth B Marsh
Infarct volume predicts critical care needs in stroke patients treated with intravenous thrombolysis,2014,Rafael H Llinas
Infarct volume predicts critical care needs in stroke patients treated with intravenous thrombolysis,2014,Victor C Urrutia
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Ayumi Yamamoto
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Atsushi Kasamatsu
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Shunsaku Ishige
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Kazuyuki Koike
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Kengo Saito
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Yukinao Kouzu
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Hirofumi Koike
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Yosuke Sakamoto
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Katsunori Ogawara
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Masashi Shiiba
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Hideki Tanzawa
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases,2012,Katsuhiro Uzawa
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,Wan-Chun Li
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,Pei-Lun Lee
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,I-Chiang Chou
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,Wan-Jung Chang
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,Shu-Chun Lin
Molecular and cellular cues of diet-associated oral carcinogenesis-with an emphasis on areca-nut-induced oral cancer development,2014,Kuo-Wei Chang
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Maria M Rodríguez
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Fernando Chaves
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Rita L Romaguera
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Peter L Ferrer
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Claudia de la Guardia
Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses,2002,Jocelyn H Bruce
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Alice Laroni
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Ilaria Gandoglia
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Claudio Solaro
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Giuseppe Ribizzi
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Tiziana Tassinari
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Matteo Pizzorno
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Sergio Parodi
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Giovanna Baldassarre
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Maria Teresa Rilla
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Simonetta Venturi
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Elisabetta Capello
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Maria Pia Sormani
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Antonio Uccelli
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection,2014,Giovanni Luigi Mancardi
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes,2014,Angela Dardano
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes,2014,Cristina Bianchi
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes,2014,Stefano Del Prato
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes,2014,Roberto Miccoli
Cognition: the new frontier for nuts and berries,2014,Peter Pribis
Cognition: the new frontier for nuts and berries,2014,Barbara Shukitt-Hale
Breast imaging for interventional pathologists,2012,David Lieu
Thermogenic adipocytes: From cells to physiology and medicine,2014,Mauricio Berriel Diaz
Thermogenic adipocytes: From cells to physiology and medicine,2014,Stephan Herzig
Thermogenic adipocytes: From cells to physiology and medicine,2014,Alexandros Vegiopoulos
Diallyl sulfide induces growth inhibition and apoptosis of anaplastic thyroid cancer cells by mitochondrial signaling pathway,2010,Hyang Ae Shin
Diallyl sulfide induces growth inhibition and apoptosis of anaplastic thyroid cancer cells by mitochondrial signaling pathway,2010,Yun Yi Cha
Diallyl sulfide induces growth inhibition and apoptosis of anaplastic thyroid cancer cells by mitochondrial signaling pathway,2010,Mun Su Park
Diallyl sulfide induces growth inhibition and apoptosis of anaplastic thyroid cancer cells by mitochondrial signaling pathway,2010,Jae Myeong Kim
Diallyl sulfide induces growth inhibition and apoptosis of anaplastic thyroid cancer cells by mitochondrial signaling pathway,2010,Young Chang Lim
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Miao Tian
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Li Sheng
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Peng Huang
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Jun Li
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Chuan-Huan Zhang
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Jun Yang
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Yu-Hua Liao
Agonistic autoantibodies against the angiotensin AT1 receptor increase in unstable angina patients after stent implantation,2014,Liu-Dong Li
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,S Fuji
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,K Takano
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,T Mori
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,T Eto
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,S Taniguchi
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,K Ohashi
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,H Sakamaki
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,Y Morishima
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,K Kato
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,K Miyamura
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,R Suzuki
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT,2014,T Fukuda
The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform,2014,D Justin Larkin
The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform,2014,R Chad Swanson
The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform,2014,Spencer Fuller
The Affordable Care Act: a case study for understanding and applying complexity concepts to health care reform,2014,Denis A Cortese
Risk prediction tools in surgical oncology,2014,Christine V Kinnier
Risk prediction tools in surgical oncology,2014,Elliot A Asare
Risk prediction tools in surgical oncology,2014,Sanjay Mohanty
Risk prediction tools in surgical oncology,2014,Jennifer L Paruch
Risk prediction tools in surgical oncology,2014,Ravi Rajaram
Risk prediction tools in surgical oncology,2014,Karl Y Bilimoria
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Maria J Perugorria
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Tatyana V Masyuk
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Jose J Marin
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Marco Marzioni
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Luis Bujanda
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Nicholas F LaRusso
Polycystic liver diseases: advanced insights into the molecular mechanisms,2014,Jesus M Banales
Multimodality evaluation of the pediatric brain: DTI and its competitors,2013,Lana Vasung
Multimodality evaluation of the pediatric brain: DTI and its competitors,2013,Elda Fischi-Gomez
Multimodality evaluation of the pediatric brain: DTI and its competitors,2013,Petra S Hüppi
Effect of oral administration of sodium bicarbonate on surface EMG activity during repeated cycling sprints,2007,Ryouta Matsuura
Effect of oral administration of sodium bicarbonate on surface EMG activity during repeated cycling sprints,2007,Takuma Arimitsu
Effect of oral administration of sodium bicarbonate on surface EMG activity during repeated cycling sprints,2007,Takehide Kimura
Effect of oral administration of sodium bicarbonate on surface EMG activity during repeated cycling sprints,2007,Takahiro Yunoki
Effect of oral administration of sodium bicarbonate on surface EMG activity during repeated cycling sprints,2007,Tokuo Yano
Role of statins in the treatment of multiple sclerosis,2014,Rosella Ciurleo
Role of statins in the treatment of multiple sclerosis,2014,Placido Bramanti
Role of statins in the treatment of multiple sclerosis,2014,Silvia Marino
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,Markus Amann
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,Gregory M Blain
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,Lester T Proctor
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,Joshua J Sebranek
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,David F Pegelow
Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans,2011,Jerome A Dempsey
Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors?,2013,Kristen B Pytynia
Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors?,2013,Kristina R Dahlstrom
Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors?,2013,Erich M Sturgis
Volumetric Brain Morphometry Changes in Patients with Obstructive Sleep Apnea Syndrome: Effects of CPAP Treatment and Literature Review,2014,Nelly T Huynh
Volumetric Brain Morphometry Changes in Patients with Obstructive Sleep Apnea Syndrome: Effects of CPAP Treatment and Literature Review,2014,Olga Prilipko
Volumetric Brain Morphometry Changes in Patients with Obstructive Sleep Apnea Syndrome: Effects of CPAP Treatment and Literature Review,2014,Clete A Kushida
Volumetric Brain Morphometry Changes in Patients with Obstructive Sleep Apnea Syndrome: Effects of CPAP Treatment and Literature Review,2014,Christian Guilleminault
Dental service utilization and costs before and after introduction of fluoride gel application for preschool children in Taiwan,2009,Shu-Fen Chen
Dental service utilization and costs before and after introduction of fluoride gel application for preschool children in Taiwan,2009,Herng-Ching Lin
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Toko Ohira
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Ryo Ando
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Tsubasa Saito
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Megumi Yahata
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Yosuke Oshima
Busulfan-induced pathological changes of the cerebellar development in infant rats,2012,Kazutoshi Tamura
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Nora L Nock
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Anastasia Dimitropoulos
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Stephen M Rao
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Chris A Flask
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Mark Schluchter
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Kristine M Zanotti
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Peter G Rose
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,John P Kirwan
Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): A randomized trial in obese endometrial cancer survivors,2014,Jay Alberts
No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women,2014,Catherine Duggan
No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women,2014,Liren Xiao
No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women,2014,Mary Beth Terry
No effect of weight loss on LINE-1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women,2014,Anne McTiernan
Infective endocarditis epidemiology over five decades: a systematic review,2013,Leandro Slipczuk
Infective endocarditis epidemiology over five decades: a systematic review,2013,J Nicolas Codolosa
Infective endocarditis epidemiology over five decades: a systematic review,2013,Carlos D Davila
Infective endocarditis epidemiology over five decades: a systematic review,2013,Abel Romero-Corral
Infective endocarditis epidemiology over five decades: a systematic review,2013,Jeong Yun
Infective endocarditis epidemiology over five decades: a systematic review,2013,Gregg S Pressman
Infective endocarditis epidemiology over five decades: a systematic review,2013,Vincent M Figueredo
Management of difficult-to-treat atopic dermatitis,2012,Peter D Arkwright
Management of difficult-to-treat atopic dermatitis,2012,Cassim Motala
Management of difficult-to-treat atopic dermatitis,2012,Hamsa Subramanian
Management of difficult-to-treat atopic dermatitis,2012,Jonathan Spergel
Management of difficult-to-treat atopic dermatitis,2012,Lynda C Schneider
Management of difficult-to-treat atopic dermatitis,2012,Andreas Wollenberg
Management of difficult-to-treat atopic dermatitis,2012,[Collective Name] Atopic Dermatitis Working Group of the Allergic Skin Diseases Committee of the AAAAI
'A chronic disease is a disease which keeps coming back…it is like the flu': chronic disease risk perception and explanatory models among French- and Swahili-speaking African migrants,2012,Maxwell Cooper
'A chronic disease is a disease which keeps coming back…it is like the flu': chronic disease risk perception and explanatory models among French- and Swahili-speaking African migrants,2012,Seeromanie Harding
'A chronic disease is a disease which keeps coming back…it is like the flu': chronic disease risk perception and explanatory models among French- and Swahili-speaking African migrants,2012,Kenneth Mullen
'A chronic disease is a disease which keeps coming back…it is like the flu': chronic disease risk perception and explanatory models among French- and Swahili-speaking African migrants,2012,Catherine O'Donnell
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,Weilin Hu
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,Yumei Ge
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,David M Ojcius
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,Dexter Sun
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,Haiyan Dong
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,X Frank Yang
p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species,2013,Jie Yan
Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization,2013,Jonathan I Silverberg
Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization,2013,Eric L Simpson
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Rahul Kumar
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Navinath Mohan
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Ashish Datt Upadhyay
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Amrendra Pratap Singh
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Vishal Sahu
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Sadanand Dwivedi
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Aparajit B Dey
Identification of serum sirtuins as novel noninvasive protein markers for frailty,2014,Sharmistha Dey
Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation,2009,Catharina M Lerche
Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation,2009,Peter A Philipsen
Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation,2009,Thomas Poulsen
Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation,2009,Hans Christian Wulf
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists,2012,Tamotsu Tsukahara
Patterns of invasion as major prognostic factors in cancer of the oral cavity,2014,Ashok R Shaha
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Esther Diana Rossi
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Patrizia Straccia
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Maurizio Martini
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Luca Revelli
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Celestino Pio Lombardi
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Alfredo Pontecorvi
The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience,2014,Guido Fadda
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Nir Kleinmann
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Wilhelmina C M Duivenvoorden
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Sarah N Hopmans
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Laura K Beatty
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Shengjun Qiao
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Daniel Gallino
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Sarka Lhotak
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Dean Daya
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Athanasios Paschos
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Richard C Austin
Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression,2013,Jehonathan H Pinthus
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,K Ramadas
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,S Arrossi
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,S Thara
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,G Thomas
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,V Jissa
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,J M Fayette
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,B Mathew
Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India,2008,R Sankaranarayanan
Visual search behaviours and verbal reports during film-based and in situ representative tasks in volleyball,2012,José Afonso
Visual search behaviours and verbal reports during film-based and in situ representative tasks in volleyball,2012,Júlio Garganta
Visual search behaviours and verbal reports during film-based and in situ representative tasks in volleyball,2012,Allistair McRobert
Visual search behaviours and verbal reports during film-based and in situ representative tasks in volleyball,2012,Mark Williams
Visual search behaviours and verbal reports during film-based and in situ representative tasks in volleyball,2012,Isabel Mesquita
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Roland Coras
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Elisabeth Pauli
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Jinmei Li
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Michael Schwarz
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Karl Rössler
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Michael Buchfelder
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Hajo Hamer
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Hermann Stefan
Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy,2014,Ingmar Blumcke
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,T Hayton
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,J Furby
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,K J Smith
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,D R Altmann
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,R Brenner
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,J Chataway
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,K Hunter
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,D J Tozer
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,D H Miller
Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine,2011,R Kapoor
Insecurities of women regarding breast cancer research: a qualitative study,2013,Marion Habersack
Insecurities of women regarding breast cancer research: a qualitative study,2013,Gero Luschin
Electrochemotherapy: from the drawing board into medical practice,2014,Damijan Miklavčič
Electrochemotherapy: from the drawing board into medical practice,2014,Barbara Mali
Electrochemotherapy: from the drawing board into medical practice,2014,Bor Kos
Electrochemotherapy: from the drawing board into medical practice,2014,Richard Heller
Electrochemotherapy: from the drawing board into medical practice,2014,Gregor Serša
Effects of caffeine on exercise performance in sedentary females,2010,Karen E Wallman
Effects of caffeine on exercise performance in sedentary females,2010,Jin W Goh
Effects of caffeine on exercise performance in sedentary females,2010,Kym J Guelfi
Predictors of large and small artery elasticity in healthy subjects from 9 to 89 years old,2011,Andrew W Gardner
Predictors of large and small artery elasticity in healthy subjects from 9 to 89 years old,2011,Donald E Parker
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,M Kono
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,T Nomura
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,Y Ohguchi
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,O Mizuno
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,S Suzuki
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,H Tsujiuchi
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,N Hamajima
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,W H I McLean
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,H Shimizu
Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations,2014,M Akiyama
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Angela S Donin
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Claire M Nightingale
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Chris G Owen
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Alicja R Rudnicka
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Michael R Perkin
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Susan A Jebb
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Alison M Stephen
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Naveed Sattar
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Derek G Cook
Regular breakfast consumption and type 2 diabetes risk markers in 9- to 10-year-old children in the child heart and health study in England (CHASE): a cross-sectional analysis,2014,Peter H Whincup
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Lisa Cosgrove
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Sheldon Krimsky
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Emily E Wheeler
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Jenesse Kaitz
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Scott B Greenspan
Tripartite conflicts of interest and high stakes patent extensions in the DSM-5,2014,Nicole L DiPentima
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Carmela R Balistreri
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Calogera Pisano
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Adriana Martorana
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Oreste F Triolo
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Domenico Lio
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Giuseppina Candore
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?,2014,Giovanni Ruvolo
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Akihiro Tokushige
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Hiroki Shiomi
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Takeshi Morimoto
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Koh Ono
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Yutaka Furukawa
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Yoshihisa Nakagawa
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Kazushige Kadota
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Kenji Ando
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Satoshi Shizuta
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Tomohisa Tada
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Junichi Tazaki
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Yoshihiro Kato
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Mamoru Hayano
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Mitsuru Abe
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Shuichi Hamasaki
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Mitsuru Ohishi
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Hitoshi Nakashima
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Kazuaki Mitsudo
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Masakiyo Nobuyoshi
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Toru Kita
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Yutaka Imoto
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Ryuzo Sakata
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Hitoshi Okabayashi
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Michiya Hanyu
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Mitsuomi Shimamoto
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Noboru Nishiwaki
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Tatsuhiko Komiya
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,Takeshi Kimura
Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2,2014,[Collective Name] CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators
Screening programmes for the early detection and prevention of oral cancer,2013,Paul Brocklehurst
Screening programmes for the early detection and prevention of oral cancer,2013,Omar Kujan
Screening programmes for the early detection and prevention of oral cancer,2013,Lucy A O'Malley
Screening programmes for the early detection and prevention of oral cancer,2013,Graham Ogden
Screening programmes for the early detection and prevention of oral cancer,2013,Simon Shepherd
Screening programmes for the early detection and prevention of oral cancer,2013,Anne-Marie Glenny
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Mir Saeed Yekaninejad
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Amir H Pakpour
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Jyothi Tadakamadla
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Santhosh Kumar
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Seyed Hamzeh Mosavi
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Bengt Fridlund
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Andrew Bottomley
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17,2014,Neil K Aaronson
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade,2014,Jiannan Liu
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade,2014,Wei Cao
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade,2014,Wantao Chen
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade,2014,Liqun Xu
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade,2014,Chenping Zhang
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Surabhi Bhatt
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Priscilla Mutharasan
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Obed A Garcia
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Nadereh Jafari
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Richard S Legro
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Andrea Dunaif
The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome,2014,Margrit Urbanek
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes,2013,Iliana Doycheva
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes,2013,Niraj Patel
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes,2013,Michael Peterson
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes,2013,Rohit Loomba
Endocrine-disrupting chemicals: associated disorders and mechanisms of action,2012,Sam De Coster
Endocrine-disrupting chemicals: associated disorders and mechanisms of action,2012,Nicolas van Larebeke
IGF-I and IGFBP-3 during continuous and interval exercise,2007,J L Copeland
IGF-I and IGFBP-3 during continuous and interval exercise,2007,L Heggie
Obesity and colorectal cancer,2013,Mark Hull
Obesity and colorectal cancer,2013,Jesper Lagergren
Neural evidence for description dependent reward processing in the framing effect,2014,Rongjun Yu
Neural evidence for description dependent reward processing in the framing effect,2014,Ping Zhang
Laquinimod for multiple sclerosis,2013,Dian He
Laquinimod for multiple sclerosis,2013,Kai Han
Laquinimod for multiple sclerosis,2013,Xiangdong Gao
Laquinimod for multiple sclerosis,2013,Shuai Dong
Laquinimod for multiple sclerosis,2013,Lan Chu
Laquinimod for multiple sclerosis,2013,ZhanHui Feng
Laquinimod for multiple sclerosis,2013,Shan Wu
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Francesco Moretto
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Monica Rampino
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Fernando Munoz
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Maria Grazia Ruo Redda
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Alessia Reali
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Vittoria Balcet
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Serena Badellino
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Cristina Piva
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Marina Schena
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Mario Airoldi
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Oliviero Ostellino
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Giancarlo Pecorari
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Riccardo Ragona
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment,2014,Umberto Ricardi
Bathing and generalized asteatotic eczema: a case-control study,2008,L-F Li
Bathing and generalized asteatotic eczema: a case-control study,2008,Y-Z Lan
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,Sara Samuel
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,Vanessa F Tumilasci
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,Stephanie Oliere
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,Thi Liên-Anh Nguyên
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,April Shamy
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,John Bell
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia,2010,John Hiscott
Attitudes of prehospital emergency care professionals toward refusal of treatment: A regional survey in Turkey,2013,Hasan Erbay
Attitudes of prehospital emergency care professionals toward refusal of treatment: A regional survey in Turkey,2013,Sultan Alan
Attitudes of prehospital emergency care professionals toward refusal of treatment: A regional survey in Turkey,2013,Selim Kadioglu
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,A Savar
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,S Acin
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,C L Gonzalez
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,T El-Sawy
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,O Mejia
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,Z Li
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,B Esmaeli
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,A Lacy-Hulbert
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,A K El-Naggar
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,J H McCarty
Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment,2014,C Caulin
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Anna Guerra
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Vincenzo Marotta
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Maurilio Deandrea
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Manuela Motta
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Paolo Piero Limone
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Alessia Caleo
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Pio Zeppa
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Silvano Esposito
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Franco Fulciniti
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma,2012,Mario Vitale
An aspirin a day: the allure (and distraction) of chemoprevention,2012,Isra G Levy
An aspirin a day: the allure (and distraction) of chemoprevention,2012,Carolyn P Pim
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Kunio Yoshizawa
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Shinichi Nozaki
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Aki Kato
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Mariko Hirai
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Mizuki Yanase
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Taisuke Yoshimoto
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Iyo Kimura
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Shiro Sugiura
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Ayako Okamune
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Hiroko Kitahara
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Natsuyo Noguchi
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Koroku Kato
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Koichiro Ueki
Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma,2012,Shuichi Kawashiri
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Daniel Grant Schwartz
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Benjamin J Cottrell
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Matthew J Teusink
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Rachel E Clark
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Katheryne L Downes
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Richard S Tannenbaum
Factors that predict postoperative motion in patients treated with reverse shoulder arthroplasty,2014,Mark A Frankle
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Dagmar Simon
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Jennifer Wittwer
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Ganna Kostylina
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Urs Buettiker
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Hans-Uwe Simon
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema,2008,Nikhil Yawalkar
Pharmacological approaches to coronary microvascular dysfunction,2014,Giacinta Guarini
Pharmacological approaches to coronary microvascular dysfunction,2014,Alda Huqi
Pharmacological approaches to coronary microvascular dysfunction,2014,Doralisa Morrone
Pharmacological approaches to coronary microvascular dysfunction,2014,Paola Capozza
Pharmacological approaches to coronary microvascular dysfunction,2014,Giancarlo Todiere
Pharmacological approaches to coronary microvascular dysfunction,2014,Mario Marzilli
17beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men,2005,Michaela C Devries
17beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men,2005,Mazen J Hamadeh
17beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men,2005,Terry E Graham
17beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men,2005,Mark A Tarnopolsky
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Aoife O'Donovan
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Beth E Cohen
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Karen H Seal
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Dan Bertenthal
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Mary Margaretten
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Kristen Nishimi
Elevated Risk for Autoimmune Disorders in Iraq and Afghanistan Veterans with Posttraumatic Stress Disorder,2014,Thomas C Neylan
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,X S Sun
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,S R Sun
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,N Guevara
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,P Y Marcy
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,I Peyrottes
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,S Lassalle
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,A Lacout
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,J L Sadoul
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,J Santini
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,D Benisvy
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,A Lepinoy
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques,2012,J Thariat
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Liwei Lang
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Xiaoyu Liu
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Yan Li
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Qing Zhou
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Ping Xie
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Chunhong Yan
A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth,2014,Xiaoguang Chen
Group search algorithm recovers effective connectivity maps for individuals in homogeneous and heterogeneous samples,2012,Kathleen M Gates
Group search algorithm recovers effective connectivity maps for individuals in homogeneous and heterogeneous samples,2012,Peter C M Molenaar
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Cheryl S Broussard
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Meghan T Frey
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Sonia Hernandez-Diaz
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Michael F Greene
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Christina D Chambers
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Leyla Sahin
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Beth A Collins Sharp
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention-convened meeting,2014,Margaret A Honein
Voice disorders in primary school teachers and barriers to care,2010,Victor Da Costa
Voice disorders in primary school teachers and barriers to care,2010,Elizabeth Prada
Voice disorders in primary school teachers and barriers to care,2010,Andrew Roberts
Voice disorders in primary school teachers and barriers to care,2010,Seth Cohen
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Gian Franco Macri
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Antonio Greco
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Andrea Gallo
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Massimo Fusconi
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Caterina Marinelli
Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations,2014,Marco de Vincentiis
TIME DISCOUNTING AND SMOKING BEHAVIOR: EVIDENCE FROM A PANEL SURVEY(*),2013,Myong-Il Kang
TIME DISCOUNTING AND SMOKING BEHAVIOR: EVIDENCE FROM A PANEL SURVEY(*),2013,Shinsuke Ikeda
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,József Dudás
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Alexandra Fullár
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Angela Romani
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Christian Pritz
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Ilona Kovalszky
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Volker Hans Schartinger
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Georg Mathias Sprinzl
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma,2012,Herbert Riechelmann
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Torsten Ruest
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,William M Holmes
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Jennifer A Barrie
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Ian R Griffiths
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Thomas J Anderson
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Deborah Dewar
High-resolution diffusion tensor imaging of fixed brain in a mouse model of Pelizaeus-Merzbacher disease: comparison with quantitative measures of white matter pathology,2011,Julia M Edgar
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease,2014,Katherine N Cahill
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease,2014,Jillian C Bensko
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease,2014,Joshua A Boyce
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease,2014,Tanya M Laidlaw
White matter changes in childhood NMDA receptor encephalitis: Bringing new light to an old phenotype,2014,E Ann Yeh
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Adeline Egron
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Pascale Olivier-Abbal
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Aurore Gouraud
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Samy Babai
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Sandrine Combret
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Jean-Louis Montastruc
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports,2014,Emmanuelle Bondon-Guitton
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Giulia Gava
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Ilaria Bartolomei
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Antonietta Costantino
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Marta Berra
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Stefano Venturoli
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Fabrizio Salvi
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis,2014,Maria Cristina Meriggiola
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Stefano Chiaravalli
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Marco Guzzo
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Gianni Bisogno
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Maria Debora De Pasquale
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Roberta Migliorati
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Francesco De Leonardis
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Paola Collini
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Michela Casanova
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Giovanni Cecchetto
Salivary gland carcinomas in children and adolescents: The Italian TREP project experience,2014,Andrea Ferrari
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study,2014,Annie Fex
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study,2014,Jean-Philippe Leduc-Gaudet
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study,2014,Marie-Eve Filion
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study,2014,Antony D Karelis
Effect of Elliptical High Intensity Interval Training on Metabolic Risk Factor in Pre- and Type 2 Diabetes Patients: A Pilot Study,2014,Mylène Aubertin-Leheudre
Potential variant of multiple endocrine neoplasia in a dog,2012,Daniela Proverbio
Potential variant of multiple endocrine neoplasia in a dog,2012,Eva Spada
Potential variant of multiple endocrine neoplasia in a dog,2012,Roberta Perego
Potential variant of multiple endocrine neoplasia in a dog,2012,Valeria Grieco
Potential variant of multiple endocrine neoplasia in a dog,2012,Matteo Lodi
Potential variant of multiple endocrine neoplasia in a dog,2012,Mauro Di Giancamillo
Potential variant of multiple endocrine neoplasia in a dog,2012,Elisabetta Ferro
Dental and craniofacial characteristics in a patient with Dubowitz syndrome: a case report,2011,Andrea Ballini
Dental and craniofacial characteristics in a patient with Dubowitz syndrome: a case report,2011,Stefania Cantore
Dental and craniofacial characteristics in a patient with Dubowitz syndrome: a case report,2011,Domenica Tullo
Dental and craniofacial characteristics in a patient with Dubowitz syndrome: a case report,2011,Apollonia Desiate
Performing a secondary executive task with affective stimuli interferes with decision making under risk conditions,2013,Bettina Gathmann
Performing a secondary executive task with affective stimuli interferes with decision making under risk conditions,2013,Mirko Pawlikowski
Performing a secondary executive task with affective stimuli interferes with decision making under risk conditions,2013,Tobias Schöler
Performing a secondary executive task with affective stimuli interferes with decision making under risk conditions,2013,Matthias Brand
Effect of an oxygen scavenger on the stability of preservative-free flour tortillas,2011,Priscilla D Antunez
Effect of an oxygen scavenger on the stability of preservative-free flour tortillas,2011,María Botero Omary
Effect of an oxygen scavenger on the stability of preservative-free flour tortillas,2011,Kurt A Rosentrater
Effect of an oxygen scavenger on the stability of preservative-free flour tortillas,2011,Melvin Pascall
Effect of an oxygen scavenger on the stability of preservative-free flour tortillas,2011,Lauren Winstone
Courage is treating patients with Ebola,2014,Margaret McCartney
The use of abstract paintings and narratives to foster reflective capacity in medical educators: a multinational faculty development workshop,2013,Khaled Karkabi
The use of abstract paintings and narratives to foster reflective capacity in medical educators: a multinational faculty development workshop,2013,Hedy S Wald
The use of abstract paintings and narratives to foster reflective capacity in medical educators: a multinational faculty development workshop,2013,Orit Cohen Castel
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Feng Wang
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Fangling Ning
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Changmin Liu
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Yanzhang Hao
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,LiMian Li
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Zeshun Yu
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Shaoshui Chen
Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer,2014,Baosheng Li
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,John M Ringman
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Joseph O'Neill
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Daniel Geschwind
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Luis Medina
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Liana G Apostolova
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Yaneth Rodriguez
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Barbara Schaffer
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Arousiak Varpetian
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Benjamin Tseng
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Freddy Ortiz
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Jaime Fitten
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,Jeffrey L Cummings
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations,2007,George Bartzokis
Role of primary closure after transoral robotic surgery for tonsillar cancer,2014,Inn-Chul Nam
Role of primary closure after transoral robotic surgery for tonsillar cancer,2014,Jun-Ook Park
Role of primary closure after transoral robotic surgery for tonsillar cancer,2014,Young-Hoon Joo
Role of primary closure after transoral robotic surgery for tonsillar cancer,2014,Kwang-Jae Cho
Role of primary closure after transoral robotic surgery for tonsillar cancer,2014,Min-Sik Kim
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Dora Il'yasova
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Frances Wang
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Ivan Spasojevic
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Karel Base
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Ralph B D'Agostino
Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI,2012,Lynne E Wagenknecht
Association of pulse pressure with serum TNF-α and neutrophil count in the elderly,2014,Eriko Yamada
Association of pulse pressure with serum TNF-α and neutrophil count in the elderly,2014,Mika Takeuchi
Association of pulse pressure with serum TNF-α and neutrophil count in the elderly,2014,Miki Kurata
Association of pulse pressure with serum TNF-α and neutrophil count in the elderly,2014,Tsutomu Kazumi
Association of pulse pressure with serum TNF-α and neutrophil count in the elderly,2014,Keisuke Fukuo
MicroRNAs in human lung cancer,2014,Sung-Min Kang
MicroRNAs in human lung cancer,2014,Heon-Jin Lee
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Yonara M F S Marques
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Fernanda S Giudice
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Vanessa M Freitas
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Maria do C C Abreu e Lima
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Keith D Hunter
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Paul M Speight
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands,2012,Suzana C O Machado de Sousa
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,2011,Mark G O'Doherty
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,2011,Neal D Freedman
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,2011,Albert R Hollenbeck
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,2011,Arthur Schatzkin
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study,2011,Christian C Abnet
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,Donald Taylor
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,Lukas Radbruch
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,Julia Revnic
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,Luis M Torres
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,John E Ellershaw
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain,2013,Michael Perelman
Treatment of Subarachnoid Hemorrhage,2014,Amanda K Raya
Treatment of Subarachnoid Hemorrhage,2014,Michael N Diringer
Optimal throughput for cognitive radio with energy harvesting in fading wireless channel,2014,Hiep Vu-Van
Optimal throughput for cognitive radio with energy harvesting in fading wireless channel,2014,Insoo Koo
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,Laura A Jansen
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,Robert F Hevner
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,William H Roden
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,Si Houn Hahn
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,Sunhee Jung
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy,2014,Sidney M Gospe
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Gaëlle Bruneteau
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Thomas Simonet
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Stéphanie Bauché
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Nathalie Mandjee
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Edoardo Malfatti
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Emmanuelle Girard
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Marie-Laure Tanguy
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Anthony Behin
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Frédéric Khiami
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Elhadi Sariali
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Caroline Hell-Remy
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,François Salachas
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Pierre-François Pradat
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Emmanuel Fournier
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Lucette Lacomblez
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Jeanine Koenig
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Norma Beatriz Romero
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Bertrand Fontaine
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Vincent Meininger
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Laurent Schaeffer
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression,2013,Daniel Hantaï
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Satoshi Hirose
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Hiroko M Kimura
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Koji Jimura
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Akira Kunimatsu
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Osamu Abe
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Kuni Ohtomo
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Yasushi Miyashita
Dissociable temporo-parietal memory networks revealed by functional connectivity during episodic retrieval,2013,Seiki Konishi
Circulating CD62P small microparticles levels are increased in hypertension,2014,Shuai-Shuai Hu
Circulating CD62P small microparticles levels are increased in hypertension,2014,Hong-Gang Zhang
Circulating CD62P small microparticles levels are increased in hypertension,2014,Qiu-Ju Zhang
Circulating CD62P small microparticles levels are increased in hypertension,2014,Rui-Juan Xiu
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome,2005,F Haab
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome,2005,L Cardozo
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome,2005,C Chapple
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome,2005,A M Ridder
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome,2005,[Collective Name] Solifenacin Study Group
Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma,2009,Liesbeth M Kager
Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma,2009,Marie-Jose Kersten
Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma,2009,Raoul Peter Kloppenborg
Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma,2009,Rien Van Oers
Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma,2009,Bert-Jan Van den Born
Influence of pedalling rate on the energy cost of cycling in humans,2002,Alain Belli
Influence of pedalling rate on the energy cost of cycling in humans,2002,Frédérique Hintzy
Respiratory Rate is a Valid and Reliable Marker for the Anaerobic Threshold: Implications for Measuring Change in Fitness,2005,Daniel G Carey
Respiratory Rate is a Valid and Reliable Marker for the Anaerobic Threshold: Implications for Measuring Change in Fitness,2005,Leslie A Schwarz
Respiratory Rate is a Valid and Reliable Marker for the Anaerobic Threshold: Implications for Measuring Change in Fitness,2005,German J Pliego
Respiratory Rate is a Valid and Reliable Marker for the Anaerobic Threshold: Implications for Measuring Change in Fitness,2005,Robert L Raymond
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Elena Garralda
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Keren Paz
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Pedro P López-Casas
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Siân Jones
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Amanda Katz
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Lisa M Kann
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Fernando López-Rios
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Francesca Sarno
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Fátima Al-Shahrour
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,David Vasquez
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Elizabeth Bruckheimer
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Samuel V Angiuoli
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Antonio Calles
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Luis A Diaz
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Victor E Velculescu
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Alfonso Valencia
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,David Sidransky
Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment,2014,Manuel Hidalgo
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Andrea Barbarossa
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Riccardo Masetti
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Teresa Gazzotti
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Daniele Zama
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Annalisa Astolfi
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Bruno Veyrand
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Andrea Pession
Perfluoroalkyl substances in human milk: a first survey in Italy,2012,Giampiero Pagliuca
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Xiao Wang
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Xinghuan Wang
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Tao Liu
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Qianwen He
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Yipeng Wang
Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy,2014,Xinhua Zhang
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Ruijuan Gao
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Lijuan Zhao
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Xichun Liu
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Brian G Rowan
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Martin Wabitsch
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Dean P Edwards
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Yoshihiro Nishi
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Toshihiko Yanase
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Qun Yu
Methylseleninic acid is a novel suppressor of aromatase expression,2011,Yan Dong
Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts,2011,Yuko Iwase
Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts,2011,Yoshie Maitani
Measuring energy expenditure in clinical populations: rewards and challenges,2013,T Psota
Measuring energy expenditure in clinical populations: rewards and challenges,2013,K Y Chen
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Jung Hoon Cha
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Si Hyun Bae
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Hye Lim Kim
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Na Ri Park
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Eun Suk Choi
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Eun Sun Jung
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Jong Young Choi
Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis,2013,Seung Kew Yoon
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,José Cameselle-Teijeiro
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Javier Caneiro-Gómez
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Alhasan Ghazzawi
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Magalí Piso-Neira
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Raquel Fernández-Rodríguez
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Rosa Reyes-Santías
Giant cell arteritis of the thyroid gland as first evidence of systemic disease,2012,Ihab Abdulkader
Anesthetizing the obese child,2011,Anette Mortensen
Anesthetizing the obese child,2011,Katja Lenz
Anesthetizing the obese child,2011,Hanne Abildstrøm
Anesthetizing the obese child,2011,Torsten L B Lauritsen
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Liang Ding
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Bing Li
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Ying Zhao
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Yi-Fu Fu
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Er-Ling Hu
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Qin-Gang Hu
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Yan-Hong Ni
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma,2014,Ya-Yi Hou
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Joost R van der Vorst
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Boudewijn E Schaafsma
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Floris P R Verbeek
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Stijn Keereweer
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Jeroen C Jansen
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Lilly-Ann van der Velden
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Antonius P M Langeveld
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Merlijn Hutteman
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Clemens W G M Löwik
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Cornelis J H van de Velde
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,John V Frangioni
Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients,2012,Alexander L Vahrmeijer
Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype,2012,Krystallenia I Alexandraki
Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype,2012,Gregory A Kaltsas
Bioenergetic profile experiment using C2C12 myoblast cells,2010,David G Nicholls
Bioenergetic profile experiment using C2C12 myoblast cells,2010,Victor M Darley-Usmar
Bioenergetic profile experiment using C2C12 myoblast cells,2010,Min Wu
Bioenergetic profile experiment using C2C12 myoblast cells,2010,Per Bo Jensen
Bioenergetic profile experiment using C2C12 myoblast cells,2010,George W Rogers
Bioenergetic profile experiment using C2C12 myoblast cells,2010,David A Ferrick
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Charles S Harmon
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Samuel E DePrimo
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Robert A Figlin
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Gary R Hudes
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Thomas E Hutson
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,M Dror Michaelson
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Sylvie Négrier
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Sindy T Kim
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Xin Huang
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,J Andrew Williams
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Tim Eisen
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma,2013,Robert J Motzer
Food-snatching behavior of free-ranging Japanese macaques observed on Shodoshima Island: a preliminary report,2012,Islamul Hadi
Food-snatching behavior of free-ranging Japanese macaques observed on Shodoshima Island: a preliminary report,2012,Yamato Tsuji
Food-snatching behavior of free-ranging Japanese macaques observed on Shodoshima Island: a preliminary report,2012,Bambang Suryobroto
Food-snatching behavior of free-ranging Japanese macaques observed on Shodoshima Island: a preliminary report,2012,Kunio Watanabe
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Ece Erdağ
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Neşe Celebisoy
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Ayşe Nur Yüceyar
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Murat Kürtüncü
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Burçak Vural
Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients,2014,Erdem Tüzün
Medication adherence and resistant hypertension,2014,D J Hyman
Medication adherence and resistant hypertension,2014,V Pavlik
A cycling workstation to facilitate physical activity in office settings,2014,Steven J Elmer
A cycling workstation to facilitate physical activity in office settings,2014,James C Martin
Effects of aerobic endurance training status and specificity on oxygen uptake kinetics during maximal exercise,2004,Fabrizio Caputo
Effects of aerobic endurance training status and specificity on oxygen uptake kinetics during maximal exercise,2004,Benedito Sérgio Denadai
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Kathryn V Papp
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Richard F Kaplan
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Beth Springate
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Nicola Moscufo
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Dorothy B Wakefield
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Charles R G Guttmann
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss,2013,Leslie Wolfson
Tumour recurrence after surgical removal of parotid pleomorphic salivary adenoma using a retrograde facial nerve dissection technique,2011,Barry O'Regan
Tumour recurrence after surgical removal of parotid pleomorphic salivary adenoma using a retrograde facial nerve dissection technique,2011,Girish Bharadwaj
Photoinhibition of germination in grass seed--implications for prairie revegetation,2014,Federico P O Mollard
Photoinhibition of germination in grass seed--implications for prairie revegetation,2014,M Anne Naeth
A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells,2011,Nyla Dil
A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells,2011,Abhijit G Banerjee
The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease,2011,Anne Lahdenperä
The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease,2011,Johnny Ludvigsson
The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease,2011,Karin Fälth-Magnusson
The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease,2011,Lotta Högberg
The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease,2011,Outi Vaarala
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Mariana N L Oliveira
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Jefferson P Hemerly
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,André U Bastos
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Rosana Tamanaha
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Flavia R M Latini
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Cléber P Camacho
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Anelise Impellizzeri
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Rui M B Maciel
The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo,2011,Janete M Cerutti
Effects of modafinil on sleep-wake cycles in larval zebrafish,2011,Benjamín Sigurgeirsson
Effects of modafinil on sleep-wake cycles in larval zebrafish,2011,Haraldur Thorsteinsson
Effects of modafinil on sleep-wake cycles in larval zebrafish,2011,Hrönn Arnardóttir
Effects of modafinil on sleep-wake cycles in larval zebrafish,2011,Ingibjörg Thorn Jóhannesdóttir
Effects of modafinil on sleep-wake cycles in larval zebrafish,2011,Karl Aegir Karlsson
MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1,2014,Jorge Delgado
MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1,2014,Diego Jaramillo
MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1,2014,Victor Ho-Fung
MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1,2014,Michael J Fisher
MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1,2014,Sudha A Anupindi
Integrative radiation systems biology,2014,Kristian Unger
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Younghun Jung
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Jingcheng Wang
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Eunsohl Lee
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Samantha McGee
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Janice E Berry
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Kenji Yumoto
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Jinlu Dai
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Evan T Keller
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Yusuke Shiozawa
Annexin 2-CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow,2014,Russell S Taichman
Approaches to patients and families with strong religious beliefs regarding end-of-life care,2014,Marc Romain
Approaches to patients and families with strong religious beliefs regarding end-of-life care,2014,Charles L Sprung
Multi-step lung carcinogenesis model induced by oral administration of N-nitrosobis(2-hydroxypropyl)amine in rats,2013,Toshifumi Tsujiuchi
Multi-step lung carcinogenesis model induced by oral administration of N-nitrosobis(2-hydroxypropyl)amine in rats,2013,Dai Nakae
Multi-step lung carcinogenesis model induced by oral administration of N-nitrosobis(2-hydroxypropyl)amine in rats,2013,Yoichi Konishi
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Xiujuan Zhang
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Annie C Bowles
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Julie A Semon
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Brittni A Scruggs
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Shijia Zhang
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Amy L Strong
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Jeffrey M Gimble
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model,2014,Bruce A Bunnell
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Johann Steiner
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Hans-Gert Bernstein
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Hendrik Bielau
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Nadine Farkas
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Jana Winter
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Henrik Dobrowolny
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Ralf Brisch
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Tomasz Gos
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Christian Mawrin
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Aye Mu Myint
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,2007,Bernhard Bogerts
Alterations of rat stomach endocrine cells under renovascular hypertension,2014,Irena Kasacka
Alterations of rat stomach endocrine cells under renovascular hypertension,2014,Zaneta Piotrowska
Alterations of rat stomach endocrine cells under renovascular hypertension,2014,Alicja Lewandowska
Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma,2012,David E Kleiner
Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma,2012,David Berman
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Vinayak Shenoy
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Kwang-Chul Kwon
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Anandharajan Rathinasabapathy
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Shina Lin
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Guiying Jin
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Chunjuan Song
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Pollob Shil
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Anand Nair
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Yanfei Qi
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Qiuhong Li
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Joseph Francis
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Michael J Katovich
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Henry Daniell
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension,2014,Mohan K Raizada
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Karine Baumstarck
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Helmut Butzkueven
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Oscar Fernández
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Peter Flachenecker
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Sergio Stecchi
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Egemen Idiman
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Jean Pelletier
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Mohamed Boucekine
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study,2013,Pascal Auquier
Minimizing unnecessary surgery for thyroid nodules,2012,J Larry Jameson
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,Robert W Motl
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,Diego Cadavid
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,Brian M Sandroff
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,Lara A Pilutti
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,John H Pula
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores,2013,Ralph H B Benedict
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Selami Suleymanoglu
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Emre Tascilar
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Ozgur Pirgon
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Serkan Tapan
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Cihan Meral
Vaspin and its correlation with insulin sensitivity indices in obese children,2009,Ayhan Abaci
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Marie-Luce Choukroun
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Hala Feghali
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Sandrine Vautrat
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Fabienne Marquant
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Fabienne Nacka
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Valériane Leroy
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Jean-Louis Demarquez
Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks,2013,Michaël J Fayon
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,M E Schram
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,A M Tedja
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,R Spijker
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,J D Bos
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,H C Williams
Is there a rural/urban gradient in the prevalence of eczema? A systematic review,2010,Ph I Spuls
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Shamil Aliyev
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Halit Eren Taskin
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Orhan Agcaoglu
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Erol Aksoy
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Mira Milas
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Allan Siperstein
Robotic transaxillary total thyroidectomy through a single axillary incision,2013,Eren Berber
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Claudio Bazzi
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Virginia Rizza
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Daniela Casellato
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Gilda Stivali
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Gregorio Rachele
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Pietro Napodano
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Maurizio Gallieni
Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome,2013,Giuseppe D'Amico
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Sang-Woon Lee
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Seong-Gon Kim
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Young-Wook Park
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Haeyong Kweon
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Jwa-Young Kim
Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study,2013,Horatiu Rotaru
Neck swellings,2014,Nick Roland
Neck swellings,2014,Patrick J Bradley
Imaging depiction of retrograde jejunogastric intussusception,2012,O P Sharma
Imaging depiction of retrograde jejunogastric intussusception,2012,Saurabh Gaharwar
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Marta Grau-Olivares
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,David Bartrés-Faz
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Adrià Arboix
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Joan-Carles Soliva
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Mariana Rovira
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Cecilia Targa
Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment,2007,Carme Junqué
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Yun Sook Kim
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Hoon Kap Jung
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Tae Kyung Kwon
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Chin Soo Kim
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Jin Hyun Cho
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Dong Kuk Ahn
Expression of transient receptor potential ankyrin 1 in human dental pulp,2012,Yong Chul Bae
Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes,2012,William H Herman
Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes,2012,Robert M Cohen
Plasticity in gray and white: neuroimaging changes in brain structure during learning,2012,Robert J Zatorre
Plasticity in gray and white: neuroimaging changes in brain structure during learning,2012,R Douglas Fields
Plasticity in gray and white: neuroimaging changes in brain structure during learning,2012,Heidi Johansen-Berg
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Maha Hussain
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Michael A Carducci
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Susan Slovin
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Jeremy Cetnar
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Jiang Qian
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Evelyn M McKeegan
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Marion Refici-Buhr
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Brenda Chyla
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Stacie P Shepherd
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Vincent L Giranda
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer,2014,Joshi J Alumkal
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Sarah E Lutz
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Estibaliz González-Fernández
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Juan Carlos Chara Ventura
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Alberto Pérez-Samartín
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Leonid Tarassishin
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Hiromitsu Negoro
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Naman K Patel
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Sylvia O Suadicani
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Sunhee C Lee
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Carlos Matute
Contribution of pannexin1 to experimental autoimmune encephalomyelitis,2013,Eliana Scemes
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Anis S Ramli
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Sharmila Lakshmanan
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Jamaiyah Haniff
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Sharmini Selvarajah
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Seng F Tong
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Mohamad-Adam Bujang
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Suraya Abdul-Razak
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Asrul A Shafie
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Verna K M Lee
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Thuhairah H Abdul-Rahman
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Maryam H Daud
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Kien K Ng
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Farnaza Ariffin
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Hasidah Abdul-Hamid
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Md-Yasin Mazapuspavina
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Nafiza Mat-Nasir
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Maizatullifah Miskan
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Jaya P Stanley-Ponniah
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Mastura Ismail
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Chun W Chan
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Yong R Abdul-Rahman
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Boon-How Chew
Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a pragmatic cluster randomised controlled trial of multifaceted chronic disease management strategies to improve diabetes and hypertension outcomes in primary care,2014,Wilson H H Low
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Konstantinos K Tsilidis
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Despoina Capothanassi
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Naomi E Allen
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Evangelos C Rizos
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,David S Lopez
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Karin van Veldhoven
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Carlotta Sacerdote
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Deborah Ashby
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Paolo Vineis
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,Ioanna Tzoulaki
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial,2014,John P A Ioannidis
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Shunsaku Ishige
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Atsushi Kasamatsu
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Kenji Ogoshi
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Yasuhiro Saito
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Katsuya Usukura
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Hidetaka Yokoe
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Yukinao Kouzu
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Hirofumi Koike
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Yosuke Sakamoto
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Katsunori Ogawara
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Masashi Shiiba
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Hideki Tanzawa
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer,2013,Katsuhiro Uzawa
The development of gyrification in childhood and adolescence,2009,Tonya White
The development of gyrification in childhood and adolescence,2009,Shu Su
The development of gyrification in childhood and adolescence,2009,Marcus Schmidt
The development of gyrification in childhood and adolescence,2009,Chiu-Yen Kao
The development of gyrification in childhood and adolescence,2009,Guillermo Sapiro
Head and neck cancer in the elderly: a retrospective study over 10 years (1999 - 2008),2010,Astrid L Kruse
Head and neck cancer in the elderly: a retrospective study over 10 years (1999 - 2008),2010,Marius Bredell
Head and neck cancer in the elderly: a retrospective study over 10 years (1999 - 2008),2010,Heinz T Luebbers
Head and neck cancer in the elderly: a retrospective study over 10 years (1999 - 2008),2010,Klaus W Grätz
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Jessica M Valenzuela
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Laura B Smith
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Jeanette M Stafford
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Ralph B D'Agostino
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Jean M Lawrence
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Joyce P Yi-Frazier
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Michael Seid
Shared Decision-Making Among Caregivers and Health Care Providers of Youth with Type 1 Diabetes,2014,Lawrence M Dolan
Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma,2012,Eliene-Magda de-Assis
Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma,2012,Luiz-Gustavo-Garcia-Santos Pimenta
Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma,2012,Edson Costa-e-Silva
Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma,2012,Paulo-Eduardo-Alencar Souza
Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma,2012,Martinho-Campolina-Rebello Horta
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,A Muraro
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,I Agache
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,A Clark
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,A Sheikh
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,G Roberts
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,C A Akdis
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,L M Borrego
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,J Higgs
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,J O'B Hourihane
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,P Jorgensen
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,A Mazon
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,D Parmigiani
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,M Said
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,S Schnadt
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,H van Os-Medendorp
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,B J Vlieg-Boerstra
EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community,2014,M Wickman
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis,2014,Young-Mo Kim
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis,2014,Jeong-Seok Choi
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis,2014,Seong Bin Hong
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis,2014,In Young Hyun
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis,2014,Jae-Yol Lim
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Jeffrey R Johnson
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Ruth A Engelberg
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Elizabeth L Nielsen
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Erin K Kross
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Nicholas L Smith
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Julie C Hanada
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,Sean K Doll O'Mahoney
The Association of Spiritual Care Providers' Activities With Family Members' Satisfaction With Care After a Death in the ICU,2014,J Randall Curtis
Dietary shortcomings in children on a gluten-free diet,2010,K Ohlund
Dietary shortcomings in children on a gluten-free diet,2010,C Olsson
Dietary shortcomings in children on a gluten-free diet,2010,O Hernell
Dietary shortcomings in children on a gluten-free diet,2010,I Ohlund
SIU/ICUD Consultation on Urethral Strictures: Anterior urethra-lichen sclerosus,2013,Laurence Stewart
SIU/ICUD Consultation on Urethral Strictures: Anterior urethra-lichen sclerosus,2013,Kurt McCammon
SIU/ICUD Consultation on Urethral Strictures: Anterior urethra-lichen sclerosus,2013,Michael Metro
SIU/ICUD Consultation on Urethral Strictures: Anterior urethra-lichen sclerosus,2013,Ramon Virasoro
Beta-Alanine Supplementation Improves Jumping Power and Affects Severe-Intensity Performance in Professional Alpine Skiers,2014,Micah Gross
Beta-Alanine Supplementation Improves Jumping Power and Affects Severe-Intensity Performance in Professional Alpine Skiers,2014,Kathrin Bieri
Beta-Alanine Supplementation Improves Jumping Power and Affects Severe-Intensity Performance in Professional Alpine Skiers,2014,Hans Hoppeler
Beta-Alanine Supplementation Improves Jumping Power and Affects Severe-Intensity Performance in Professional Alpine Skiers,2014,Barbara Norman
Beta-Alanine Supplementation Improves Jumping Power and Affects Severe-Intensity Performance in Professional Alpine Skiers,2014,Michael Vogt
Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin,2013,Pedro Weslley Rosario
Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin,2013,Maria Regina Calsolari
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,Javier Gilabert-Juan
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,Emilio Varea
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,Ramón Guirado
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,José Miguel Blasco-Ibáñez
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,Carlos Crespo
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients,2012,Juan Nácher
Immunomodulation neuroprotection and remyelination - The fundamental therapeutic effects of glatiramer acetate: A critical review,2014,Rina Aharoni
Usefulness of the Cameron tracheostomy scoring system after oral tumor surgery],2014,J Benatar-Haserfaty
Usefulness of the Cameron tracheostomy scoring system after oral tumor surgery],2014,M Picón-Molina
Usefulness of the Cameron tracheostomy scoring system after oral tumor surgery],2014,D A Meléndez-Salinas
Usefulness of the Cameron tracheostomy scoring system after oral tumor surgery],2014,C Palacios-López
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Manuel Vázquez-Marrufo
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Alejandro Galvao-Carmona
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Javier J González-Rosa
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Antonio R Hidalgo-Muñoz
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Mónica Borges
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Juan Luis Ruiz-Peña
Neural correlates of alerting and orienting impairment in multiple sclerosis patients,2014,Guillermo Izquierdo
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Christopher Schneeweis
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Jianxing Qiu
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Bernhard Schnackenburg
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Alexander Berger
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Sebastian Kelle
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Eckart Fleck
Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease,2014,Rolf Gebker
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Masaaki Iigo
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,David B Alexander
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Jiegou Xu
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Mitsuru Futakuchi
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Masumi Suzui
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Takahiro Kozu
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Takayuki Akasu
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Daizo Saito
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Tadao Kakizoe
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Koji Yamauchi
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Fumiaki Abe
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Mitsunori Takase
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Kazunori Sekine
Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine,2014,Hiroyuki Tsuda
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Rita Lok-Hay Yim
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Juliana Tsz-Yan Lee
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Cora H Bow
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Björn Meij
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Victor Leung
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Kenneth M C Cheung
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Patrick Vavken
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics,2014,Dino Samartzis
Tractography delineates microstructural changes in the trigeminal nerve after focal radiosurgery for trigeminal neuralgia,2012,Mojgan Hodaie
Tractography delineates microstructural changes in the trigeminal nerve after focal radiosurgery for trigeminal neuralgia,2012,David Qixiang Chen
Tractography delineates microstructural changes in the trigeminal nerve after focal radiosurgery for trigeminal neuralgia,2012,Jessica Quan
Tractography delineates microstructural changes in the trigeminal nerve after focal radiosurgery for trigeminal neuralgia,2012,Normand Laperriere
Energy restriction and the prevention of breast cancer,2012,Michelle Harvie
Energy restriction and the prevention of breast cancer,2012,Anthony Howell
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Nadia Lago Costa
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Marize Campos Valadares
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Pedro Paulo Chaves Souza
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Elismauro Francisco Mendonça
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,José Carlos Oliveira
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Tarcíla Aparecida Silva
Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma,2012,Aline Carvalho Batista
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Alicia W Yang
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Jens H Jensen
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Caixia C Hu
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Ali Tabesh
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Maria F Falangola
Effect of cerebral spinal fluid suppression for diffusional kurtosis imaging,2012,Joseph A Helpern
Rationale for early treatment of polycystic kidney disease,2014,Jared J Grantham
Effects of body posture and exercise training on cardiorespiratory responses to exercise,2013,C J Ade
Effects of body posture and exercise training on cardiorespiratory responses to exercise,2013,R M Broxterman
Effects of body posture and exercise training on cardiorespiratory responses to exercise,2013,T J Barstow
Rates of fluid ingestion alter pacing but not thermoregulatory responses during prolonged exercise in hot and humid conditions with appropriate convective cooling,2008,J P Dugas
Rates of fluid ingestion alter pacing but not thermoregulatory responses during prolonged exercise in hot and humid conditions with appropriate convective cooling,2008,U Oosthuizen
Rates of fluid ingestion alter pacing but not thermoregulatory responses during prolonged exercise in hot and humid conditions with appropriate convective cooling,2008,R Tucker
Rates of fluid ingestion alter pacing but not thermoregulatory responses during prolonged exercise in hot and humid conditions with appropriate convective cooling,2008,T D Noakes
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Junjie Xiong
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Quentin M Nunes
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Chunlu Tan
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Nengwen Ke
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Yonghua Chen
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Weiming Hu
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Xubao Liu
Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients,2013,Gang Mai
Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway,2013,Hong-Jun Yuan
Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway,2013,Ke-Wang Sun
Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway,2013,Kun Yu
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Wiesław Marcol
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Wojciech Slusarczyk
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Marek Gzik
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Magdalena Larysz-Brysz
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Michał Bobrowski
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Beata Grynkiewicz-Bylina
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Paulina Rosicka
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Katarzyna Kalita
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Władysław Węglarz
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Jarosław J Barski
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Katarzyna Kotulska
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Krzysztof Labuzek
Air gun impactor--a novel model of graded white matter spinal cord injury in rodents,2012,Joanna Lewin-Kowalik
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,B Brurok
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,T Tørhaug
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,G Leivseth
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,T Karlsen
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,J Helgerud
Effect of leg vascular occlusion on arm cycling peak oxygen uptake in spinal cord-injured individuals,2011,J Hoff
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Sung-Woon Hong
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Hwon Heo
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Jeong-hwa Yang
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Maeum Han
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Dong-Hyun Kim
Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats,2013,Yunhee Kim Kwon
Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: secondary outcomes from a randomized controlled trial,2012,Louise Farrer
Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: secondary outcomes from a randomized controlled trial,2012,Helen Christensen
Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: secondary outcomes from a randomized controlled trial,2012,Kathleen M Griffiths
Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: secondary outcomes from a randomized controlled trial,2012,Andrew Mackinnon
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Joseph C Murray
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Dalal Aldeghaither
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Shangzi Wang
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Rochelle E Nasto
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Sandra A Jablonski
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Yong Tang
c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity (ADCC),2014,Louis M Weiner
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report,2013,Katrin Christina Sczesni
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report,2013,Reinhard Wiebringhaus
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report,2013,Lothar Heuser
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report,2013,Sabine Skodda
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report,2013,Jens Eyding
Thyroid metastasis of lobular breast carcinoma],2011,Nerea Egaña
Thyroid metastasis of lobular breast carcinoma],2011,Catalina Socias
Thyroid metastasis of lobular breast carcinoma],2011,Tomasso Matteucci
Thyroid metastasis of lobular breast carcinoma],2011,Ismene Bilbao
Thyroid metastasis of lobular breast carcinoma],2011,Mariano Alvarez-Coca
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Toby Maurer
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Lori K E Rodrigues
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Niloufar Ameli
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Nittaya Phanuphak
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Stephen J Gange
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Jack DeHovitz
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Audrey L French
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Marshall Glesby
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Carol Jordan
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Ann Khalsa
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women,2004,Nancy A Hessol
Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan,2008,Che-Chun Su
Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan,2008,Jian-An Chung
Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan,2008,Yun-Ying Hsu
Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan,2008,Su-Ju Huang
Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan,2008,Ie-Bin Lian
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Han B Man
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Hansung Kim
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Ho-Joong Kim
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Erik Robinson
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Wing Kam Liu
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Edward Kai-Hua Chow
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia,2013,Dean Ho
1H magnetic resonance spectroscopy in multiple sclerosis and related disorders,2013,Alex Rovira
1H magnetic resonance spectroscopy in multiple sclerosis and related disorders,2013,Juli Alonso
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,W-T Lee
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,C-C Huang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,K-C Chen
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,T-Y Wong
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,C-Y Ou
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,S-T Tsai
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,C-J Yen
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,S-Y Fang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,H-I Lo
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,Y-H Wu
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,W-T Hsueh
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,M-W Yang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,F-C Lin
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,J-R Hsiao
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,J-S Huang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,J-Y Chang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,K-Y Chang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,S-Y Wu
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,C-L Lin
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,Y-H Wang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,Y-L Weng
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,H-C Yang
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer,2014,Js Chang
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,J-B Chanson
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,J Lamy
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,F Rousseau
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,F Blanc
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,N Collongues
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,M Fleury
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,J-P Armspach
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,S Kremer
White matter volume is decreased in the brain of patients with neuromyelitis optica,2012,J de Seze
Unusual presentation of a metastatic tumor to the temporal bone: severe otalgia and facial paralysis,2014,Sung Ho Choi
Unusual presentation of a metastatic tumor to the temporal bone: severe otalgia and facial paralysis,2014,Il-Seok Park
Unusual presentation of a metastatic tumor to the temporal bone: severe otalgia and facial paralysis,2014,Young Bok Kim
Unusual presentation of a metastatic tumor to the temporal bone: severe otalgia and facial paralysis,2014,Seok Min Hong
Coupling inflammation with evo-devo,2012,María-Angeles Aller
Coupling inflammation with evo-devo,2012,Natalia Arias
Coupling inflammation with evo-devo,2012,Sherezade Fuentes-Julian
Coupling inflammation with evo-devo,2012,Alejandro Blazquez-Martinez
Coupling inflammation with evo-devo,2012,Salvador Argudo
Coupling inflammation with evo-devo,2012,Maria-Paz de Miguel
Coupling inflammation with evo-devo,2012,Jorge-Luis Arias
Coupling inflammation with evo-devo,2012,Jaime Arias
Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation,2012,Marc P Pusztaszeri
Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation,2012,Peter M Sadow
Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation,2012,William C Faquin
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Diane T Stephenson
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Sharon M O'Neill
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Sapna Narayan
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Aadhya Tiwari
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Elizabeth Arnold
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Harry D Samaroo
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Fu Du
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Robert H Ring
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Brian Campbell
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Mathew Pletcher
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Vidita A Vaidya
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis,2011,Daniel Morton
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Agnieszka Cudnoch-Jedrzejewska
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Ryszard Gomolka
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Ewa Szczepanska-Sadowska
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Katarzyna Czarzasta
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Robert Wrzesien
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,[Collective Name] LukaszKoperski
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Liana Puchalska
High fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague Dawley rats,2014,Agnieszka Wsol
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Nicolò Constantino Brembilla
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Elisa Montanari
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Marie-Elise Truchetet
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Elena Raschi
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Pierluigi Meroni
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts,2013,Carlo Chizzolini
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Roberta Galetti
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Alan Roger Santos-Silva
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Alberto Nogueira da Gama Antunes
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Fabio de Abreu Alves
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Marcio Ajudarte Lopes
Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients,2013,Mario Fernando de Goes
Peripheral primitive neuroectodermal tumor of the parotid gland in a child: A case report,2014,Xing Wang
Peripheral primitive neuroectodermal tumor of the parotid gland in a child: A case report,2014,Jian Meng
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial,2014,Roberto Gatti
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial,2014,Andrea Tettamanti
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial,2014,Simone Lambiase
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial,2014,Paolo Rossi
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial,2014,Mauro Comola
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,R D Newbould
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,R Nicholas
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,C L Thomas
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,R Quest
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,J S Z Lee
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,L Honeyfield
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,A Colasanti
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,O Malik
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,M Mattoscio
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,P M Matthews
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,M P Sormani
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,A D Waldman
Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis,2014,P A Muraro
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Monica Nizzardo
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Chiara Simone
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Federica Rizzo
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Margherita Ruggieri
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Sabrina Salani
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Giulietta Riboldi
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Irene Faravelli
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Chiara Zanetta
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Nereo Bresolin
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Giacomo P Comi
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model,2013,Stefania Corti
An atypical clinical presentation of renovascular hypertension,2014,Beniamino Pagliaro
An atypical clinical presentation of renovascular hypertension,2014,Giuliano Tocci
An atypical clinical presentation of renovascular hypertension,2014,Erika Pagannone
An atypical clinical presentation of renovascular hypertension,2014,M Beatrice Musumeci
An atypical clinical presentation of renovascular hypertension,2014,Marco Testa
An atypical clinical presentation of renovascular hypertension,2014,Isabella Sensini
An atypical clinical presentation of renovascular hypertension,2014,Camillo Autore
An atypical clinical presentation of renovascular hypertension,2014,Andrea Ferrucci
An atypical clinical presentation of renovascular hypertension,2014,Massimo Volpe
Opportunities for scientists to influence policy: when does radiation metrology matter in development of national policy?,2013,Bert M Coursey
Superior labrum anterior to posterior lesions of the shoulder: Diagnosis and arthroscopic management,2014,Nuri Aydin
Superior labrum anterior to posterior lesions of the shoulder: Diagnosis and arthroscopic management,2014,Evrim Sirin
Superior labrum anterior to posterior lesions of the shoulder: Diagnosis and arthroscopic management,2014,Alp Arya
Ror2 may be downregulated in oral squamous cell carcinoma,2013,Gangli Liu
Ror2 may be downregulated in oral squamous cell carcinoma,2013,Maria A Kukuruzinska
Ror2 may be downregulated in oral squamous cell carcinoma,2013,Xin Xu
Non-small cell lung cancer metastasis to the oral cavity: a case report,2014,Jb Olsen
Non-small cell lung cancer metastasis to the oral cavity: a case report,2014,F Sim
Non-small cell lung cancer metastasis to the oral cavity: a case report,2014,A Chandu
Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer],2012,Manuel Luque-Ramírez
Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer],2012,Joaquín Gómez Ramírez
Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer],2012,Andrea Azcárate Villalón
Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer],2012,Elena Martín Pérez
Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer],2012,Eduardo Larrañaga Barrera
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Wei-Te Wu
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Yu-Jen Lin
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Huei-Sheng Shiue
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Chung-Yi Li
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Perng-Jy Tsai
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Chun-Yuh Yang
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Saou-Hsing Liou
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos,2014,Trong-Neng Wu
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Martin Grimm
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Marcel Cetindis
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Max Lehmann
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Thorsten Biegner
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Adelheid Munz
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Peter Teriete
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Wiebke Kraut
Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?,2014,Siegmar Reinert
NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development,2013,Rosa Berga-Bolaños
NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development,2013,Maria Alberdi
NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development,2013,Maria Buxadé
NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development,2013,José Aramburu
NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development,2013,Cristina López-Rodríguez
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Daniel Hirschhorn-Cymerman
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Sadna Budhu
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Shigehisa Kitano
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Cailian Liu
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Feng Zhao
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Hong Zhong
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Alexander M Lesokhin
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Francesca Avogadri-Connors
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Jianda Yuan
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Yanyun Li
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Alan N Houghton
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Taha Merghoub
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype,2012,Jedd D Wolchok
Differential dendritic cell-mediated activation and functions of invariant NKT-cell subsets in oral cancer,2014,Ak Singh
Differential dendritic cell-mediated activation and functions of invariant NKT-cell subsets in oral cancer,2014,P Gaur
Differential dendritic cell-mediated activation and functions of invariant NKT-cell subsets in oral cancer,2014,Nk Shukla
Differential dendritic cell-mediated activation and functions of invariant NKT-cell subsets in oral cancer,2014,Sn Das
Do smartphone applications in healthcare require a governance and legal framework? It depends on the application!,2014,Esmita Charani
Do smartphone applications in healthcare require a governance and legal framework? It depends on the application!,2014,Enrique Castro-Sánchez
Do smartphone applications in healthcare require a governance and legal framework? It depends on the application!,2014,Luke S P Moore
Do smartphone applications in healthcare require a governance and legal framework? It depends on the application!,2014,Alison Holmes
Characteristics of Integrated Care Programmes and their Impact on Patient Benefit: A Discrete-Choice Experiment for Integrated Care Networks,2014,A C Mühlbacher
Characteristics of Integrated Care Programmes and their Impact on Patient Benefit: A Discrete-Choice Experiment for Integrated Care Networks,2014,S Bethge
Characteristics of Integrated Care Programmes and their Impact on Patient Benefit: A Discrete-Choice Experiment for Integrated Care Networks,2014,S Eble
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Timothy M Fernandes
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,William R Auger
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Peter F Fedullo
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Nick H Kim
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,David S Poch
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Michael M Madani
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Victor G Pretorius
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Stuart W Jamieson
Baseline Body Mass Index Does Not Significantly Affect Outcomes After Pulmonary Thromboendarterectomy,2014,Kim M Kerr
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Yuichiro Yano
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Shouichi Fujimoto
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Yuji Sato
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Tsuneo Konta
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Kunitoshi Iseki
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Chiho Iseki
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Toshiki Moriyama
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Kunihiro Yamagata
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Kazuhiko Tsuruya
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Ichiei Narita
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Masahide Kondo
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Kenjiro Kimura
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Koichi Asahi
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Issei Kurahashi
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Yasuo Ohashi
New-onset hypertension and risk for chronic kidney disease in the Japanese general population,2014,Tsuyoshi Watanabe
Molecular mechanisms of depression: perspectives on new treatment strategies,2013,Undine E Lang
Molecular mechanisms of depression: perspectives on new treatment strategies,2013,Stefan Borgwardt
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Weiqin Jiang
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Weibin Wang
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Fangfang Fu
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Xiaodong Teng
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Haohao Wang
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Haiyong Wang
A more sensitive platform for the detection of low-abundance BRAF(V⁶⁰⁰E) mutations,2012,Lisong Teng
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,J Nagarajah
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,J Farahati
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,R Görges
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,F Grabellus
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,A Bockisch
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules,2012,S-Y Sheu-Grabellus
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Nicolas Molnarfi
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Ulf Schulze-Topphoff
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Martin S Weber
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Juan C Patarroyo
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Thomas Prod'homme
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Michel Varrin-Doyer
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Aparna Shetty
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Christopher Linington
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Anthony J Slavin
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Juan Hidalgo
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Dieter E Jenne
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Hartmut Wekerle
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Raymond A Sobel
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Claude C A Bernard
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Mark J Shlomchik
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies,2013,Scott S Zamvil
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Keiji Tanimoto
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Tetsuya Hiraiwa
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Ranko Ibata
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Jungo Terasaki
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Akiko Soyama
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Takahiro Katsumata
Intravascular and intra-atrial extension of follicular thyroid carcinoma,2011,Toshiaki Hanafusa
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,M G Chon
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,J H Suk
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,K H Oh
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,K I Kim
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,Y J Kim
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,H G Lee
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,S M Kim
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,K I Cho
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,M K Kim
Influence of long-term statin use in type 2 diabetic patients on thyroid nodularity in iodine-sufficient area,2011,T I Kim
Adolescent brain maturation and smoking: What we know and where we're headed,2014,David M Lydon
Adolescent brain maturation and smoking: What we know and where we're headed,2014,Stephen J Wilson
Adolescent brain maturation and smoking: What we know and where we're headed,2014,Amanda Child
Adolescent brain maturation and smoking: What we know and where we're headed,2014,Charles F Geier
Sites of institutional racism in public health policy making in New Zealand,2014,Heather Came
Hypolipidemic and Antioxidant Activity of Enoki Mushrooms (Flammulina velutipes),2014,Ming-Yei Yeh
Hypolipidemic and Antioxidant Activity of Enoki Mushrooms (Flammulina velutipes),2014,Wen-Ching Ko
Hypolipidemic and Antioxidant Activity of Enoki Mushrooms (Flammulina velutipes),2014,Li-Yun Lin
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Ziyuan Xu
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Zhengyu Shen
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Linjun Shi
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Hongying Sun
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Wei Liu
Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus,2013,Zengtong Zhou
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Hrvoje Gasparovic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Tomislav Kopjar
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Milan Rados
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Alan Anticevic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Marko Rados
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Branko Malojcic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Visnja Ivancan
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Tea Fabijanic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Maja Cikes
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Davor Milicic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Vladimir Gasparovic
Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial,2014,Bojan Biocina
Obesity and diabetes: newer concepts in imaging,2013,Kavita Garg
Obesity and diabetes: newer concepts in imaging,2013,Samuel Chang
Obesity and diabetes: newer concepts in imaging,2013,Ann Scherzinger
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Esme Ekizoglu
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Erdem Tuzun
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Mark Woodhall
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Bethan Lang
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Leslie Jacobson
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Sema Icoz
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Nerses Bebek
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Candan Gurses
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Aysen Gokyigit
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Patrick Waters
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Angela Vincent
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes,2014,Betul Baykan
Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy,2011,Babak Hajhosseini
Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy,2011,Vahid Montazeri
Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy,2011,Lachin Hajhosseini
Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy,2011,Nariman Nezami
Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy,2011,Ramin E Beygui
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer,2010,Bruce G Robinson
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer,2010,Luis Paz-Ares
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer,2010,Annetta Krebs
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer,2010,James Vasselli
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer,2010,Robert Haddad
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Soo Young Chung
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Jae Seok Lee
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Hyebin Lee
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Sung Hee Park
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Soo Jin Kim
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma,2013,Han Suk Ryu
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis,2011,Yeo-Hoon Yoon
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis,2011,Hak Joon Kim
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis,2011,Jin Woo Lee
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis,2011,Jin Man Kim
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis,2011,Bon Seok Koo
Oral S-1 in advanced cutaneous squamous cell carcinoma,2014,Yukiko Teramoto
Oral S-1 in advanced cutaneous squamous cell carcinoma,2014,Yasuhiro Nakamura
Oral S-1 in advanced cutaneous squamous cell carcinoma,2014,Katsuhiro Yamada
Oral S-1 in advanced cutaneous squamous cell carcinoma,2014,Akifumi Yamamoto
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Yulong Zheng
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Weijia Fang
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Chenyu Mao
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Joing Qian
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Peng Zhao
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Xiaochen Zhang
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Haiping Jiang
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Yi Zheng
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study,2014,Nong Xu
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Kei Ishii
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Nan Liang
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Anna Oue
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Ai Hirasawa
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Kohei Sato
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Tomoko Sadamoto
Central command contributes to increased blood flow in the noncontracting muscle at the start of one-legged dynamic exercise in humans,2012,Kanji Matsukawa
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Altaf Mohammed
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Naveena B Janakiram
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Misty Brewer
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Rebekah L Ritchie
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Anuj Marya
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Stan Lightfoot
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Vernon E Steele
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling,2013,Chinthalapally V Rao
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Bryan McIver
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,M Regina Castro
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,John C Morris
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Victor Bernet
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Robert Smallridge
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Michael Henry
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Laura Kosok
An Independent Study of a Gene Expression Classifier (Afirma™) in the Evaluation of Cytologically Indeterminate Thyroid Nodules,2014,Honey Reddi
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Conrado Medici
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Claudio Varacchi
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Gabriel Gonzalez
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Aida Lemes
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Alfredo Cerisola
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Virginia Pedemonte
Unusual Case of Phenylketonuria With Atypical Brain Magnetic Resonance Imaging Findings,2012,Nenad Blau
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Jennifer L Gnerlich
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Katharine A Yao
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Philip S Fitchev
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Robert A Goldschmidt
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Michael C Bond
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Mona Cornwell
Peritumoral expression of adipokines and fatty acids in breast cancer,2013,Susan E Crawford
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Robin T Wilson
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,James D Bortner
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Alanna Roff
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Arunangshu Das
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Eric J Battaglioli
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,John P Richie
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Jill Barnholtz-Sloan
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Vernon M Chinchilli
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Arthur Berg
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Guodong Liu
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Anna C Salzberg
Genetic and environmental influences on plasma vitamin D-binding protein concentrations,2014,Karam El-Bayoumy
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,K Caeyenberghs
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,A Leemans
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,C De Decker
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,M Heitger
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,D Drijkoningen
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,C Vander Linden
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,S Sunaert
Brain connectivity and postural control in young traumatic brain injury patients: A diffusion MRI based network analysis,2012,S P Swinnen
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Sadaf Sadia Arain
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Tasneem Gul Kazi
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Jamshed Bashir Arain
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Hassan Imran Afridi
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Atif Gul Kazi
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Syeda Nasreen
Determination of nickel in blood and serum samples of oropharyngeal cancer patients consumed smokeless tobacco products by cloud point extraction coupled with flame atomic absorption spectrometry,2014,Kapil Dev Brahman
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Chun-Ta Liao
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Chuen Hsueh
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Li-Yu Lee
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Chien-Yu Lin
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Kang-Hsing Fan
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Hung-Ming Wang
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Shiang-Fu Huang
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,I-How Chen
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Chung-Jan Kang
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Shu-Hang Ng
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Chung-Kan Tsao
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Yu-Chen Huang
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy,2011,Tzu-Chen Yen
Physical therapists' clinical knowledge of multidisciplinary low back pain treatment guidelines,2014,Kenneth E Learman
Physical therapists' clinical knowledge of multidisciplinary low back pain treatment guidelines,2014,Alyson R Ellis
Physical therapists' clinical knowledge of multidisciplinary low back pain treatment guidelines,2014,Adam P Goode
Physical therapists' clinical knowledge of multidisciplinary low back pain treatment guidelines,2014,Christopher Showalter
Physical therapists' clinical knowledge of multidisciplinary low back pain treatment guidelines,2014,Chad E Cook
"Describing the complexity of systems: multivariable ""set complexity"" and the information basis of systems biology",2013,David J Galas
"Describing the complexity of systems: multivariable ""set complexity"" and the information basis of systems biology",2013,Nikita A Sakhanenko
"Describing the complexity of systems: multivariable ""set complexity"" and the information basis of systems biology",2013,Alexander Skupin
"Describing the complexity of systems: multivariable ""set complexity"" and the information basis of systems biology",2013,Tomasz Ignac
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma,2014,Daniel J Givens
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma,2014,Luke O Buchmann
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma,2014,Archana M Agarwal
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma,2014,Johannes F Grimmer
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma,2014,Jason P Hunt
Hemolysis as a rare but potentially life-threatening complication of hemodialysis: a case report,2014,Jenni Yoon
Hemolysis as a rare but potentially life-threatening complication of hemodialysis: a case report,2014,Sritika Thapa
Hemolysis as a rare but potentially life-threatening complication of hemodialysis: a case report,2014,Robert Dobbin Chow
Hemolysis as a rare but potentially life-threatening complication of hemodialysis: a case report,2014,Bernard G Jaar
Atopic diseases and related risk factors among Dutch adolescents,2006,Monique O M van de Ven
Atopic diseases and related risk factors among Dutch adolescents,2006,Regina J J M van den Eijnden
Atopic diseases and related risk factors among Dutch adolescents,2006,Rutger C M E Engels
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Diana Raedler
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Nikolaus Ballenberger
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Elisabeth Klucker
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Andreas Böck
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Ragna Otto
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Olivia Prazeres da Costa
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Otto Holst
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Thomas Illig
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Thorsten Buch
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Erika von Mutius
Identification of novel immune phenotypes for allergic and nonallergic childhood asthma,2014,Bianca Schaub
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells,2012,Alejandro Vazquez-Tello
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells,2012,Rabih Halwani
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells,2012,Qutayba Hamid
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells,2012,Saleh Al-Muhsen
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Michaela K Bode
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Päivi Lindholm
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Vesa Kiviniemi
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Irma Moilanen
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Hanna Ebeling
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Juha Veijola
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Jouko Miettunen
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Tuula Hurtig
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Tanja Nordström
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Tuomo Starck
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Jukka Remes
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Osmo Tervonen
DTI abnormalities in adults with past history of attention deficit hyperactivity disorder: a tract-based spatial statistics study,2014,Juha Nikkinen
Programming towards childhood obesity,2011,Patrick Tounian
Influence of obesity and bariatric surgery on the periodontal condition,2011,André Luiz Pataro
Influence of obesity and bariatric surgery on the periodontal condition,2011,Fernando Oliveira Costa
Influence of obesity and bariatric surgery on the periodontal condition,2011,Sheila Cavalca Cortelli
Influence of obesity and bariatric surgery on the periodontal condition,2011,José Roberto Cortelli
Influence of obesity and bariatric surgery on the periodontal condition,2011,Ana Carolina Dupim Souza
Influence of obesity and bariatric surgery on the periodontal condition,2011,Mauro Henrique Nogueira Guimarães Abreu
Influence of obesity and bariatric surgery on the periodontal condition,2011,Marcelo Gomes Girundi
Influence of obesity and bariatric surgery on the periodontal condition,2011,José Eustáquio Costa
Ebola Virus Disease,2014,Jill Jin
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Taeko Matsushima-Miyagi
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Koji Hatano
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Motonari Nomura
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Liu Li-Wen
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Tomoyuki Nishikawa
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Kotaro Saga
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Takashi Shimbo
TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles,2012,Yasufumi Kaneda
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,B Marin
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,B Hamidou
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,P Couratier
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,M Nicol
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,A Delzor
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,M Raymondeau
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,M Druet-Cabanac
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,G Lautrette
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,F Boumediene
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,P M Preux
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register),2014,[Collective Name] French register of ALS in Limousin (FRALim)
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Shinji Yamamoto
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Mari Gotoh
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Yuuki Kawamura
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Kota Yamashina
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Sosuke Yagishita
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Takeo Awaji
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Motomu Tanaka
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Kei Maruyama
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Kimiko Murakami-Murofushi
Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice,2014,Keisuke Yoshikawa
Meta-analysis of prevalence,2013,Jan J Barendregt
Meta-analysis of prevalence,2013,Suhail A Doi
Meta-analysis of prevalence,2013,Yong Yi Lee
Meta-analysis of prevalence,2013,Rosana E Norman
Meta-analysis of prevalence,2013,Theo Vos
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Andrew P Stein
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Sandeep Saha
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Cheng Z Liu
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Gregory K Hartig
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Paul F Lambert
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts,2014,Randall J Kimple
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Cielito C Reyes-Gibby
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Karen O Anderson
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Kelly W Merriman
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Knox H Todd
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Sanjay S Shete
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival,2014,Ehab Y Hanna
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Xuezheng Sun
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Patricia Casbas-Hernandez
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Carol Bigelow
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Liza Makowski
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,D Joseph Jerry
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Sallie Smith Schneider
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression,2011,Melissa A Troester
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Doron D Sommer
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Stephanie Hoffbauer
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Michael Au
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Leigh J Sowerby
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Michael K Gupta
Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study,2014,Smriti Nayan
When does transformational leadership enhance employee proactive behavior? The role of autonomy and role breadth self-efficacy,2011,Deanne N Den Hartog
When does transformational leadership enhance employee proactive behavior? The role of autonomy and role breadth self-efficacy,2011,Frank D Belschak
Renal sympathetic denervation for treatment of resistant hypertension: Egyptian experience,2014,Mohamed Hamza
Renal sympathetic denervation for treatment of resistant hypertension: Egyptian experience,2014,Hazem Khamis
Regulation of TLR2 and NLRP3 in Primary Murine Renal Tubular Epithelial Cells,2014,Sashi G Kasimsetty
Regulation of TLR2 and NLRP3 in Primary Murine Renal Tubular Epithelial Cells,2014,Sean E DeWolf
Regulation of TLR2 and NLRP3 in Primary Murine Renal Tubular Epithelial Cells,2014,Alana A Shigeoka
Regulation of TLR2 and NLRP3 in Primary Murine Renal Tubular Epithelial Cells,2014,Dianne B McKay
Calculation of oxygen uptake efficiency slope based on heart rate reserve end-points in healthy elderly subjects,2007,Silvia Pogliaghi
Calculation of oxygen uptake efficiency slope based on heart rate reserve end-points in healthy elderly subjects,2007,Elisa Dussin
Calculation of oxygen uptake efficiency slope based on heart rate reserve end-points in healthy elderly subjects,2007,Cantor Tarperi
Calculation of oxygen uptake efficiency slope based on heart rate reserve end-points in healthy elderly subjects,2007,Antonio Cevese
Calculation of oxygen uptake efficiency slope based on heart rate reserve end-points in healthy elderly subjects,2007,Federico Schena
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Yung-Yang Liu
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Chi-Huei Chiang
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Chiao-Hui Chuang
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Shiou-Ling Liu
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Yi-Han Jheng
Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs,2014,Jay H Ryu
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Xiaojuan Guo
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Zhiqun Wang
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Kuncheng Li
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Ziyi Li
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Zhigang Qi
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Zhen Jin
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Li Yao
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease,2009,Kewei Chen
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Lauren Staggs
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Meagan Peek
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Gary Southard
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Ed Gracely
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Sidney Baxendale
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,Keith P Cross
Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems,2012,In K Kim
Endometrial cancer in young patients: report of 17 cases],2013,Anna Dudnyikova
Endometrial cancer in young patients: report of 17 cases],2013,Katalin Horváth
Endometrial cancer in young patients: report of 17 cases],2013,Imre Pete
Severe aortic stenosis: Forgotten associations,2014,Ana Rita Godinho
Severe aortic stenosis: Forgotten associations,2014,Sandra Amorim
Severe aortic stenosis: Forgotten associations,2014,Manuel Campelo
Severe aortic stenosis: Forgotten associations,2014,Elisabete Martins
Severe aortic stenosis: Forgotten associations,2014,Elisa Lopez Rodriguez
Severe aortic stenosis: Forgotten associations,2014,Rosa Coelho
Severe aortic stenosis: Forgotten associations,2014,Guilherme Macedo
Severe aortic stenosis: Forgotten associations,2014,Maria Júlia Maciel
Two-week normobaric intermittent hypoxia exposures enhance oxyhemoglobin equilibrium and cardiac responses during hypoxemia,2014,Peizhen Zhang
Two-week normobaric intermittent hypoxia exposures enhance oxyhemoglobin equilibrium and cardiac responses during hypoxemia,2014,H Fred Downey
Two-week normobaric intermittent hypoxia exposures enhance oxyhemoglobin equilibrium and cardiac responses during hypoxemia,2014,Shande Chen
Two-week normobaric intermittent hypoxia exposures enhance oxyhemoglobin equilibrium and cardiac responses during hypoxemia,2014,Xiangrong Shi
Advances in clinical cardiology,2014,Andrew H McNeice
Advances in clinical cardiology,2014,Neil M McAleavey
Advances in clinical cardiology,2014,Ian B A Menown
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer,2014,Jingshuang Yu
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer,2014,Furong Xie
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer,2014,Xin Bao
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer,2014,Wantao Chen
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer,2014,Qin Xu
Health-related quality of life of patients treated with primary chemoradiotherapy for oral cavity squamous cell carcinoma: a comparison with surgery,2013,Anthony K Crombie
Health-related quality of life of patients treated with primary chemoradiotherapy for oral cavity squamous cell carcinoma: a comparison with surgery,2013,Camile S Farah
Health-related quality of life of patients treated with primary chemoradiotherapy for oral cavity squamous cell carcinoma: a comparison with surgery,2013,Martin D Batstone
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Marc Remacle
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Nayla Matar
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Georges Lawson
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Vincent Bachy
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Monique Delos
Combining a new CO2 laser wave guide with transoral robotic surgery: a feasibility study on four patients with malignant tumors,2011,Marie-Cécile Nollevaux
Prebiotics in infants for prevention of allergy,2013,David A Osborn
Prebiotics in infants for prevention of allergy,2013,John K H Sinn
Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population,2012,Myrian Camara Brew
Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population,2012,Rita Trapp
Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population,2012,Juliana Balbinot Hilgert
Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population,2012,Virgínia Minghelli Schmitt
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Muhammad M Hammami
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Eman A Al-Gaai
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Yussuf Al-Jawarneh
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Hala Amer
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Muhammad B Hammami
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Abdullah Eissa
Patients' perceived purpose of clinical informed consent: Mill's individual autonomy model is preferred,2014,Mohammad Al Qadire
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Jia Huang
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Renmin Ni
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Xiaoli Chen
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Lili Huang
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Yaqin Mo
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China,2010,Dongzi Yang
Increased optic nerve radiosensitivity following optic neuritis,2014,Nicolae Sanda
Increased optic nerve radiosensitivity following optic neuritis,2014,Francoise Heran
Increased optic nerve radiosensitivity following optic neuritis,2014,Nicolas Daly-Schveitzer
Increased optic nerve radiosensitivity following optic neuritis,2014,Jose-Alain Sahel
Increased optic nerve radiosensitivity following optic neuritis,2014,Avinoam Bezalel Safran
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Ming-Xu Xia
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Xu Ding
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Jun Qi
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Jun Gu
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Gang Hu
Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain,2014,Xiu-Lan Sun
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Masayuki Nakano
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Akio Nakashima
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Taiki Nagano
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Shintaro Ishikawa
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Ushio Kikkawa
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 protein,2013,Shinji Kamada
The cadence and water temperature effect on physiological responses during water cycling,2013,Flávia Yazigi
The cadence and water temperature effect on physiological responses during water cycling,2013,Stephanie Pinto
The cadence and water temperature effect on physiological responses during water cycling,2013,Juan Colado
The cadence and water temperature effect on physiological responses during water cycling,2013,Yolanda Escalante
The cadence and water temperature effect on physiological responses during water cycling,2013,Paulo A S Armada-da-Silva
The cadence and water temperature effect on physiological responses during water cycling,2013,Roxana Brasil
The cadence and water temperature effect on physiological responses during water cycling,2013,Francisco Alves
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,E Margat
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,S Dargère
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,C Daurel
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,M Fines-Guyon
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,J Michon
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,R Verdon
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis],2013,V Cattoir
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Shafali Spurling Jeste
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Joyce Y Wu
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Damla Senturk
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Kandice Varcin
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Jordan Ko
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Brigid McCarthy
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Christina Shimizu
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Kira Dies
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Vanessa Vogel-Farley
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Mustafa Sahin
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex,2014,Charles A Nelson
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Dong-Ho Geum
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Young-Chea Roh
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Sang-Yong Yoon
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Hyo-Geon Kim
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Jung-Han Lee
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Jae-Min Song
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Jae-Yeol Lee
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Dae-Seok Hwang
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Yong-Deok Kim
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Sang-Hun Shin
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,In-Kyo Chung
The impact factors on 5-year survival rate in patients operated with oral cancer,2013,Uk-Kyu Kim
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Shannon M Conroy
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Gertraud Maskarinec
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Lynne R Wilkens
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Kami K White
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Brian E Henderson
Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study,2011,Laurence N Kolonel
Specific patient-related prognostic factors for rotator cuff repair: a systematic review,2014,Frederik O Lambers Heerspink
Specific patient-related prognostic factors for rotator cuff repair: a systematic review,2014,Oscar Dorrestijn
Specific patient-related prognostic factors for rotator cuff repair: a systematic review,2014,Jos J A M van Raay
Specific patient-related prognostic factors for rotator cuff repair: a systematic review,2014,Ron L Diercks
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy,2013,Punnada Athibovonsuk
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy,2013,Tarinee Manchana
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy,2013,Nakarin Sirisabya
The challenge of doing what is right in renal transplantation: balancing equity and utility,2008,Aisling E Courtney
The challenge of doing what is right in renal transplantation: balancing equity and utility,2008,Alexander P Maxwell
Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies,2014,Byung Ju Kang
Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies,2014,Sang-Do Lee
Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies,2014,Yeon-Mok Oh
Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies,2014,Jae Seung Lee
Dual perforator propeller internal mammary artery perforator (IMAP) flap for soft-tissue defect of the contralateral clavicular area,2012,Eva Meia Rüegg
Dual perforator propeller internal mammary artery perforator (IMAP) flap for soft-tissue defect of the contralateral clavicular area,2012,Laurent Lantieri
Dual perforator propeller internal mammary artery perforator (IMAP) flap for soft-tissue defect of the contralateral clavicular area,2012,Alexandre Marchac
A new naturally derived photosensitizer and its phototoxicity on head and neck cancer cells,2011,Siang Hui Lim
A new naturally derived photosensitizer and its phototoxicity on head and neck cancer cells,2011,Hong Boon Lee
A new naturally derived photosensitizer and its phototoxicity on head and neck cancer cells,2011,Anthony Siong Hock Ho
Current and advancing treatments for pulmonary arterial hypertension in childhood,2014,Willemijn M H Zijlstra
Current and advancing treatments for pulmonary arterial hypertension in childhood,2014,Mark-Jan Ploegstra
Current and advancing treatments for pulmonary arterial hypertension in childhood,2014,Rolf M F Berger
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Vera Oppedijk
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Ate van der Gaast
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Jan J B van Lanschot
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Pieter van Hagen
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Rob van Os
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Caroline M van Rij
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Maurice J van der Sangen
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Jannet C Beukema
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Heidi Rütten
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Patty H Spruit
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Janny G Reinders
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Dick J Richel
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Mark I van Berge Henegouwen
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials,2014,Maarten C C M Hulshof
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,D Samocha-Bonet
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,V D Dixit
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,C R Kahn
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,R L Leibel
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,X Lin
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,M Nieuwdorp
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,K H Pietiläinen
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,R Rabasa-Lhoret
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,M Roden
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,P E Scherer
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,S Klein
Metabolically healthy and unhealthy obese - the 2013 Stock Conference report,2014,E Ravussin
Demographic factors determining termination of pregnancy following the detection of lethal fetal malignancy,2013,Anna Michalik
Demographic factors determining termination of pregnancy following the detection of lethal fetal malignancy,2013,Krzysztof Preis
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Alexander Frizell Santillo
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Johanna Mårtensson
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Olof Lindberg
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Markus Nilsson
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Amir Manzouri
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Maria Landqvist Waldö
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Danielle van Westen
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Lars-Olof Wahlund
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Jimmy Lätt
Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia,2013,Christer Nilsson
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Ralf Conrad
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Yang Ji
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Matthias Noll
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Melanie Klose
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Peter Claus
Response of the methanogenic microbial communities in Amazonian oxbow lake sediments to desiccation stress,2013,Alex Enrich-Prast
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Takashi Naohara
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Hiromichi Aono
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Tsunehiro Maehara
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Hideyuki Hirazawa
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Shinya Matsutomo
Heat generation and transfer behaviors of ti-coated carbon steel rod adaptable for ablation therapy of oral cancer,2013,Yuji Watanabe
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Kourosh Rezania
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Ori Gottlieb
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Amy Guralnick
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Vivek Prachand
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Bobbie J Sweitzer
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Wickii Vigneswaran
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Steven R White
Venous thromboembolism after Diaphragm Pacing in amyotrophic lateral sclerosis,2014,Raymond P Roos
Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia,2014,Julia Tünsmeyer
Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia,2014,Klaus Hopster
Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia,2014,Karsten Feige
Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia,2014,Sabine Br Kästner
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Donghui Li
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Hongwei Tang
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Manal M Hassan
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Elizabeth A Holly
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Paige M Bracci
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies,2010,Debra T Silverman
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Rebecca S Rudicell
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,James Holland Jones
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Emily E Wroblewski
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Gerald H Learn
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Yingying Li
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Joel D Robertson
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Elizabeth Greengrass
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Falk Grossmann
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Shadrack Kamenya
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Lilian Pintea
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Deus C Mjungu
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Elizabeth V Lonsdorf
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Anna Mosser
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Clarence Lehman
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,D Anthony Collins
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Brandon F Keele
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Jane Goodall
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Beatrice H Hahn
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Anne E Pusey
Impact of simian immunodeficiency virus infection on chimpanzee population dynamics,2010,Michael L Wilson
Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome,2014,J Wang
Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome,2014,Y-M Yang
Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome,2014,J Zhu
IFITMs restrict the replication of multiple pathogenic viruses,2013,Jill M Perreira
IFITMs restrict the replication of multiple pathogenic viruses,2013,Christopher R Chin
IFITMs restrict the replication of multiple pathogenic viruses,2013,Eric M Feeley
IFITMs restrict the replication of multiple pathogenic viruses,2013,Abraham L Brass
Remediation of at-risk medical students: theory in action,2013,Kalman A Winston
Remediation of at-risk medical students: theory in action,2013,Cees P M Van Der Vleuten
Remediation of at-risk medical students: theory in action,2013,Albert J J A Scherpbier
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Teruki Miyake
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Teru Kumagi
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Shinya Furukawa
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Masashi Hirooka
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Keitarou Kawasaki
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Mitsuhito Koizumi
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Yasuhiko Todo
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Shin Yamamoto
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Masanori Abe
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Kohichiro Kitai
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Bunzo Matsuura
Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: a community-based study,2014,Yoichi Hiasa
Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension,2014,Maria Alicia Carrillo-Sepulveda
Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension,2014,Henry L Keen
Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension,2014,Deborah R Davis
Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension,2014,Justin L Grobe
Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension,2014,Curt D Sigmund
Metformin is associated with improved survival in endometrial cancer,2013,Emily M Ko
Metformin is associated with improved survival in endometrial cancer,2013,Paige Walter
Metformin is associated with improved survival in endometrial cancer,2013,Amanda Jackson
Metformin is associated with improved survival in endometrial cancer,2013,Leslie Clark
Metformin is associated with improved survival in endometrial cancer,2013,Jason Franasiak
Metformin is associated with improved survival in endometrial cancer,2013,Corey Bolac
Metformin is associated with improved survival in endometrial cancer,2013,Laura J Havrilesky
Metformin is associated with improved survival in endometrial cancer,2013,Angeles Alvarez Secord
Metformin is associated with improved survival in endometrial cancer,2013,Dominic T Moore
Metformin is associated with improved survival in endometrial cancer,2013,Paola A Gehrig
Metformin is associated with improved survival in endometrial cancer,2013,Victoria Bae-Jump
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Pinki Surana
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Shan Tang
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Marilyn McDougall
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Cheuk Yan William Tong
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Esse Menson
Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review,2011,Ming Lim
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Tomoko Ota
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Hirofumi Jono
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Kazutoshi Ota
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Satoru Shinriki
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Mitsuharu Ueda
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Takanao Sueyoshi
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Ken Nakatani
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Yukihiro Hiraishi
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Takeshi Wada
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Shigeyuki Fujita
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Konen Obayashi
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Masanori Shinohara
Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma,2012,Yukio Ando
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India,2014,Manish Mittal
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India,2014,Garima Mittal
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness,2013,Dobromir Dimitrov
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness,2013,Marie-Claude Boily
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness,2013,Elizabeth R Brown
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness,2013,Timothy B Hallett
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Cristina Romei
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Laura Fugazzola
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Efisio Puxeddu
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Francesco Frasca
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,David Viola
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Marina Muzza
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Sonia Moretti
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Maria Luisa Nicolosi
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Carlotta Giani
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Valentina Cirello
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Nicola Avenia
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Stefania Rossi
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Paolo Vitti
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Aldo Pinchera
Modifications in the papillary thyroid cancer gene profile over the last 15 years,2012,Rossella Elisei
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Ara Cho
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Hong-Seok Jang
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Yoon Seok Roh
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Hee Jin Park
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,A F S M Talha
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Seung-Young So
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Chae Woong Lim
Detrimental effects of cement mortar and fly ash mortar on asthma progression,2013,Bumseok Kim
Simplified topical anesthesia protocol for ambulatory cataract surgery: Safety and patient and surgeon satisfaction],2014,B Batta
Simplified topical anesthesia protocol for ambulatory cataract surgery: Safety and patient and surgeon satisfaction],2014,T Fuchs-Buder
Simplified topical anesthesia protocol for ambulatory cataract surgery: Safety and patient and surgeon satisfaction],2014,F Tréchot
Simplified topical anesthesia protocol for ambulatory cataract surgery: Safety and patient and surgeon satisfaction],2014,K Angioi
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Trevor S Ferguson
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Marshall K Tulloch-Reid
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Novie O M Younger
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Jennifer M Knight-Madden
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Maureen Samms-Vaughan
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Deanna Ashley
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Jan Van den Broeck
Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study,2010,Rainford J Wilks
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,David Price
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Mike Thomas
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,John Haughney
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Richard A Lewis
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Anne Burden
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Julie von Ziegenweidt
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Alison Chisholm
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Elizabeth V Hillyer
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma,2013,Christopher J Corrigan
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method,2010,Yohei Kurosaki
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method,2010,Allen Grolla
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method,2010,Aiko Fukuma
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method,2010,Heinz Feldmann
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method,2010,Jiro Yasuda
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,C Tur
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,Z Khaleeli
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,O Ciccarelli
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,D R Altmann
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,M Cercignani
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,D H Miller
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS,2010,A J Thompson
Cytokine release assays: current practices and future directions,2014,D Finco
Cytokine release assays: current practices and future directions,2014,C Grimaldi
Cytokine release assays: current practices and future directions,2014,M Fort
Cytokine release assays: current practices and future directions,2014,M Walker
Cytokine release assays: current practices and future directions,2014,A Kiessling
Cytokine release assays: current practices and future directions,2014,B Wolf
Cytokine release assays: current practices and future directions,2014,T Salcedo
Cytokine release assays: current practices and future directions,2014,R Faggioni
Cytokine release assays: current practices and future directions,2014,A Schneider
Cytokine release assays: current practices and future directions,2014,A Ibraghimov
Cytokine release assays: current practices and future directions,2014,S Scesney
Cytokine release assays: current practices and future directions,2014,D Serna
Cytokine release assays: current practices and future directions,2014,R Prell
Cytokine release assays: current practices and future directions,2014,R Stebbings
Cytokine release assays: current practices and future directions,2014,P K Narayanan
Resistance training exercise program for intervention to enhance gait function in elderly chronically ill patients: multivariate multiscale entropy for center of pressure signal analysis,2014,Ming-Shu Chen
Resistance training exercise program for intervention to enhance gait function in elderly chronically ill patients: multivariate multiscale entropy for center of pressure signal analysis,2014,Bernard C Jiang
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Rajendra H Mehta
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Cynthia M Westerhout
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Yinggan Zheng
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Robert P Giugliano
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Kurt Huber
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Dorairaj Prabhakaran
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Robert A Harrington
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Kristin L Newby
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,Paul W Armstrong
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes,2014,[Collective Name] EARLY ACS Investigators
Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?,2014,C Raina MacIntyre
Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?,2014,Abrar Ahmad Chughtai
Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?,2014,Holly Seale
Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?,2014,Guy A Richards
Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?,2014,Patricia M Davidson
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Aikaterini Xekardaki
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Micaela Santos
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Patrick Hof
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Eniko Kövari
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Constantin Bouras
Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden,2012,Panteleimon Giannakopoulos
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major,2009,Kallistheni Farmaki
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major,2009,Ioanna Tzoumari
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major,2009,Christina Pappa
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major,2009,Giorgos Chouliaras
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major,2009,Vasilios Berdoukas
Oral mucosal lesions: findings from the Australian National Survey of Adult Oral Health,2014,L G Do
Oral mucosal lesions: findings from the Australian National Survey of Adult Oral Health,2014,A J Spencer
Oral mucosal lesions: findings from the Australian National Survey of Adult Oral Health,2014,F Dost
Oral mucosal lesions: findings from the Australian National Survey of Adult Oral Health,2014,C S Farah
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Josef S Smolen
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Robert Landewé
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Ferdinand C Breedveld
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Maya Buch
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Gerd Burmester
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Maxime Dougados
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Paul Emery
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Cécile Gaujoux-Viala
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Laure Gossec
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Jackie Nam
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Sofia Ramiro
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Kevin Winthrop
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Maarten de Wit
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Daniel Aletaha
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Neil Betteridge
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Johannes W J Bijlsma
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Maarten Boers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Frank Buttgereit
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Bernard Combe
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Maurizio Cutolo
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Nemanja Damjanov
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Johanna M W Hazes
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Marios Kouloumas
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Tore K Kvien
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Xavier Mariette
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Karel Pavelka
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Piet L C M van Riel
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Andrea Rubbert-Roth
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Marieke Scholte-Voshaar
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,David L Scott
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Tuulikki Sokka-Isler
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,John B Wong
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update,2013,Désirée van der Heijde
Emergency department noise: mental activation or mental stress?,2014,Lindy-Lee Folscher
Emergency department noise: mental activation or mental stress?,2014,Lara Nicole Goldstein
Emergency department noise: mental activation or mental stress?,2014,Mike Wells
Emergency department noise: mental activation or mental stress?,2014,David Rees
Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel,2011,Sang Min Lee
Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel,2011,Jong Seong Ahn
Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel,2011,Chang Suk Noh
Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel,2011,Sei Won Lee
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Karsten Mueller
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Alfred Anwander
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Harald E Möller
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Annette Horstmann
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Jöran Lepsien
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Franziska Busse
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Siawoosh Mohammadi
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Matthias L Schroeter
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Michael Stumvoll
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Arno Villringer
Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging,2011,Burkhard Pleger
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,Michael Bauer
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,Rhonda Nay
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,Laura Tarzia
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,Deirdre Fetherstonhaugh
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,David Wellman
'We need to know what's going on': Views of family members toward the sexual expression of people with dementia in residential aged care,2013,Elizabeth Beattie
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Michael J O'Connell
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Linda H Colangelo
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Robert W Beart
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Nicholas J Petrelli
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Carmen J Allegra
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Saima Sharif
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Henry C Pitot
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Anthony F Shields
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Jerome C Landry
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,David P Ryan
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,David S Parda
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Mohammed Mohiuddin
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Amit Arora
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Lisa S Evans
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Nathan Bahary
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Gamini S Soori
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Janice Eakle
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,John M Robertson
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Dennis F Moore
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Michael R Mullane
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Benjamin T Marchello
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Patrick J Ward
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Timothy F Wozniak
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Mark S Roh
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Greg Yothers
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04,2014,Norman Wolmark
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,A E Anderson
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,K G Flores
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,W Boonyasiriwat
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,A Gammon
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,W Kohlmann
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,W C Birmingham
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,M D Schwartz
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,J Samadder
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,K Boucher
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk,2014,A Y Kinney
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,Wei Ni
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,Stephanie W Watts
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,Michael Ng
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,Songcang Chen
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,Denis J Glenn
Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function,2014,David G Gardner
Physician pushes for improved Ebola care,2014,Miriam Shuchman
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Soichi Takiguchi
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Natsuki Korenaga
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Kazuko Inoue
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Erika Sugi
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Yasufumi Kataoka
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Kimihiko Matsusue
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Koujiro Futagami
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Yin-Ji Li
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Toshio Kukita
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Norihiro Teramoto
Involvement of CXCL14 in osteolytic bone metastasis from lung cancer,2014,Haruo Iguchi
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Rafael Gabriel
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Carlos Brotons
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,M José Tormo
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Antonio Segura
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Fernando Rigo
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Roberto Elosua
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Julio A Carbayo
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Diana Gavrila
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Irene Moral
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Jaakko Tuomilehto
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,Javier Muñiz
The ERICE-score: the New Native Cardiovascular Score for the Low-risk and Aged Mediterranean Population of Spain,2014,[Collective Name] on behalf of the ERICE study group
Predictors of size for gestational age in St. Louis City and County,2014,Pamela K Xaverius
Predictors of size for gestational age in St. Louis City and County,2014,Joanne Salas
Predictors of size for gestational age in St. Louis City and County,2014,Candice L Woolfolk
Predictors of size for gestational age in St. Louis City and County,2014,Frances Leung
Predictors of size for gestational age in St. Louis City and County,2014,Jessica Yuan
Predictors of size for gestational age in St. Louis City and County,2014,Jen Jen Chang
Differential activation of proapoptotic molecules between mouse and rat models of distal motor trigeminal denervation,2011,Shiori Harada
Differential activation of proapoptotic molecules between mouse and rat models of distal motor trigeminal denervation,2011,Satoshi O Suzuki
Differential activation of proapoptotic molecules between mouse and rat models of distal motor trigeminal denervation,2011,Yoshihiro Seki
Differential activation of proapoptotic molecules between mouse and rat models of distal motor trigeminal denervation,2011,Seiji Nakamura
Differential activation of proapoptotic molecules between mouse and rat models of distal motor trigeminal denervation,2011,Toru Iwaki
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Gillian E Walker
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Roberta Ricotti
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Marta Roccio
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Stefania Moia
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Simonetta Bellone
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Flavia Prodam
Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions,2014,Gianni Bona
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Dirk Rades
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Nina D Seibold
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Maximilian P Gebhard
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Frank Noack
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Steven E Schild
Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN),2011,Christoph Thorns
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Dafnis Batalle
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Emma Muñoz-Moreno
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Ariadna Arbat-Plana
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Miriam Illa
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Francesc Figueras
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Elisenda Eixarch
Long-term reorganization of structural brain networks in a rabbit model of intrauterine growth restriction,2014,Eduard Gratacos
Automatic commissioning of a GPU-based Monte Carlo radiation dose calculation code for photon radiotherapy,2014,Zhen Tian
Automatic commissioning of a GPU-based Monte Carlo radiation dose calculation code for photon radiotherapy,2014,Yan Jiang Graves
Automatic commissioning of a GPU-based Monte Carlo radiation dose calculation code for photon radiotherapy,2014,Xun Jia
Automatic commissioning of a GPU-based Monte Carlo radiation dose calculation code for photon radiotherapy,2014,Steve B Jiang
Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients,2014,Alexander J Antoniou
Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients,2014,Charles Marcus
Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients,2014,Abdel K Tahari
Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients,2014,Richard L Wahl
Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients,2014,Rathan M Subramaniam
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Qiong-wen Zhang
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Lei Liu
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Chang-yang Gong
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Hua-shan Shi
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Yun-hui Zeng
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Xiao-ze Wang
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Yu-wei Zhao
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature,2012,Yu-quan Wei
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Rajesh Kumar
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Tiffany T Pham
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Paul M Macey
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Mary A Woo
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Frisca L Yan-Go
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea,2014,Ronald M Harper
Joint probability of statistical success of multiple phase III trials,2013,Jianliang Zhang
Joint probability of statistical success of multiple phase III trials,2013,Jenny J Zhang
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Zivota Selaković
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Dejan Opsenica
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Brett Eaton
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Cary Retterer
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Sina Bavari
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,James C Burnett
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Bogdan A Solaja
A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor,2012,Rekha G Panchal
Controversies in the treatment of early stage endometrial carcinoma,2012,Joshua Z Press
Controversies in the treatment of early stage endometrial carcinoma,2012,Walter H Gotlieb
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Erol Aksoy
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Halit Eren Taskin
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Shamil Aliyev
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Jamie Mitchell
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Allan Siperstein
Robotic versus laparoscopic adrenalectomy in obese patients,2012,Eren Berber
Effect of paternal diabetes on pre-diabetic phenotypes in adult offspring,2010,Adela Penesova
Effect of paternal diabetes on pre-diabetic phenotypes in adult offspring,2010,Joy C Bunt
Effect of paternal diabetes on pre-diabetic phenotypes in adult offspring,2010,Clifton Bogardus
Effect of paternal diabetes on pre-diabetic phenotypes in adult offspring,2010,Jonathan Krakoff
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Alejandro Rios
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Jianing He
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Gerald N Glickman
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Robert Spears
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Emet D Schneiderman
Evaluation of photodynamic therapy using a light-emitting diode lamp against Enterococcus faecalis in extracted human teeth,2011,Allen L Honeyman
Sleep disorders in multiple sclerosis and their relationship to fatigue,2013,Christian Veauthier
Sleep disorders in multiple sclerosis and their relationship to fatigue,2013,Friedemann Paul
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Ursula Nemec
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Stefan F Nemec
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Clemens Novotny
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Michael Weber
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Christian Czerny
Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy,2012,Christian R Krestan
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Concetto Regalbuto
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Rosario Le Moli
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Vincenzo Muscia
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Marco Russo
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Riccardo Vigneri
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule,2011,Vincenzo Pezzino
High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study,2013,Johannes Dorst
High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study,2013,Joschka Cypionka
High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study,2013,Albert C Ludolph
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Twan van den Beucken
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Elizabeth Koch
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Kenneth Chu
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Rajesha Rupaimoole
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Peggy Prickaerts
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Michiel Adriaens
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Jan Willem Voncken
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Adrian L Harris
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Francesca M Buffa
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Syed Haider
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Maud H W Starmans
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Cindy Q Yao
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Mircea Ivan
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Cristina Ivan
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Chad V Pecot
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Paul C Boutros
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Anil K Sood
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Marianne Koritzinsky
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER,2014,Bradly G Wouters
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Shirui Zheng
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Zhiyuan Ma
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Jianfeng Ye
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Guangfa Wang
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Ruwei Wang
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Hui Zhou
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Su Zeng
Determination of three triterpene alcohols in rat plasma after oral administration of pollen of Brassica campestris based on the utilization of fetal bovine serum as surrogate matrix,2013,Huidi Jiang
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Leslie Wilson
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Aimee Loucks
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Christine Bui
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Greg Gipson
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Lixian Zhong
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Amy Schwartzburg
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Elizabeth Crabtree
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Douglas Goodin
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Emmanuelle Waubant
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices,2014,Charles McCulloch
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,Elba Mauriz
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,A Laliena
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,D Vallejo
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,M J Tuñón
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,J M Rodríguez-López
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,R Rodríguez-Pérez
Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents,2013,M C García-Fernández
Migration of radioactive iodine-125 seeds: case report,2012,Wanfu Zhang
Migration of radioactive iodine-125 seeds: case report,2012,Kaiyuan Luo
Pharmacokinetic evaluation of axitinib,2012,Brian Patson
Pharmacokinetic evaluation of axitinib,2012,Roger B Cohen
Pharmacokinetic evaluation of axitinib,2012,Anthony J Olszanski
Platysma myocutaneous flap - its current role in reconstructive surgery of oral soft tissue defects,2013,André M Eckardt
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,P Dimitropoulou
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,R M Martin
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,E L Turner
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,J A Lane
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,R Gilbert
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,M Davis
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,J L Donovan
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,F C Hamdy
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study,2011,D E Neal
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial,2012,Sanne L Nijhof
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial,2012,Gijs Bleijenberg
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial,2012,Cuno S P M Uiterwaal
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial,2012,Jan L L Kimpen
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial,2012,Elise M van de Putte
Progressive multifocal leukoencephalopathy and palliative care: a report of three cases and review of the literature,2012,Penelope Janet Helen Cotton
Progressive multifocal leukoencephalopathy and palliative care: a report of three cases and review of the literature,2012,Brian Le
Active-assisted cycling improves tremor and bradykinesia in Parkinson's disease,2012,Angela L Ridgel
Active-assisted cycling improves tremor and bradykinesia in Parkinson's disease,2012,Corey A Peacock
Active-assisted cycling improves tremor and bradykinesia in Parkinson's disease,2012,Emily J Fickes
Active-assisted cycling improves tremor and bradykinesia in Parkinson's disease,2012,Chul-Ho Kim
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Gundula Behrens
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Carmen Jochem
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Marlen Keimling
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Cristian Ricci
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Daniela Schmid
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis,2014,Michael Fred Leitzmann
Association of paediatric inflammatory bowel disease with other immune-mediated diseases,2011,Michael D Kappelman
Association of paediatric inflammatory bowel disease with other immune-mediated diseases,2011,Joseph A Galanko
Association of paediatric inflammatory bowel disease with other immune-mediated diseases,2011,Carol Q Porter
Association of paediatric inflammatory bowel disease with other immune-mediated diseases,2011,Robert S Sandler
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Sophia Zoungas
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,John Chalmers
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Bruce Neal
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Laurent Billot
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Qiang Li
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Yoichiro Hirakawa
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Hisatomi Arima
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Helen Monaghan
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Rohina Joshi
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Stephen Colagiuri
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Mark E Cooper
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Paul Glasziou
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Diederick Grobbee
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Pavel Hamet
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Stephen Harrap
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Simon Heller
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Liu Lisheng
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Giuseppe Mancia
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Michel Marre
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,David R Matthews
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Carl E Mogensen
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Vlado Perkovic
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Neil Poulter
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Anthony Rodgers
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Bryan Williams
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Stephen MacMahon
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Anushka Patel
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,Mark Woodward
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes,2014,[Collective Name] ADVANCE-ON Collaborative Group
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Paula C Chandler-Laney
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Radhika P Phadke
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Wesley M Granger
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Julian A Muñoz
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Chaira Dalla Man
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Claudio Cobelli
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Fernando Ovalle
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Jose R Fernández
Adiposity and β-cell function: relationships differ with ethnicity and age,2010,Barbara A Gower
Effect of caffeine ingestion after creatine supplementation on intermittent high-intensity sprint performance,2011,Chia-Lun Lee
Effect of caffeine ingestion after creatine supplementation on intermittent high-intensity sprint performance,2011,Jung-Charng Lin
Effect of caffeine ingestion after creatine supplementation on intermittent high-intensity sprint performance,2011,Ching-Feng Cheng
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Claudia Lill
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Sven Schneider
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Bahil Ghanim
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Markus Brunner
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Gregor Heiduschka
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Robert Loewe
Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck,2013,Dietmar Thurnher
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis,2013,Andrew Eisen
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis,2013,Martin R Turner
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis,2013,Roger Lemon
Systemic Adverse Events after Intravitreal Bevacizumab versus Ranibizumab for Age-Related Macular Degeneration: A Meta-Analysis,2014,Wei Wang
Systemic Adverse Events after Intravitreal Bevacizumab versus Ranibizumab for Age-Related Macular Degeneration: A Meta-Analysis,2014,Xiulan Zhang
Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp,2012,Naoto Ohkura
Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp,2012,Yoshimi Shigetani
Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp,2012,Nagako Yoshiba
Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp,2012,Kunihiko Yoshiba
Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp,2012,Takashi Okiji
C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy,2014,Rui Zhang
C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy,2014,Jiansong Lin
C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy,2014,Lijuan Qu
C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy,2014,Feng Zheng
C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy,2014,Zhiyong Zheng
Twenty-first century weight loss: banding versus bypass,2014,Stephen W Davies
Twenty-first century weight loss: banding versus bypass,2014,Jimmy T Efird
Twenty-first century weight loss: banding versus bypass,2014,Christopher A Guidry
Twenty-first century weight loss: banding versus bypass,2014,Rachel I Penn
Twenty-first century weight loss: banding versus bypass,2014,Robert G Sawyer
Twenty-first century weight loss: banding versus bypass,2014,Bruce D Schirmer
Twenty-first century weight loss: banding versus bypass,2014,Peter T Hallowell
Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms,2014,Mariusz Sikora
Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms,2014,Adrian Drapala
Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms,2014,Marcin Ufnal
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Vincenzo Marotta
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Anna Guerra
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Maria C Zatelli
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Ettore Degli Uberti
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Vincenza Di Stasi
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Antongiulio Faggiano
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Annamaria Colao
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present,2013,Mario Vitale
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers,2013,Terry H Landowski
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers,2013,Betty K Samulitis
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers,2013,Robert T Dorr
Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy,2011,A Amelink
Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy,2011,H J C M Sterenborg
Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy,2011,J L N Roodenburg
Non-invasive measurement of the microvascular properties of non-dysplastic and dysplastic oral leukoplakias by use of optical spectroscopy,2011,M J H Witjes
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Malin Sjöström
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Göran Umefjord
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Hans Stenlund
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Per Carlbring
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Gerhard Andersson
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training,2013,Eva Samuelsson
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients,2007,Lawrence F Eichenfield
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients,2007,Diamant Thaci
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients,2007,Yves de Prost
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients,2007,Lluis Puig
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients,2007,Carle Paul
A Tool for Training in Decision Making for Emergency General Surgery-Explicit Training is Possible Through Facilitation,2014,Zita M Jessop
A Tool for Training in Decision Making for Emergency General Surgery-Explicit Training is Possible Through Facilitation,2014,Nebil Behar
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?,2014,A M Tata
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?,2014,L Velluto
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?,2014,C D'Angelo
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?,2014,M Reale
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,F J Díaz
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,E de la Peña
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,V Hernández
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,B López
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,J M de La Morena
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,M D Martín
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,I Jiménez-Valladolid
Optimization of an early discharge program after laparoscopic radical prostatectomy,2014,C Llorente
A functional inference for multivariate current status data with mismeasured covariate,2014,Chi-Chung Wen
A functional inference for multivariate current status data with mismeasured covariate,2014,Yih-Huei Huang
A functional inference for multivariate current status data with mismeasured covariate,2014,Yuh-Jenn Wu
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Dehong Gao
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Yongjun Wang
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Yan Liu
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Fei Ding
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Xiaosong Gu
The molecular cloning of glial fibrillary acidic protein in Gekko japonicus and its expression changes after spinal cord transection,2010,Zhengli Li
Excitation BolsTORs motor neurons in ALS mice,2013,Mark P Mattson
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Michael D Kennedy
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Mark J Haykowsky
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Carol A Boliek
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Ben T A Esch
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Jessica M Scott
Regional muscle oxygenation differences in vastus lateralis during different modes of incremental exercise,2006,Darren E R Warburton
History of the rare cancer network and past research,2014,René-Olivier Mirimanoff
History of the rare cancer network and past research,2014,Mahmut Ozsahin
History of the rare cancer network and past research,2014,Juliette Thariat
History of the rare cancer network and past research,2014,Enis Ozyar
History of the rare cancer network and past research,2014,Ulrike Schick
History of the rare cancer network and past research,2014,Berrin Pehlivan
History of the rare cancer network and past research,2014,Marco Krengli
History of the rare cancer network and past research,2014,Alessandra Franzetti Pellanda
History of the rare cancer network and past research,2014,Hansjörg Vees
History of the rare cancer network and past research,2014,Ling Cai
History of the rare cancer network and past research,2014,Luciano Scandolaro
History of the rare cancer network and past research,2014,Yazid Belkacemi
History of the rare cancer network and past research,2014,Salvador Villà
History of the rare cancer network and past research,2014,Sefik Igdem
History of the rare cancer network and past research,2014,Myroslav Lutsyk
History of the rare cancer network and past research,2014,Robert C Miller
Caspase expression in oral squamous cell carcinoma,2010,Cláudia Malheiros Coutinho-Camillo
Caspase expression in oral squamous cell carcinoma,2010,Silvia Vanessa Lourenço
Caspase expression in oral squamous cell carcinoma,2010,Ines Nobuko Nishimoto
Caspase expression in oral squamous cell carcinoma,2010,Luiz Paulo Kowalski
Caspase expression in oral squamous cell carcinoma,2010,Fernando Augusto Soares
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Anuja Krishnan
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Emily Happy Miller
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Andrew S Herbert
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Melinda Ng
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Esther Ndungo
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Sean P Whelan
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,John M Dye
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor,2012,Kartik Chandran
Treatment strategy for the patient with hippocampal sclerosis who failed to the first antiepileptic drug,2014,Sang Kun Lee
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Olivia Namusisi
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Juliet N Sekandi
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Simon Kasasa
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Peter Wasswa
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Nicholas T Kamara
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Medard Bitekyerezo
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Placid Mihayo
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,Sheba N Gitta
Risk factors for non-communicable diseases in rural Uganda: a pilot surveillance project among diabetes patients at a referral hospital clinic,2011,David Mukanga
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Céline Genton
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Amandine Pierre
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Romane Cristescu
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Florence Lévréro
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Sylvain Gatti
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Jean-Sébastien Pierre
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Nelly Ménard
How Ebola impacts social dynamics in gorillas: a multistate modelling approach,2014,Pascaline Le Gouar
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Ahmet Oğuz Baktır
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Bahadır Sarlı
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,R Emre Altekin
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Ahmet Karaman
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Hüseyin Arınç
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Hayrettin Sağlam
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Yasemin Doğan
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Abdulsamet Erden
Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography,2014,Hatice Karaman
Pre-symptomatic electrophysiological tests predict clinical onset and survival in SOD1(G93A) ALS mice,2014,Renzo Mancuso
Pre-symptomatic electrophysiological tests predict clinical onset and survival in SOD1(G93A) ALS mice,2014,Rosario Osta
Pre-symptomatic electrophysiological tests predict clinical onset and survival in SOD1(G93A) ALS mice,2014,Xavier Navarro
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Anu Mary Varghese
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Aparna Sharma
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Poojashree Mishra
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Kalyan Vijayalakshmi
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Hindalahalli Chandregowda Harsha
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Talakad N Sathyaprabha
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Srinivas Mm Bharath
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Atchayaram Nalini
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Phalguni Anand Alladi
Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis,2013,Trichur R Raju
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome,2013,Olafur Sveinsson
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome,2013,Henrik Matell
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome,2013,Lars Herrman
The influence of preterm birth on the developing thalamocortical connectome,2012,Gareth Ball
The influence of preterm birth on the developing thalamocortical connectome,2012,James P Boardman
The influence of preterm birth on the developing thalamocortical connectome,2012,Paul Aljabar
The influence of preterm birth on the developing thalamocortical connectome,2012,Anand Pandit
The influence of preterm birth on the developing thalamocortical connectome,2012,Tomoki Arichi
The influence of preterm birth on the developing thalamocortical connectome,2012,Nazakat Merchant
The influence of preterm birth on the developing thalamocortical connectome,2012,Daniel Rueckert
The influence of preterm birth on the developing thalamocortical connectome,2012,A David Edwards
The influence of preterm birth on the developing thalamocortical connectome,2012,Serena J Counsell
Feature integration within and across visual streams occurs at different visual processing stages,2014,Carolyn J Perry
Feature integration within and across visual streams occurs at different visual processing stages,2014,Abdullah Tahiri
Feature integration within and across visual streams occurs at different visual processing stages,2014,Mazyar Fallah
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Marci J Pugnale
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Alison Maresh
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Pranava Sinha
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Christopher Rossi
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Jonathan Murnick
Pediatric tracheal tumor masked by a history of travel: Case report and literature review,2014,Brian K Reilly
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Guoqing Wei
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Uzoma Nwakuche
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Gustavo Cadavid
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Asim Ajaz
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Karen Seiter
Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma,2012,Delong Liu
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Yiwen Cui
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Katsuhisa Masaki
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Ryo Yamasaki
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Shihoko Imamura
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Satoshi O Suzuki
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Shintaro Hayashi
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Shinya Sato
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Yuko Nagara
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Mami F Kawamura
Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model,2014,Jun-ichi Kira
Dopaminergic modulation of impulsive decision making in the rat insular cortex,2014,Tommy Pattij
Dopaminergic modulation of impulsive decision making in the rat insular cortex,2014,Dustin Schetters
Dopaminergic modulation of impulsive decision making in the rat insular cortex,2014,Anton N M Schoffelmeer
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Chao Quan
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Jingzi ZhangBao
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Sushan Luo
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Kun Fang
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Jianying Xi
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Zunguo Du
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Chongbo Zhao
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma,2014,Jiahong Lu
The contribution of electrophysiology to functional connectivity mapping,2013,Marieke L Schölvinck
The contribution of electrophysiology to functional connectivity mapping,2013,David A Leopold
The contribution of electrophysiology to functional connectivity mapping,2013,Matthew J Brookes
The contribution of electrophysiology to functional connectivity mapping,2013,Patrick H Khader
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Suvi-Tuuli Vilen
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Juho Suojanen
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Fidel Salas
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Juha Risteli
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Merja Ylipalosaari
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Outi Itkonen
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Hannu Koistinen
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Marc Baumann
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Ulf-Håkan Stenman
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Timo Sorsa
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Tuula Salo
Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP,2012,Pia Nyberg
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,Jeffrey S Spence
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,Patrick S Carmack
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,Richard F Gunst
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,William R Schucany
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,Wayne A Woodward
Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses,2006,Robert W Haley
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Laurie Miller Brotman
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Spring Dawson-McClure
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Esther J Calzada
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Keng-Yen Huang
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Dimitra Kamboukos
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Joseph J Palamar
Cluster (school) RCT of ParentCorps: impact on kindergarten academic achievement,2013,Eva Petkova
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Julia Oh
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Alexandra F Freeman
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,[Collective Name] NISC Comparative Sequencing Program
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Morgan Park
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Robert Sokolic
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Fabio Candotti
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Steven M Holland
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Julia A Segre
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies,2013,Heidi H Kong
Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever,2011,Kelly Lyn Warfield
Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever,2011,Gene Garrard Olinger
Unhealed tooth extraction wound in a breast cancer patient,2014,Holger Moysich
Unhealed tooth extraction wound in a breast cancer patient,2014,Andreas Neff
Unhealed tooth extraction wound in a breast cancer patient,2014,Poramate Pitak-Arnnop
Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam,2014,Tran Quang Binh
Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam,2014,Pham Tran Phuong
Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam,2014,Bui Thi Nhung
Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam,2014,Do Dinh Tung
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Harpal S Randeva
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Bee K Tan
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Martin O Weickert
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Konstantinos Lois
Cardiometabolic aspects of the polycystic ovary syndrome,2012,John E Nestler
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Naveed Sattar
Cardiometabolic aspects of the polycystic ovary syndrome,2012,Hendrik Lehnert
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Nadhim Bayatti
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Johnathan Cooper-Knock
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Joanna J Bury
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Matthew Wyles
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Paul R Heath
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Janine Kirby
Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis,2014,Pamela J Shaw
Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern,2014,Louis J Gooren
Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern,2014,Katrien Wierckx
Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern,2014,Erik J Giltay
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial,2014,Ylva Elisabet Nilsagård
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial,2014,Lena Kristina von Koch
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial,2014,Malin Nilsson
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial,2014,Anette Susanne Forsberg
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Katherine Hodgetts
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Janet E Hiller
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Jackie M Street
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Drew Carter
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Annette J Braunack-Mayer
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Amber M Watt
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,John R Moss
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,Adam G Elshaug
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups,2014,[Collective Name] ASTUTE Health study group
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Paolo Gontero
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Richard Sylvester
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Francesca Pisano
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Steven Joniau
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Kathy Vander Eeckt
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Vincenzo Serretta
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Stéphane Larré
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Savino Di Stasi
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Bas Van Rhijn
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Alfred J Witjes
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Anne J Grotenhuis
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Lambertus A Kiemeney
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Renzo Colombo
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Alberto Briganti
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Marek Babjuk
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Per-Uno Malmström
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Marco Oderda
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Jacques Irani
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Nuria Malats
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Jack Baniel
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Roy Mano
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Tommaso Cai
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Eugene K Cha
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Peter Ardelt
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,John Varkarakis
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Riccardo Bartoletti
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Martin Spahn
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Robert Johansson
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Bruno Frea
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Viktor Soukup
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Evanguelos Xylinas
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Guido Dalbagni
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,R Jeffrey Karnes
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Shahrokh F Shariat
Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients,2014,Joan Palou
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Leonard H Verhey
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Alessio Signori
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Douglas L Arnold
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Amit Bar-Or
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,A Dessa Sadovnick
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Ruth Ann Marrie
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Brenda Banwell
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials,2013,Maria Pia Sormani
A tale of two cancers: carcinomas of the oral cavity and oropharynx,2013,Jeffrey N Myers
A tale of two cancers: carcinomas of the oral cavity and oropharynx,2013,Erich M Sturgis
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Chi-Wen Liang
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Roy Yi-Xiu Zhong
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Yun-Chen Chung
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Chun-Hung Pan
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Muh-Yong Yen
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Chung-Ping Cheng
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers,2014,Wen-Yau Hsu
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Julien Aucouturier
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Mélanie Rance
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Martine Meyer
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Laurie Isacco
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,David Thivel
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Nicole Fellmann
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Martine Duclos
Determination of the maximal fat oxidation point in obese children and adolescents: validity of methods to assess maximal aerobic power,2008,Pascale Duché
Dialysis modality decision-making for older adults with chronic kidney disease,2014,Lori Harwood
Dialysis modality decision-making for older adults with chronic kidney disease,2014,Alexander M Clark
The role of stakeholder attitudes in managing contaminated sites: survey of Romanian stakeholder awareness,2013,I C Stezar
The role of stakeholder attitudes in managing contaminated sites: survey of Romanian stakeholder awareness,2013,A Ozunu
The role of stakeholder attitudes in managing contaminated sites: survey of Romanian stakeholder awareness,2013,D L Barry
Biomechanics of submaximal recumbent cycling in adolescents with and without cerebral palsy,2007,Therese E Johnston
Biomechanics of submaximal recumbent cycling in adolescents with and without cerebral palsy,2007,Ann E Barr
Biomechanics of submaximal recumbent cycling in adolescents with and without cerebral palsy,2007,Samuel Ck Lee
Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity,2014,How Hwee Ong
Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity,2014,O'Dhaniel A Mullette-Gillman
Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity,2014,Kenneth Kwok
Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity,2014,Julian Lim
First experience in the thyroid and parathyroid surgery using the da Vinci® system],2013,B Al Kadah
First experience in the thyroid and parathyroid surgery using the da Vinci® system],2013,S Siemer
First experience in the thyroid and parathyroid surgery using the da Vinci® system],2013,B Schick
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Andrea H S Loewen
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Lawrence Korngut
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Karen Rimmer
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Omar Damji
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Tanvir C Turin
Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis,2014,Patrick J Hanly
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Jørgen Gravning
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Marit Kristine Smedsrud
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Torbjørn Omland
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Christian Eek
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Helge Skulstad
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Lars Aaberge
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Bjørn Bendz
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,John Kjekshus
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Lars Mørkrid
Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis,2013,Thor Edvardsen
Health-care utilization in Dutch systemic sclerosis patients,2013,Jessica Meijs
Health-care utilization in Dutch systemic sclerosis patients,2013,Elisabeth J M Zirkzee
Health-care utilization in Dutch systemic sclerosis patients,2013,Anne A Schouffoer
Health-care utilization in Dutch systemic sclerosis patients,2013,Stella M Henquet
Health-care utilization in Dutch systemic sclerosis patients,2013,Monique A A Caljouw
Health-care utilization in Dutch systemic sclerosis patients,2013,Theo Stijnen
Health-care utilization in Dutch systemic sclerosis patients,2013,Tom W J Huizinga
Health-care utilization in Dutch systemic sclerosis patients,2013,Annemie J M Schuerwegh
Health-care utilization in Dutch systemic sclerosis patients,2013,Theodora P M Vliet Vlieland
Designing and evaluation of the teaching quality assessment form from the point of view of the Lorestan University of Medical Sciences students - 2010,2012,Aziz Kamran
Designing and evaluation of the teaching quality assessment form from the point of view of the Lorestan University of Medical Sciences students - 2010,2012,Mohammed Zibaei
Designing and evaluation of the teaching quality assessment form from the point of view of the Lorestan University of Medical Sciences students - 2010,2012,Kamal Mirkaimi
Designing and evaluation of the teaching quality assessment form from the point of view of the Lorestan University of Medical Sciences students - 2010,2012,Hussein Shahnazi
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Richard W Browne
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Bianca Weinstock-Guttman
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Dana Horakova
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Robert Zivadinov
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Mary Lou Bodziak
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Miriam Tamaño-Blanco
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Darlene Badgett
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Michaela Tyblova
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Manuela Vaneckova
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Zdenek Seidl
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Jan Krasensky
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Niels Bergsland
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Deepa P Ramasamy
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Jesper Hagemeier
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Eva Havrdova
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes,2014,Murali Ramanathan
Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey,2013,Sadeq A Quraishi
Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey,2013,Edward A Bittner
Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey,2013,Kenneth B Christopher
Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey,2013,Carlos A Camargo
Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation,2013,George Kypriotakis
Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation,2013,Linda E Francis
Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation,2013,Elizabeth O'Toole
Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation,2013,Tanyanika Phillips Towe
Preferences for aggressive care in underserved populations with advanced-stage lung cancer: looking beyond race and resuscitation,2013,Julia Hannum Rose
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Yu'ning Song
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Xiaoqian Lin
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Dongwei Kang
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Xiao Li
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Peng Zhan
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Xinyong Liu
Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate,2014,Qingzhu Zhang
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,Rodrigo Rocamora
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,Juan L Becerra
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,Pilar Fossas
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,María Gomez
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,Rosa M Vivanco-Hidalgo
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,José A Mauri
Pilomotor seizures: An autonomic semiology of limbic encephalitis?,2014,Albert Molins
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,László Dézsi
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Tamás Fülöp
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Tamás Mészáros
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Gábor Szénási
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Rudolf Urbanics
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Csenge Vázsonyi
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Erik Orfi
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,László Rosivall
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Réka Nemes
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Robbert Jan Kok
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Josbert M Metselaar
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,Gert Storm
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses,2014,János Szebeni
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Enrico Papini
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Giancarlo Bizzarri
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Antonio Bianchini
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Dario Valle
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Irene Misischi
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Rinaldo Guglielmi
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Massimo Salvatori
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Luigi Solbiati
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Anna Crescenzi
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Claudio Maurizio Pacella
Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer,2012,Hossein Gharib
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,K Kawasako
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,T Doi
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,T Kanno
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,Y Wako
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,M Hamamura
Thyroid follicular adenoma with accumulation of collagen type IV in a common marmoset (Callithrix jacchus),2013,M Tsuchitani
Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate?,2014,Chandramohan Sharma
Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate?,2014,Jigar Parekh
Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate?,2014,Bansi Lal Kumawat
Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate?,2014,Mihir Acharya
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Lars Frings
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Belinda Yew
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Emma Flanagan
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Bonnie Y K Lam
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Michael Hüll
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Hans-Jürgen Huppertz
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,John R Hodges
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease,2014,Michael Hornberger
Reply: To PMID 23673354,2013,Douglas A Corley
Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment,2014,A Bose
Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment,2014,A Elyagoby
Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment,2014,T W Wong
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Pachiyappan Kamarajan
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Turki Y Alhazzazi
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Theodora Danciu
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Nisha J D'silva
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Eric Verdin
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis,2012,Yvonne L Kapila
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Susanne Ring-Dimitriou
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Bernhard Paulweber
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Serge P von Duvillard
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Monika Stadlmann
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Linda M LeMura
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Josef Lang
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome,2006,Erich Müller
Agreement in Swedish childless couples' reproductive intentions in relation to age,2013,E Schytt
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Masaharu Ishida
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Makoto Sunamura
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Toru Furukawa
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Liviu P Lefter
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Rina Morita
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Masanori Akada
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Shinichi Egawa
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Michiaki Unno
The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer,2008,Akira Horii
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Francesca Avogadri
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Taha Merghoub
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Maureen F Maughan
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Daniel Hirschhorn-Cymerman
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,John Morris
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Erika Ritter
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Robert Olmsted
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Alan N Houghton
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity,2010,Jedd D Wolchok
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Rajalaxmi Natarajan
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Vinamrata Singal
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Richard Benes
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Junling Gao
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Hoi Chan
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Haijun Chen
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Yongjia Yu
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Jia Zhou
STAT3 modulation to enhance motor neuron differentiation in human neural stem cells,2014,Ping Wu
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Young Joong Kim
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Jung Hwan Baek
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Eun Ju Ha
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Hyun Kyung Lim
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Jeong Hyun Lee
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Jin Young Sung
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Jae Kyun Kim
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Tae Yong Kim
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Won Bae Kim
Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors,2012,Young Kee Shong
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,Deborah T Gold
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,David L Weinstein
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,Gerhardt Pohl
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,Kelly D Krohn
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,Yi Chen
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study,2011,Eric S Meadows
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Morito Takano
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Keigo Hikishima
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Kanehiro Fujiyoshi
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Shinsuke Shibata
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Akimasa Yasuda
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Tsunehiko Konomi
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Akiko Hayashi
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Hiroko Baba
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Koichi Honke
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Yoshiaki Toyama
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Hideyuki Okano
MRI characterization of paranodal junction failure and related spinal cord changes in mice,2012,Masaya Nakamura
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Elçin Sehitoğlu
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Filiz Cavuş
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Canan Ulusoy
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Melike Küçükerden
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Arda Orçen
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Deniz Akbaş-Demir
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Arzu Coban
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Burçak Vural
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Erdem Tüzün
Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study,2014,Recai Türkoğlu
Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life,2013,R Glynne-Jones
Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life,2013,M Harrison
Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life,2013,R Hughes
Predictors of health care use by adults 50 years and over in a rural South African setting,2014,Soter Ameh
Predictors of health care use by adults 50 years and over in a rural South African setting,2014,Francesc Xavier Gómez-Olivé
Predictors of health care use by adults 50 years and over in a rural South African setting,2014,Kathleen Kahn
Predictors of health care use by adults 50 years and over in a rural South African setting,2014,Stephen M Tollman
Predictors of health care use by adults 50 years and over in a rural South African setting,2014,Kerstin Klipstein-Grobusch
Characteristics of inline speedskating--incremental tests and effect of drafting,2006,A Krieg
Characteristics of inline speedskating--incremental tests and effect of drafting,2006,T Meyer
Characteristics of inline speedskating--incremental tests and effect of drafting,2006,S Clas
Characteristics of inline speedskating--incremental tests and effect of drafting,2006,W Kindermann
A three pulse phase response curve to three milligrams of melatonin in humans,2007,Helen J Burgess
A three pulse phase response curve to three milligrams of melatonin in humans,2007,Victoria L Revell
A three pulse phase response curve to three milligrams of melatonin in humans,2007,Charmane I Eastman
Cardiovascular co-medication among users of antiobesity drugs: a population-based study,2010,Merethe Omdal Amundsen
Cardiovascular co-medication among users of antiobesity drugs: a population-based study,2010,Bo Engdahl
Cardiovascular co-medication among users of antiobesity drugs: a population-based study,2010,Christian Berg
Cardiovascular co-medication among users of antiobesity drugs: a population-based study,2010,Hedvig Nordeng
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Pei-Chang Lee
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Ying-Ying Yang
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Wei-Ping Lee
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Kuei-Chuan Lee
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Yun-Cheng Hsieh
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Tzung-Yan Lee
Vitamin D3 treatment has comparative portal hypotensive effects as propranolol by decreasing intrahepatic resistance in cirrhotic rats,2014,Han-Chieh Lin
Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis,2014,Parvathi Menon
Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis,2014,Matthew C Kiernan
Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis,2014,Steve Vucic
High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials,2013,Zhenxing Liu
High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials,2013,Shengyun Huang
High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials,2013,Dongsheng Zhang
Body position and oxygenation: An intriguing relationship,2014,Patrícia Rodrigues
Body position and oxygenation: An intriguing relationship,2014,Marta Monteiro
Body position and oxygenation: An intriguing relationship,2014,Paulo Palma
Body position and oxygenation: An intriguing relationship,2014,Luís Sousa-Pereira
Body position and oxygenation: An intriguing relationship,2014,Sofia Cabral
Body position and oxygenation: An intriguing relationship,2014,Filomena Oliveira
Body position and oxygenation: An intriguing relationship,2014,Vasco Dias
Body position and oxygenation: An intriguing relationship,2014,Severo Torres
Synchronous metastatic adenoid cystic and squamous cell carcinoma of the cervical lymph nodes 31 years after ablation of the primary palatal tumour,2012,Stergios Doumas
Synchronous metastatic adenoid cystic and squamous cell carcinoma of the cervical lymph nodes 31 years after ablation of the primary palatal tumour,2012,Andrew W Barrett
Synchronous metastatic adenoid cystic and squamous cell carcinoma of the cervical lymph nodes 31 years after ablation of the primary palatal tumour,2012,Mauricio Carrillo
Synchronous metastatic adenoid cystic and squamous cell carcinoma of the cervical lymph nodes 31 years after ablation of the primary palatal tumour,2012,John V Tighe
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update,2013,Samuel A Wells
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update,2013,Furio Pacini
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update,2013,Bruce G Robinson
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update,2013,Massimo Santoro
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?,2014,Alireza Nikseresht
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?,2014,Maryam Sharifian
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?,2014,Sadegh Izadi
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?,2014,Alireza Hamidian Jahromi
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?,2014,Abbas Rezaianzadeh
Misdiagnosed pneumothorax interpreted as necrotizing fasciitis of the chest wall: case report of a potentially preventable death,2014,Lucas S McDonald
Misdiagnosed pneumothorax interpreted as necrotizing fasciitis of the chest wall: case report of a potentially preventable death,2014,Paul G Shupe
Misdiagnosed pneumothorax interpreted as necrotizing fasciitis of the chest wall: case report of a potentially preventable death,2014,Kian Raiszadeh
Misdiagnosed pneumothorax interpreted as necrotizing fasciitis of the chest wall: case report of a potentially preventable death,2014,Anshuman Singh
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Beth A Lown
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Lin H Chen
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Pauline V Han
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Emily S Jentes
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Mary E Wilson
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Christine M Benoit
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Karen A Avery
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Winnie Ooi
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Davidson H Hamer
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,Elizabeth D Barnett
Preferences and decision needs of Boston-area travelers to countries with risk of yellow Fever virus transmission: implications for health care providers,2014,[Collective Name] Boston Area Travel Medicine Network
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Kiril L Hristov
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Serge A Y Afeli
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Shankar P Parajuli
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Qiuping Cheng
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Eric S Rovner
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels,2013,Georgi V Petkov
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Vasileios Rafailidis
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Anna Gavriilidou
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Christos Liouliakis
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Maria Poultsaki
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Triantafyllos Theodoridis
Imaging of a renal artery aneurysm detected incidentally on ultrasonography,2014,Vasileios Charalampidis
Oxidative stress induces endothelial cell senescence via downregulation of Sirt6,2014,Rong Liu
Oxidative stress induces endothelial cell senescence via downregulation of Sirt6,2014,Hua Liu
Oxidative stress induces endothelial cell senescence via downregulation of Sirt6,2014,Yonju Ha
Oxidative stress induces endothelial cell senescence via downregulation of Sirt6,2014,Ronald G Tilton
Oxidative stress induces endothelial cell senescence via downregulation of Sirt6,2014,Wenbo Zhang
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,B Hesselmar
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,A-M Bergin
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,H Park
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,M Hahn-Zoric
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,B Eriksson
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,L-A Hanson
Interleukin-4 receptor polymorphisms in asthma and allergy: relation to different disease phenotypes,2009,L Padyukov
Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population,2013,Woo Ri Park
Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population,2013,Tae Keun Oh
Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population,2013,Hyun Jeong Jeon
Review article: the management of cirrhosis in women,2014,A M Allen
Review article: the management of cirrhosis in women,2014,J E Hay
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Naoya Arai
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Hiroaki Tsuno
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Motonori Okabe
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Toshiko Yoshida
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Chika Koike
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Makoto Noguchi
Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa,2011,Toshio Nikaido
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,C Cramer
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,E Link
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,C-P Bauer
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,U Hoffmann
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,A von Berg
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,I Lehmann
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,O Herbarth
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,M Borte
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,B Schaaf
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,S Sausenthaler
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,H-E Wichmann
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,J Heinrich
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,U Krämer
Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus,2010,[Collective Name] LISAplus study group
Reconstruction of through-and-through oral cavity defects with folded extended vertical lower trapezius island myocutaneous flap,2013,Zhao-hui Yang
Reconstruction of through-and-through oral cavity defects with folded extended vertical lower trapezius island myocutaneous flap,2013,Da-ming Zhang
Reconstruction of through-and-through oral cavity defects with folded extended vertical lower trapezius island myocutaneous flap,2013,Wei-liang Chen
Reconstruction of through-and-through oral cavity defects with folded extended vertical lower trapezius island myocutaneous flap,2013,You-yuan Wang
Reconstruction of through-and-through oral cavity defects with folded extended vertical lower trapezius island myocutaneous flap,2013,Song Fan
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome,2013,Andrew M Allmendinger
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome,2013,Narayan Viswanadhan
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome,2013,Roman A Klufas
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome,2013,Liangge Hsu
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Douglas B Johnson
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Vita Saranga-Perry
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Patrick J M Lavin
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,W Bryan Burnette
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Stephen W Clark
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,David R Uskavitch
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Deborah E Wallace
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Mark A Dickson
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Ragini R Kudchadkar
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma,2014,Jeffrey A Sosman
Nocturnal Parasympathetic Modulation of Heart Rate in Obesity-Hypoventilation Patients,2014,A Brzecka
Nocturnal Parasympathetic Modulation of Heart Rate in Obesity-Hypoventilation Patients,2014,M Pawelec-Winiarz
Nocturnal Parasympathetic Modulation of Heart Rate in Obesity-Hypoventilation Patients,2014,A Teplicki
Nocturnal Parasympathetic Modulation of Heart Rate in Obesity-Hypoventilation Patients,2014,P Piesiak
Nocturnal Parasympathetic Modulation of Heart Rate in Obesity-Hypoventilation Patients,2014,R Jankowska
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Thomas Pausch
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Werner Hartwig
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Ulf Hinz
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Thomas Swolana
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Bogota D Bundy
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Thilo Hackert
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Lars Grenacher
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Markus W Büchler
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer,2012,Jens Werner
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Hye Rim Cho
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Dong Hyun Kim
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Daehong Kim
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Philip Doble
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,David Bishop
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Dominic Hare
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Chul-Kee Park
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Woo Kyung Moon
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Moon Hee Han
Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model,2014,Seung Hong Choi
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Sergey Borisovich Yakovlev
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Aleksei Vasilievich Bocharov
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Ketevan Mikeladze
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Sergey Surenovich Gasparian
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Natalia Konstantinovna Serova
Endovascular treatment of acute thrombosis of cerebral veins and sinuses,2014,Alexander Romanovich Shakhnovich
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Gianluca Bagnato
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Alessandra Bitto
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Natasha Irrera
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Gabriele Pizzino
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Donatella Sangari
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Maurizio Cinquegrani
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,William Roberts
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Marco Atteritano
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Domenica Altavilla
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Francesco Squadrito
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Gianfilippo Bagnato
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis,2013,Antonino Saitta
Seamless adaptive servo-ventilation therapy after triple-valve surgery,2014,Takehiro Inoue
Seamless adaptive servo-ventilation therapy after triple-valve surgery,2014,Shintaro Yugami
Seamless adaptive servo-ventilation therapy after triple-valve surgery,2014,Takako Nishino
Seamless adaptive servo-ventilation therapy after triple-valve surgery,2014,Toshihiko Saga
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Michelle Janssens
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Jeroen van Smeden
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Gert S Gooris
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Wim Bras
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Guiseppe Portale
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Peter J Caspers
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Rob J Vreeken
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Thomas Hankemeier
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Sanja Kezic
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Ron Wolterbeek
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Adriana P Lavrijsen
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients,2012,Joke A Bouwstra
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,Zhe Su
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,Hua Tian
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,Hong-quan Song
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,Rui Zhang
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,An-mei Deng
PTPN12 inhibits oral squamous epithelial carcinoma cell proliferation and invasion and can be used as a prognostic marker,2013,Hong-wen Liu
Serotonin risk factors for the development of hypertension in pregnancy,2014,Senka Sabolovic Rudman
Serotonin risk factors for the development of hypertension in pregnancy,2014,Maja Mustapic
Serotonin risk factors for the development of hypertension in pregnancy,2014,Vesna Kosec
Serotonin risk factors for the development of hypertension in pregnancy,2014,Nela Pivac
Serotonin risk factors for the development of hypertension in pregnancy,2014,Franjo Rudman
Serotonin risk factors for the development of hypertension in pregnancy,2014,Dorotea Muck-Seler
Estimating a test's accuracy using tailored meta-analysis-How setting-specific data may aid study selection,2014,Brian H Willis
Estimating a test's accuracy using tailored meta-analysis-How setting-specific data may aid study selection,2014,Christopher J Hyde
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Cristina Cereda
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Emanuela Leoni
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Pamela Milani
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Orietta Pansarasa
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Giuliano Mazzini
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Stefania Guareschi
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Elena Alvisi
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Andrea Ghiroldi
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Luca Diamanti
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Stefano Bernuzzi
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Mauro Ceroni
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis,2013,Emanuela Cova
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Asari Sai
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Taro Shimono
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Koji Sakai
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Akitoshi Takeda
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Hiroyuki Shimada
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Taro Tsukamoto
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Hiroko Maeda
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Shinichi Sakamoto
Diffusion-weighted imaging thermometry in multiple sclerosis,2013,Yukio Miki
Schwannoma of the tongue with a happy ending,2011,Lucia Ferrari
Schwannoma of the tongue with a happy ending,2011,Juan José Segura Fonseca
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Mee Young Ahn
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Hyo-Eun Yoon
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Seong-Min Kwon
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Jun Lee
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Seung-Ki Min
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Yong-Chul Kim
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Sang-Gun Ahn
Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells,2012,Jung-Hoon Yoon
Getting more and more complex: the pathophysiology of atopic eczema,2007,Laura Maintz
Getting more and more complex: the pathophysiology of atopic eczema,2007,Natalija Novak
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,Maria Brake
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,Paige Moore
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,S Mark Taylor
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,Jonathan Trites
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,Scott Murray
Expectantly waiting: a survey of thyroid surgery wait times among Canadian otolaryngologists,2013,Rob Hart
Biomarkers and evolution in Alzheimer disease,2011,Stanley I Rapoport
Biomarkers and evolution in Alzheimer disease,2011,Peter T Nelson
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Ping-Ping Bao
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Ying Zheng
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Sarah Nechuta
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Kai Gu
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Hui Cai
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Peng Peng
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Xiao-Ou Shu
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study,2013,Wei Lu
Tissue heterogeneity as a mechanism for localized neural stimulation by applied electric fields,2007,P C Miranda
Tissue heterogeneity as a mechanism for localized neural stimulation by applied electric fields,2007,L Correia
Tissue heterogeneity as a mechanism for localized neural stimulation by applied electric fields,2007,R Salvador
Tissue heterogeneity as a mechanism for localized neural stimulation by applied electric fields,2007,P J Basser
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Satyendra Chandra Tripathi
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Jatinder Kaur
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Ajay Matta
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Xin Gao
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Bin Sun
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Shyam Singh Chauhan
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Alok Thakar
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Nootan Kumar Shukla
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Ritu Duggal
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Ajoy Roy Choudhary
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Siddhartha DattaGupta
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Mehar Chand Sharma
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,Ranju Ralhan
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma,2011,K W Michael Siu
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia,2014,Joo-Hwa Kim
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia,2014,Tae-Shik Cho
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia,2014,Jin-Hwa Moon
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia,2014,Chang-Ryul Kim
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia,2014,Jae-Won Oh
Genomic instability in blood cells is able to predict the oral cancer risk: an experimental study in rats,2008,Daniel A Ribeiro
Genomic instability in blood cells is able to predict the oral cancer risk: an experimental study in rats,2008,Daniela G Grilli
Genomic instability in blood cells is able to predict the oral cancer risk: an experimental study in rats,2008,Daisy M F Salvadori
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Donna J Cross
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Yoshimi Anzai
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Eric C Petrie
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Nathalie Martin
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Todd L Richards
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Kenneth R Maravilla
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Elaine R Peskind
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment,2013,Satoshi Minoshima
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,Chao Huang
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,Jian Zhan
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,Yu-Jian Liu
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,De-Jia Li
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,Su-Qing Wang
Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies,2014,Qi-Qiang He
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Alessandro Mussa
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Maria Carolina Salerno
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Gianni Bona
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Malgorzata Wasniewska
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Maria Segni
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Alessandra Cassio
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Maria Cristina Vigone
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Roberto Gastaldi
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Lorenzo Iughetti
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Arianna Santanera
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Donatella Capalbo
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Patrizia Matarazzo
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Filippo De Luca
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Giovanna Weber
Serum thyrotropin concentration in children with isolated thyroid nodules,2013,Andrea Corrias
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,S J Hotte
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,A Oza
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,E W Winquist
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,M Moore
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,E X Chen
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,S Brown
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,G R Pond
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,J E Dancey
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study,2005,H W Hirte
Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans,2005,Daryl P Wilkerson
Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans,2005,Jörn Rittweger
Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans,2005,Nicolas J A Berger
Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans,2005,Patrick F Naish
Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans,2005,Andrew M Jones
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Emmanuel Adu-Gyamfi
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Smita P Soni
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Yi Xue
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Michelle A Digman
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Enrico Gratton
The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress,2013,Robert V Stahelin
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,David Conde-Estévez
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,Esther Salas
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,Joan Albanell
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Haina Du
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Nannan Guo
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Bin Shi
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Qian Zhang
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Zhipeng Chen
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Kai Lu
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Yongqian Shu
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Tao Chen
The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis,2014,Lingjun Zhu
Multi-Gaussian fitting for pulse waveform using Weighted Least Squares and multi-criteria decision making method,2013,Lu Wang
Multi-Gaussian fitting for pulse waveform using Weighted Least Squares and multi-criteria decision making method,2013,Lisheng Xu
Multi-Gaussian fitting for pulse waveform using Weighted Least Squares and multi-criteria decision making method,2013,Shuting Feng
Multi-Gaussian fitting for pulse waveform using Weighted Least Squares and multi-criteria decision making method,2013,Max Q-H Meng
Multi-Gaussian fitting for pulse waveform using Weighted Least Squares and multi-criteria decision making method,2013,Kuanquan Wang
Incidence and characteristics of acute referred orofacial pain caused by a posterior single tooth pulpitis in an Iranian population,2013,Maryam Alsadat Hashemipour
Incidence and characteristics of acute referred orofacial pain caused by a posterior single tooth pulpitis in an Iranian population,2013,Roya Borna
Use of complementary alternative medicine in pediatric otolaryngology patients: a survey,2013,Maayan Gruber
Use of complementary alternative medicine in pediatric otolaryngology patients: a survey,2013,Eran Ben-Arye
Use of complementary alternative medicine in pediatric otolaryngology patients: a survey,2013,Nitai Kerem
Use of complementary alternative medicine in pediatric otolaryngology patients: a survey,2013,Raanan Cohen-Kerem
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Alfiya Distler
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Veronika Lang
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Tina Del Vecchio
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Jingang Huang
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Yun Zhang
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Christian Beyer
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Neng-Yu Lin
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Katrin Palumbo-Zerr
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Oliver Distler
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Georg Schett
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability,2014,Jörg Hw Distler
Shift work and cancer research: can chronotype predict susceptibility in night-shift and rotating-shift workers?,2013,Thomas C Erren
De novo acute myeloid leukemia risk factors: a Texas case-control study,2012,Sara S Strom
De novo acute myeloid leukemia risk factors: a Texas case-control study,2012,Robert Oum
De novo acute myeloid leukemia risk factors: a Texas case-control study,2012,Kplola Y Elhor Gbito
De novo acute myeloid leukemia risk factors: a Texas case-control study,2012,Guillermo Garcia-Manero
De novo acute myeloid leukemia risk factors: a Texas case-control study,2012,Yuko Yamamura
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,D A Jones
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,K S Rathod
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,N Sekhri
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,C Junghans
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,S Gallagher
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,M T Rothman
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,S Mohiddin
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A Kapur
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,C Knight
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A Archbold
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A K Jain
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,P G Mills
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,R Uppal
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A Mathur
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A D Timmis
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention,2011,A Wragg
The VO2 response to exhaustive square wave exercise: influence of exercise intensity and mode,2003,S B Draper
The VO2 response to exhaustive square wave exercise: influence of exercise intensity and mode,2003,D M Wood
The VO2 response to exhaustive square wave exercise: influence of exercise intensity and mode,2003,J L Fallowfield
Indirect measures of substrate utilisation following exercise-induced muscle damage,2013,Jonathan Hughes
Indirect measures of substrate utilisation following exercise-induced muscle damage,2013,Phillip Chapman
Indirect measures of substrate utilisation following exercise-induced muscle damage,2013,Stephen Brown
Indirect measures of substrate utilisation following exercise-induced muscle damage,2013,Nathan Johnson
Indirect measures of substrate utilisation following exercise-induced muscle damage,2013,Stephen Stannard
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Shahrukh Mallik
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Nils Muhlert
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Rebecca S Samson
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Varun Sethi
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Claudia A M Wheeler-Kingshott
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,David H Miller
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study,2014,Declan T Chard
Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease,2014,Thiago Cardoso Vale
Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease,2014,Paulo Caramelli
Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease,2014,Francisco Cardoso
Third-party punishment increases cooperation in children through (misaligned) expectations and conditional cooperation,2014,Philipp Lergetporer
Third-party punishment increases cooperation in children through (misaligned) expectations and conditional cooperation,2014,Silvia Angerer
Third-party punishment increases cooperation in children through (misaligned) expectations and conditional cooperation,2014,Daniela Glätzle-Rützler
Third-party punishment increases cooperation in children through (misaligned) expectations and conditional cooperation,2014,Matthias Sutter
Lymphocyte activation in silica-exposed workers,2013,Michelle Rocha-Parise
Lymphocyte activation in silica-exposed workers,2013,Leonilda M B Santos
Lymphocyte activation in silica-exposed workers,2013,Jan G M C Damoiseaux
Lymphocyte activation in silica-exposed workers,2013,Ericson Bagatin
Lymphocyte activation in silica-exposed workers,2013,Alessandro V Lido
Lymphocyte activation in silica-exposed workers,2013,Cristiane Okuda Torello
Lymphocyte activation in silica-exposed workers,2013,Jan W Cohen Tervaert
Lymphocyte activation in silica-exposed workers,2013,Mary L S Queiroz
Assessing Health-related Quality of Life in Hand Eczema Patients: How to Overcome Psychometric Faults when Using the Dermatology Life Quality Index,2014,Robert F Ofenloch
Assessing Health-related Quality of Life in Hand Eczema Patients: How to Overcome Psychometric Faults when Using the Dermatology Life Quality Index,2014,Thomas L Diepgen
Assessing Health-related Quality of Life in Hand Eczema Patients: How to Overcome Psychometric Faults when Using the Dermatology Life Quality Index,2014,Elke Weisshaar
Assessing Health-related Quality of Life in Hand Eczema Patients: How to Overcome Psychometric Faults when Using the Dermatology Life Quality Index,2014,Peter Elsner
Assessing Health-related Quality of Life in Hand Eczema Patients: How to Overcome Psychometric Faults when Using the Dermatology Life Quality Index,2014,Christian J Apfelbacher
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications,2013,Saroj Vadhan-Raj
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications,2013,Jenna D Goldberg
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications,2013,Miguel-Angel Perales
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications,2013,Dietmar P Berger
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications,2013,Marcel R M van den Brink
The genetics of multiple sclerosis: review of current and emerging candidates,2013,Maider Muñoz-Culla
The genetics of multiple sclerosis: review of current and emerging candidates,2013,Haritz Irizar
The genetics of multiple sclerosis: review of current and emerging candidates,2013,David Otaegui
Motor effort alters changes of mind in sensorimotor decision making,2014,Diana Burk
Motor effort alters changes of mind in sensorimotor decision making,2014,James N Ingram
Motor effort alters changes of mind in sensorimotor decision making,2014,David W Franklin
Motor effort alters changes of mind in sensorimotor decision making,2014,Michael N Shadlen
Motor effort alters changes of mind in sensorimotor decision making,2014,Daniel M Wolpert
A giant primary retroperitoneal mature cystic teratoma in right adrenal region in a 39-year-old female,2014,Dong-Dong Tang
A giant primary retroperitoneal mature cystic teratoma in right adrenal region in a 39-year-old female,2014,Xian-Sheng Zhang
A giant primary retroperitoneal mature cystic teratoma in right adrenal region in a 39-year-old female,2014,Zong-Yao Hao
A giant primary retroperitoneal mature cystic teratoma in right adrenal region in a 39-year-old female,2014,Jun Zhou
A giant primary retroperitoneal mature cystic teratoma in right adrenal region in a 39-year-old female,2014,Chao-Zhao Liang
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Hebah Alhajeri
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Marie Hudson
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Marvin Fritzler
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Janet Pope
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Solène Tatibouet
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Janet Markland
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,David Robinson
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Niall Jones
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Nader Khalidi
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Peter Docherty
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Elzbieta Kaminska
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Ariel Masetto
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Evelyn Sutton
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Jean-Pierre Mathieu
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Sophie Ligier
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Tamara Grodzicky
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Sharon LeClercq
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Carter Thorne
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Geneviève Gyger
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Douglas Smith
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Paul R Fortin
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Maggie Larché
The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group,2014,Murray Baron
Safety considerations when choosing the appropriate treatment for patients with multiple sclerosis,2014,Angel P Sempere
Safety considerations when choosing the appropriate treatment for patients with multiple sclerosis,2014,Juana Gimenez-Martinez
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Jonathan Myers
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Paul McAuley
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Carl Lavie
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Jean-Pierre Despres
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Ross Arena
Physical Activity and Cardiorespiratory Fitness as Major Markers of Cardiovascular Risk: Their Independent and Interwoven Importance to Health Status,2014,Peter Kokkinos
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,William D Figg
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Manish Monga
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Donna Headlee
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Avni Shah
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Cindy H Chau
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Cody Peer
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Richard Messman
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Yusri A Elsayed
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Anthony J Murgo
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Giovanni Melillo
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Qin C Ryan
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Mikhail Kalnitskiy
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Adrian M Senderowicz
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Melinda Hollingshead
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Susan G Arbuck
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms,2014,Edward A Sausville
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Armen Nersesyan
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Michael Kundi
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Georg Krupitza
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Gustavo Barcelos
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Miroslav Mišík
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Georg Wultsch
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Juan Carrion
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Gladys Carrion-Carrera
Induction of nuclear anomalies in exfoliated buccal cells of coca chewers: results of a field study,2012,Siegfried Knasmueller
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Kristin A Anderson
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Fumin Lin
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Thomas J Ribar
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Robert D Stevens
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Michael J Muehlbauer
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Christopher B Newgard
Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse,2012,Anthony R Means
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Masaya Kubota
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Masahito Shimizu
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Hiroyasu Sakai
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Yoichi Yasuda
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Tomohiko Ohno
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Takahiro Kochi
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Hisashi Tsurumi
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Takuji Tanaka
Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,2011,Hisataka Moriwaki
Unbalanced estrogen metabolism in thyroid cancer,2013,Muhammad Zahid
Unbalanced estrogen metabolism in thyroid cancer,2013,Whitney Goldner
Unbalanced estrogen metabolism in thyroid cancer,2013,Cheryl L Beseler
Unbalanced estrogen metabolism in thyroid cancer,2013,Eleanor G Rogan
Unbalanced estrogen metabolism in thyroid cancer,2013,Ercole L Cavalieri
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Charles L Howe
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Tatiana Kaptzan
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Setty M Magaña
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Jennifer R Ayers-Ringler
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Reghann G LaFrance-Corey
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures,2014,Claudia F Lucchinetti
Ultrasound-guided fine-needle aspiration biopsy of the thyroid: methods to decrease the rate of unsatisfactory biopsies in the absence of an on-site pathologist,2012,Cyrille Naïm
Ultrasound-guided fine-needle aspiration biopsy of the thyroid: methods to decrease the rate of unsatisfactory biopsies in the absence of an on-site pathologist,2012,Ramy Karam
Ultrasound-guided fine-needle aspiration biopsy of the thyroid: methods to decrease the rate of unsatisfactory biopsies in the absence of an on-site pathologist,2012,Donald Eddé
The pituitary tumor transforming gene in thyroid cancer,2012,G D Lewy
The pituitary tumor transforming gene in thyroid cancer,2012,N Sharma
The pituitary tumor transforming gene in thyroid cancer,2012,R I Seed
The pituitary tumor transforming gene in thyroid cancer,2012,V E Smith
The pituitary tumor transforming gene in thyroid cancer,2012,K Boelaert
The pituitary tumor transforming gene in thyroid cancer,2012,C J McCabe
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Karin Dedek
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Chethan Pandarinath
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Nazia M Alam
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Kerstin Wellershaus
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Timm Schubert
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Klaus Willecke
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Glen T Prusky
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Reto Weiler
Ganglion cell adaptability: does the coupling of horizontal cells play a role?,2008,Sheila Nirenberg
Inpatient service providers' perspectives on service user involvement in Norwegian community mental health centres,2010,Marianne Storm
Inpatient service providers' perspectives on service user involvement in Norwegian community mental health centres,2010,Kjell Hausken
Inpatient service providers' perspectives on service user involvement in Norwegian community mental health centres,2010,Knud Knudsen
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Maria Assunta Rocca
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Sarlota Mesaros
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Elisabetta Pagani
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Maria Pia Sormani
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Giancarlo Comi
Thalamic damage and long-term progression of disability in multiple sclerosis,2010,Massimo Filippi
Vandetanib for the treatment of medullary thyroid cancer,2012,Nicole G Chau
Vandetanib for the treatment of medullary thyroid cancer,2012,Robert I Haddad
The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database,2011,J Kyle Anderson
The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database,2011,Shaheen Alanee
The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database,2011,Bruce Lindgren
The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database,2011,Joel Slaton
Self-determination and older people--a concept analysis,2013,Christina Ekelund
Self-determination and older people--a concept analysis,2013,Synneve Dahlin-Ivanoff
Self-determination and older people--a concept analysis,2013,Kajsa Eklund
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Guangwen Zhu
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Hong Li
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Yanjun Zhang
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Yaming Li
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Shujun Liang
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques,2011,Jia Liu
Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2,2013,Zacharoula Nikolakopoulou
Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2,2013,Georgios Nteliopoulos
Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2,2013,Adina T Michael-Titus
Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2,2013,Eric Kenneth Parkinson
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Shin-Hyuk Kim
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Hyung Seok Park
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Ki-Ho Kim
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Ho Yoo
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Byung-Joo Chae
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Ja-Seong Bae
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Sang-Seol Jung
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer,2014,Byung-Joo Song
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,Jorge J Castillo
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,Randall R Ingham
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,John L Reagan
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,Michael Furman
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,Samir Dalia
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies,2013,Joanna Mitri
Alpers syndrome with prominent white matter changes,2007,Xinhua Bao
Alpers syndrome with prominent white matter changes,2007,Ye Wu
Alpers syndrome with prominent white matter changes,2007,Lee-Jun C Wong
Alpers syndrome with prominent white matter changes,2007,Yuehua Zhang
Alpers syndrome with prominent white matter changes,2007,Hui Xiong
Alpers syndrome with prominent white matter changes,2007,Ping-Chieh Chou
Alpers syndrome with prominent white matter changes,2007,Cavatina K Truong
Alpers syndrome with prominent white matter changes,2007,Yuwu Jiang
Alpers syndrome with prominent white matter changes,2007,Jiong Qin
Alpers syndrome with prominent white matter changes,2007,Yun Yuan
Alpers syndrome with prominent white matter changes,2007,Qing Lin
Alpers syndrome with prominent white matter changes,2007,Xiru Wu
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Sharon Abrahams
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Laura H Goldstein
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,John Suckling
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Virginia Ng
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Andy Simmons
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Xavier Chitnis
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Louise Atkins
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,Steve C R Williams
Frontotemporal white matter changes in amyotrophic lateral sclerosis,2005,P N Leigh
The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers,2012,Xinying Li
The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers,2012,Asim B Abdel-Mageed
The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers,2012,Debasis Mondal
The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers,2012,Emad Kandil
OntoTrader: An Ontological Web Trading Agent Approach for Environmental Information Retrieval,2014,Luis Iribarne
OntoTrader: An Ontological Web Trading Agent Approach for Environmental Information Retrieval,2014,Nicolás Padilla
OntoTrader: An Ontological Web Trading Agent Approach for Environmental Information Retrieval,2014,Rosa Ayala
OntoTrader: An Ontological Web Trading Agent Approach for Environmental Information Retrieval,2014,José A Asensio
OntoTrader: An Ontological Web Trading Agent Approach for Environmental Information Retrieval,2014,Javier Criado
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Oktay Algin
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Ozlem Taskapilioglu
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Bahattin Hakyemez
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Gokhan Ocakoglu
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Sukran Yurtogullari
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Sevda Erer
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease,2010,Mufit Parlak
McArdle disease: another systemic low-inflammation disorder?,2007,Alejandro Lucia
McArdle disease: another systemic low-inflammation disorder?,2007,Lucille Smith
McArdle disease: another systemic low-inflammation disorder?,2007,Melissa Naidoo
McArdle disease: another systemic low-inflammation disorder?,2007,Marta González-Freire
McArdle disease: another systemic low-inflammation disorder?,2007,Margarita Pérez
McArdle disease: another systemic low-inflammation disorder?,2007,Juan C Rubio
McArdle disease: another systemic low-inflammation disorder?,2007,Miguel A Martín
McArdle disease: another systemic low-inflammation disorder?,2007,A L Andreu
McArdle disease: another systemic low-inflammation disorder?,2007,Joaquín Arenas
An overview of the effects of anti-IgE therapies,2014,Arzu Didem Yalcin
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Chang-Min Chung
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Hui-Wen Cheng
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Jung-Jung Chang
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Yu-Sheng Lin
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Ju-Feng Hsiao
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Shih-Tai Chang
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient,2014,Jen-Te Hsu
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,David H Salat
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,Victoria J Williams
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,Elizabeth C Leritz
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,David M Schnyer
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,James L Rudolph
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,Lewis A Lipsitz
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,Regina E McGlinchey
Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults,2011,William P Milberg
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Guy B Marks
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Seema Mihrshahi
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Andrew S Kemp
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Euan R Tovey
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Karen Webb
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Catarina Almqvist
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Rosario D Ampon
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Daniel Crisafulli
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Elena G Belousova
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Craig M Mellis
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Jennifer K Peat
Prevention of asthma during the first 5 years of life: a randomized controlled trial,2006,Stephen R Leeder
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Masaaki Kodama
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Amit Khanal
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Manabu Habu
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Kenjiro Iwanaga
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Izumi Yoshioka
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Tatsurou Tanaka
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Yasuhiro Morimoto
Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas,2009,Kazuhiro Tominaga
The effect of a long term regular physical activity with hypertension and body mass index in type 2 diabetes patients,2014,A Yavari
The effect of a long term regular physical activity with hypertension and body mass index in type 2 diabetes patients,2014,M Mobasseri
The effect of a long term regular physical activity with hypertension and body mass index in type 2 diabetes patients,2014,F Najafipoor
The effect of a long term regular physical activity with hypertension and body mass index in type 2 diabetes patients,2014,A Aliasgarzadeh
The effect of a long term regular physical activity with hypertension and body mass index in type 2 diabetes patients,2014,M Niafar
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,Yousef Rezaei Chianeh
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,Rashmi Manjunath
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,Krishnananda Prabhu
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,Donald Fernandes
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,M Vidyasagar
Protein thiols and butryrylcholinestrase in saliva of oral cancer patients,2013,Asha Kamath
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Madiha F Abdel-Maksoud
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Betsy C Risendal
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Marty L Slattery
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Anna R Giuliano
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Kathy B Baumgartner
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors,2011,Tim E Byers
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Kim A Staats
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Lawrence Van Helleputte
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Ashley R Jones
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,André Bento-Abreu
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Annelies Van Hoecke
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Aleksey Shatunov
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Claire L Simpson
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Robin Lemmens
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Tom Jaspers
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Kiyoko Fukami
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Yoshikazu Nakamura
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Robert H Brown
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Philip Van Damme
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Adrian Liston
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Wim Robberecht
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Ammar Al-Chalabi
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice,2013,Ludo Van Den Bosch
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Eun Ju Ha
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Jung Hwan Baek
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Jeong Hyun Lee
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Jin Yong Sung
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Ducky Lee
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Jae Kyun Kim
Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy,2013,Young Kee Shong
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Chunfang Zhang
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Luping Yu
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Tao Xu
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Yichang Hao
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Xiaowei Zhang
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Zhenhua Liu
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Yunbei Xiao
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Xiaofeng Wang
Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study,2013,Qiang Zeng
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Lukasz Paschke
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Marcin Rucinski
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Agnieszka Ziolkowska
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Tomasz Zemleduch
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Witold Malendowicz
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Zbigniew Kwias
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology,2013,Ludwik K Malendowicz
Vascular burden and Alzheimer disease pathologic progression,2012,Raymond Y Lo
Vascular burden and Alzheimer disease pathologic progression,2012,William J Jagust
Vascular burden and Alzheimer disease pathologic progression,2012,[Collective Name] Alzheimer's Disease Neuroimaging Initiative
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Franziska Rausch
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Daniela Mier
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Sarah Eifler
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Christine Esslinger
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Claudia Schilling
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Frederike Schirmbeck
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Susanne Englisch
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Andreas Meyer-Lindenberg
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Peter Kirsch
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,2014,Mathias Zink
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Hee Eun Lee
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Dong Hoon Kim
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Young Hye Cho
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Kyungeun Kim
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Seoung Wan Chae
Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma,2011,Jin Hee Sohn
Differences in Parent and Teacher Rating of Everyday Executive Function in Pediatric Brain Tumor Survivors,2014,G C Wochos
Differences in Parent and Teacher Rating of Everyday Executive Function in Pediatric Brain Tumor Survivors,2014,C H Semerjian
Differences in Parent and Teacher Rating of Everyday Executive Function in Pediatric Brain Tumor Survivors,2014,K S Walsh
Validation of a questionnaire against clinical assessment in the diagnosis of asthma in school children,2014,Tonje Elisabeth Hansen
Validation of a questionnaire against clinical assessment in the diagnosis of asthma in school children,2014,Bjørg Evjenth
Validation of a questionnaire against clinical assessment in the diagnosis of asthma in school children,2014,Jan Holt
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives,2014,Jürgen Dinger
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives,2014,Kristina Bardenheuer
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives,2014,Klaas Heinemann
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Raul Zamora-Ros
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Sabina Rinaldi
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Carine Biessy
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Anne Tjønneland
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Jytte Halkjaer
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Agnes Fournier
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Marie-Christine Boutron-Ruault
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Sylvie Mesrine
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Kaja Tikk
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Reneé T Fortner
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Heiner Boeing
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Jana Förster
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Antonia Trichopoulou
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Dimitrios Trichopoulos
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Eleni-Maria Papatesta
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Giovanna Masala
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Giovanna Tagliabue
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Salvatore Panico
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Rosario Tumino
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Silvia Polidoro
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Petra H M Peeters
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,H Bas Bueno-de-Mesquita
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Elisabete Weiderpass
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Eiliv Lund
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Marcial Argüelles
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Antonio Agudo
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Esther Molina-Montes
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Carmen Navarro
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Aurelio Barricarte
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Nerea Larrañaga
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Jonas Manjer
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Martin Almquist
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Maria Sandström
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Joakim Hennings
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Konstantinos K Tsilidis
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Julie A Schmidt
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Kay-Thee Khaw
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Nicholas J Wareham
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Isabelle Romieu
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Graham Byrnes
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Marc J Gunter
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Elio Riboli
Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study,2014,Silvia Franceschi
Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis,2013,Vadakke Peringode Sivadas
Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis,2013,Nebu Abraham George
Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis,2013,Jayasree Kattoor
Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis,2013,S Kannan
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Dimitris A Tsitsikas
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Henry Seligman
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Bala Sirigireddy
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Liz Odeh
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Ruben Nzouakou
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease,2014,Roger J Amos
Nocturnal versus diurnal CO2 uptake: how flexible is Agave angustifolia?,2014,Klaus Winter
Nocturnal versus diurnal CO2 uptake: how flexible is Agave angustifolia?,2014,Milton Garcia
Nocturnal versus diurnal CO2 uptake: how flexible is Agave angustifolia?,2014,Joseph A M Holtum
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Ping-Ho Chen
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Ka-Wo Lee
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Cheng-Chieh Hsu
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Jeff Yi-Fu Chen
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Yan-Hsiung Wang
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Ker-Kong Chen
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Hui-Min David Wang
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Hurng-Wern Huang
Expression of a splice variant of CYP26B1 in betel quid-related oral cancer,2014,Bin Huang
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Seema G Trivedi
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Justine Newson
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Ravindra Rajakariar
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Thomas S Jacques
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Robert Hannon
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Yoshihide Kanaoka
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Naomi Eguchi
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Paul Colville-Nash
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity,2006,Derek W Gilroy
Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study,2011,Yoshihiro Miyake
Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study,2011,Hitomi Okubo
Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study,2011,Satoshi Sasaki
Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study,2011,Keiko Tanaka
Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study,2011,Yoshio Hirota
What are exosomes and how can they be used in multiple sclerosis therapy?,2014,Aya D Pusic
What are exosomes and how can they be used in multiple sclerosis therapy?,2014,Kae M Pusic
What are exosomes and how can they be used in multiple sclerosis therapy?,2014,Richard P Kraig
Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges,2014,Lilian Calderón-Garcidueñas
Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges,2014,Ricardo Torres-Jardón
Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges,2014,Randy J Kulesza
Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges,2014,Su-Bin Park
Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges,2014,Amedeo D'Angiulli
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Tao Li
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Keliang Wu
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Li You
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Xiuye Xing
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Peng Wang
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Linlin Cui
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Hongbin Liu
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Yuqian Cui
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Yuehong Bian
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Yunna Ning
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Han Zhao
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Rong Tang
Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome,2013,Zi-Jiang Chen
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Kelly L McCoy
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Sally E Carty
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Michaele J Armstrong
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Raja R Seethala
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,N Paul Ohori
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Adam S Kabaker
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Michael T Stang
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Steven P Hodak
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Yuri E Nikiforov
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer,2012,Linwah Yip
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Janina Mertens
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Stephanie Stock
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Markus Lüngen
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Andrea von Berg
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Ursula Krämer
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Birgit Filipiak-Pittroff
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Joachim Heinrich
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Sibylle Koletzko
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Armin Grübl
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,H-Erich Wichmann
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Carl-P Bauer
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Dietrich Reinhardt
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Dietrich Berdel
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany,2012,Andreas Gerber
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Lauren E Gyllenhammer
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Marc J Weigensberg
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Donna Spruijt-Metz
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Hooman Allayee
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Michael I Goran
Modifying influence of dietary sugar in the relationship between cortisol and visceral adipose tissue in minority youth,2013,Jaimie N Davis
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Patricia G Moorman
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Laura J Havrilesky
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Jennifer M Gierisch
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Remy R Coeytaux
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,William J Lowery
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Rachel Peragallo Urrutia
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Michaela Dinan
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Amanda J McBroom
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Vic Hasselblad
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Gillian D Sanders
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,2013,Evan R Myers
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,Sarah Manney
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,C M Meddings
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,R M Harrison
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,A H Mansur
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,A Karakatsani
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,A Analitis
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,Klea Katsouyanni
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,D Perifanou
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,I G Kavouras
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,N Kotronarou
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,J J de Hartog
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,J Pekkanen
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,K Hämeri
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,Harry ten Brink
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,Gerard Hoek
Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease,2012,Jon G Ayres
Variability is adaptability…also during weaning!,2014,Laurent Brochard
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Michele Del Vecchio
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Roberta Mortarini
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Gabrina Tragni
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Lorenza Di Guardo
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Ilaria Bersani
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Giuseppe Di Tolla
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Francesco Agustoni
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Valentina Colonna
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Jeffrey S Weber
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma,2011,Andrea Anichini
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Matthew Benson
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Jobayer Hossain
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Michael P Caulfield
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Ligeia Damaso
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Samuel Gidding
Lipoprotein subfractions by ion mobility in lean and obese children,2012,Nelly Mauras
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease,2014,Peixuan Pey
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease,2014,Ronald K B Pearce
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease,2014,Michail E Kalaitzakis
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease,2014,W Sue T Griffin
Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease,2014,Steve M Gentleman
The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study,2014,Marit Falkegård
The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study,2014,Henrik Schirmer
The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study,2014,Maja-Lisa Løchen
The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study,2014,Pål Oian
The validity of self-reported information about hypertensive disorders of pregnancy in a population-based survey: the Tromsø Study,2014,Ganesh Acharya
Burnout as a predictor of all-cause mortality among industrial employees: a 10-year prospective register-linkage study,2010,Kirsi Ahola
Burnout as a predictor of all-cause mortality among industrial employees: a 10-year prospective register-linkage study,2010,Ari Väänänen
Burnout as a predictor of all-cause mortality among industrial employees: a 10-year prospective register-linkage study,2010,Aki Koskinen
Burnout as a predictor of all-cause mortality among industrial employees: a 10-year prospective register-linkage study,2010,Anne Kouvonen
Burnout as a predictor of all-cause mortality among industrial employees: a 10-year prospective register-linkage study,2010,Arie Shirom
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides,2010,Jakob Mutanu Jungersted
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides,2010,Julie K Høgh
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides,2010,Lars I Hellgren
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides,2010,Gregor B E Jemec
Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides,2010,Tove Agner
Slow-growing nodule on the lower lip],2012,C Prada-García
Slow-growing nodule on the lower lip],2012,M Lamoca-Martín
Slow-growing nodule on the lower lip],2012,M Á Rodríguez-Prieto
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Fangyao Hu
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Karthik Vishwanath
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,H Wolfgang Beumer
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Liana Puscas
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Hamid R Afshari
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Ramon M Esclamado
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Richard Scher
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Samuel Fisher
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Justin Lo
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Christine Mulvey
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Nirmala Ramanujam
Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma,2014,Walter T Lee
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Chenxi Ren
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Jie Zhang
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Yu Xu
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Baihui Xu
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Wanwan Sun
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Jichao Sun
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Tiange Wang
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Min Xu
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Jieli Lu
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Weiqing Wang
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Yufang Bi
Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese,2014,Yuhong Chen
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Rea Kuehl
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Friederike Scharhag-Rosenberger
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Kai Schommer
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Martina E Schmidt
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Peter Dreger
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Gerhard Huber
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Martin Bohus
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Cornelia M Ulrich
Exercise Intensity Classification in Cancer Patients Undergoing Allogeneic HSCT,2014,Joachim Wiskemann
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,P Ingiliz
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,I Krznaric
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,H-J Stellbrink
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,G Knecht
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,T Lutz
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,C Noah
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,H Stocker
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,M Obermeier
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,S Dupke
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,C Boesecke
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,J K Rockstroh
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,A Baumgarten
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance,2014,C Hoffmann
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Don L Gibbons
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Sabrina Pricl
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Paola Posocco
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Erik Laurini
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Maurizio Fermeglia
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Hanshi Sun
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Moshe Talpaz
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Nicholas Donato
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy,2014,Alfonso Quintás-Cardama
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Kaalak Reddy
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Monika H M Schmidt
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Jaimie M Geist
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Neha P Thakkar
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Gagan B Panigrahi
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Yuh-Hwa Wang
Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability,2014,Christopher E Pearson
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,Andreas Gravvanis
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,Dimosthenis Tsoutsos
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,George Papanikolaou
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,Ahmed Diab
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,Penelope Lambropoulou
Refining perforator selection for deep inferior epigastric perforator flap: the impact of the dominant venous perforator,2013,Dimitrios Karakitsos
Bariatric surgery for severely obese adolescents,2014,Dominic A Fitzgerald
Bariatric surgery for severely obese adolescents,2014,Louise Baur
Predictors of changes in suicidality in multiple sclerosis over time,2013,Sara Flood
Predictors of changes in suicidality in multiple sclerosis over time,2013,Frederick W Foley
Predictors of changes in suicidality in multiple sclerosis over time,2013,Vance Zemon
Predictors of changes in suicidality in multiple sclerosis over time,2013,MaryAnn Picone
Predictors of changes in suicidality in multiple sclerosis over time,2013,Matthew Bongardino
Predictors of changes in suicidality in multiple sclerosis over time,2013,Helen Quinn
Obesity and metabolic syndrome and functional and structural brain impairments in adolescence,2012,Po Lai Yau
Obesity and metabolic syndrome and functional and structural brain impairments in adolescence,2012,Mary Grace Castro
Obesity and metabolic syndrome and functional and structural brain impairments in adolescence,2012,Adrian Tagani
Obesity and metabolic syndrome and functional and structural brain impairments in adolescence,2012,Wai Hon Tsui
Obesity and metabolic syndrome and functional and structural brain impairments in adolescence,2012,Antonio Convit
Comparison of physical activity levels between cancer survivors and non-cancer participants in the 2009 BRFSS,2011,Soyang Kwon
Comparison of physical activity levels between cancer survivors and non-cancer participants in the 2009 BRFSS,2011,Ningqi Hou
Comparison of physical activity levels between cancer survivors and non-cancer participants in the 2009 BRFSS,2011,Meme Wang
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Nadine S M Offermans
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Roel Vermeulen
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Alex Burdorf
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,R Alexandra Goldbohm
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,András P Keszei
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Susan Peters
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Timo Kauppinen
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Hans Kromhout
Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study,2014,Piet A van den Brandt
The dose-response relationship between pseudoephedrine ingestion and exercise performance,2013,Kellie R Pritchard-Peschek
The dose-response relationship between pseudoephedrine ingestion and exercise performance,2013,David G Jenkins
The dose-response relationship between pseudoephedrine ingestion and exercise performance,2013,Mark A Osborne
The dose-response relationship between pseudoephedrine ingestion and exercise performance,2013,Gary J Slater
The dose-response relationship between pseudoephedrine ingestion and exercise performance,2013,Dennis R Taaffe
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Kyoko Hirota
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Naohiro Wakisaka
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Seiko Sawada-Kitamura
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Satoru Kondo
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Kazuhira Endo
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Akira Tsuji
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Shigeyuki Murono
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue,2012,Tomokazu Yoshizaki
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults,2014,Constanze Fey
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults,2014,Ursula Thyroff-Friesinger
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults,2014,Spencer Jones
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,S Umesh Rudrapatna
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Tadeusz Wieloch
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Kerstin Beirup
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Karsten Ruscher
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Wouter Mol
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Pavel Yanev
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Alexander Leemans
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Annette van der Toorn
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology,2014,Rick M Dijkhuizen
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease,2013,Peter J Barnes
The role of chronic hyperviscosity in vascular disease,2014,Gregory Sloop
The role of chronic hyperviscosity in vascular disease,2014,Ralph E Holsworth
The role of chronic hyperviscosity in vascular disease,2014,Joseph J Weidman
The role of chronic hyperviscosity in vascular disease,2014,John A St Cyr
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Ali Mirza Onder
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Robert Lopez
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Uygar Teomete
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Denise Francoeur
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Rita Bhatia
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Obioma Knowbi
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Rana Hizaji
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Jayanthi Chandar
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Carolyn Abitbol
Posterior reversible encephalopathy syndrome in the pediatric renal population,2007,Gaston Zilleruelo
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Ellen G Engelhardt
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Mirjam M Garvelink
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,J Hanneke C J M de Haes
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Jacobus J M van der Hoeven
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Ellen M A Smets
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Arwen H Pieterse
Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models,2013,Anne M Stiggelbout
Exercise intervention for management of obesity,2011,Susan S Deusinger
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Yehuda Zadik
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Vladimir Vainstein
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Ilana Heling
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Tzahi Neuman
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Scott Drucker
Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain,2010,Sharon Elad
Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort,2011,Pamela L Horn-Ross
Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort,2011,Alison J Canchola
Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort,2011,Huiyan Ma
Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort,2011,Peggy Reynolds
Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort,2011,Leslie Bernstein
Regulation of dietary choice by the decision-making circuitry,2013,Antonio Rangel
5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines,2007,Sulbha Sharma
5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines,2007,Anjana Jajoo
5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines,2007,Alok Dube
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Bengt-Åke Andersson
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Freddi Lewin
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Jan Lundgren
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Mats Nilsson
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Lars-Erik Rutqvist
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Sture Löfgren
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma,2014,Nongnit Laytragoon-Lewin
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Masayuki Someya
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Takashi Kojima
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Marie Ogawa
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Takafumi Ninomiya
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Kazuaki Nomura
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Akira Takasawa
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Masaki Murata
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Satoshi Tanaka
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Tsuyoshi Saito
Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano,2013,Norimasa Sawada
MicroRNAs as novel regulators of neuroinflammation,2013,Dominika Justyna Ksiazek-Winiarek
MicroRNAs as novel regulators of neuroinflammation,2013,Magdalena Justyna Kacperska
MicroRNAs as novel regulators of neuroinflammation,2013,Andrzej Glabinski
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Chunkai Wang
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Qingjie Zhao
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Jaeki Min
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Sakthivel Muniyan
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Mireille Vargas
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Xiaofang Wang
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Yuxiang Dong
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,R Kiplin Guy
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Ming-Fong Lin
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Jennifer Keiser
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978,2014,Jonathan L Vennerstrom
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Fania R Gärtner
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Liv M Freeman
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Marlies E Rijnders
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Johanna M Middeldorp
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Kitty Wm Bloemenkamp
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,Anne M Stiggelbout
A comprehensive representation of the birth-experience: identification and prioritization of birth-specific domains based on a mixed-method design,2014,M Elske van den Akker-van Marle
Decision making in the patient of very advanced age with heart disease. Beyond cardiology risk scores],2013,María Teresa Vidán
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,Hussnain Mirza
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,James Ziegler
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,Sara Ford
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,James Padbury
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,Richard Tucker
Pulmonary Hypertension in Preterm Infants: Prevalence and Association with Bronchopulmonary Dysplasia,2014,Abbot Laptook
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Heather M Starmer
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,WuYang Yang
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Raju Raval
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Christine G Gourin
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Marian Richardson
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Rachit Kumar
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Bronwyn Jones
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Todd McNutt
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Zhi Cheng
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Sierra Cheng
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer,2014,Harry Quon
Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial,2012,Andrew D Hirschhorn
Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial,2012,David A B Richards
Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial,2012,Sean F Mungovan
Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial,2012,Norman R Morris
Does the mode of exercise influence recovery of functional capacity in the early postoperative period after coronary artery bypass graft surgery? A randomized controlled trial,2012,Lewis Adams
A Hierarchical Bayesian Modeling Approach to Searching and Stopping in Multi-Attribute Judgment,2014,Don van Ravenzwaaij
A Hierarchical Bayesian Modeling Approach to Searching and Stopping in Multi-Attribute Judgment,2014,Chris P Moore
A Hierarchical Bayesian Modeling Approach to Searching and Stopping in Multi-Attribute Judgment,2014,Michael D Lee
A Hierarchical Bayesian Modeling Approach to Searching and Stopping in Multi-Attribute Judgment,2014,Ben R Newell
Gratitude: A Tool for Reducing Economic Impatience,2014,David DeSteno
Gratitude: A Tool for Reducing Economic Impatience,2014,Ye Li
Gratitude: A Tool for Reducing Economic Impatience,2014,Leah Dickens
Gratitude: A Tool for Reducing Economic Impatience,2014,Jennifer S Lerner
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Hideo Shigeishi
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Adrian Biddle
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Luke Gammon
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Camila O Rodini
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Miho Yamasaki
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Sayaka Seino
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Masaru Sugiyama
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Masaaki Takechi
Elevation in 5-FU-induced apoptosis in Head and Neck Cancer Stem Cells by a combination of CDHP and GSK3β inhibitors,2014,Ian C Mackenzie
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Felippe Borlot
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Paula Ricci Arantes
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Caio Robledo Quaio
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,José Francisco da Silva Franco
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Charles Marques Lourenço
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Israel Gomy
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Debora Romeo Bertola
Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement,2014,Chong Ae Kim
Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts,2010,Abby L Parrill
Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts,2010,Daniel L Baker
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Kyoung Min Lee
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Soon-Sun Kwon
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Chin Youb Chung
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Seung Yeol Lee
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Tae Gyun Kim
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Young Choi
Gender- and body-site-specific factors associated with bone mineral density in a non-institutionalized Korean population aged ≥50 years,2014,Moon Seok Park
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Giada Pozzi
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Alessia Ferrarese
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Alessandro Borello
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Silvia Catalano
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Alessandra Surace
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Silvia Marola
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Valentina Gentile
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Valter Martino
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Mario Solej
Percutaneous drainage and sclerosis of mesenteric cysts: Literature overview and report of an innovative approach,2014,Mario Nano
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Zhi Hua Huang
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Buvana Manickam
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Victoria Ryvkin
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Xiaohong Joe Zhou
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Giamila Fantuzzi
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Theodore Mazzone
PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity,2012,Susan Sam
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Andreas Clemens
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Andreas Strack
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Herbert Noack
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Stavros Konstantinides
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Martina Brueckmann
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?,2014,Gregory Y H Lip
Estrogen metabolites and breast cancer,2014,Richard J Santen
Estrogen metabolites and breast cancer,2014,Wei Yue
Estrogen metabolites and breast cancer,2014,Ji-Ping Wang
Survival after diagnosis of cancer of the oral cavity,2007,Katayoun Sargeran
Survival after diagnosis of cancer of the oral cavity,2007,Heikki Murtomaa
Survival after diagnosis of cancer of the oral cavity,2007,Seyed Mohammad Reza Safavi
Survival after diagnosis of cancer of the oral cavity,2007,Miira M Vehkalahti
Survival after diagnosis of cancer of the oral cavity,2007,Olli Teronen
Oral cancer prevention and control--the approach of the World Health Organization,2008,Poul Erik Petersen
Neural antecedents of social decision-making in a partner choice task,2013,Samuel C D Cartmell
Neural antecedents of social decision-making in a partner choice task,2013,Marvin M Chun
Neural antecedents of social decision-making in a partner choice task,2013,Timothy J Vickery
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,M Fallah
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,X Liu
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,J Ji
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,A Försti
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,K Sundquist
Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study,2014,K Hemminki
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,Brett D Thombs
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,Lisa R Jewett
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,Linda Kwakkenbos
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,Marie Hudson
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,Murray Baron
Major Depression Diagnoses are Often Transient among Patients with Systemic Sclerosis: Baseline and 1-Month Follow-up,2014,[Collective Name] the Canadian Scleroderma Research Group
ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance,2014,Liang Liu
ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance,2014,Lian Fu Zuo
ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance,2014,Jian Wen Guo
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Young-Sil An
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Joon-Kee Yoon
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Su Jin Lee
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Hee-Sung Song
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Seok-Ho Yoon
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer,2013,Kyung-Sook Jo
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Ilya Chumakov
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Marta Blumenfeld
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Oxana Guerassimenko
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Laurent Cavarec
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Marta Palicio
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Hadi Abderrahim
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Lydie Bougueleret
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Caroline Barry
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Hiroaki Tanaka
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Philippe La Rosa
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Anne Puech
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Nadia Tahri
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Annick Cohen-Akenine
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Sylvain Delabrosse
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Sébastien Lissarrague
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Françoise-Pascaline Picard
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Karelle Maurice
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Laurent Essioux
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Philippe Millasseau
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Pascale Grel
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Virginie Debailleul
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Anne-Marie Simon
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Dominique Caterina
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Isabelle Dufaure
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Kattayoun Malekzadeh
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Maria Belova
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Jian-Jian Luan
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Michel Bouillot
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Jean-Luc Sambucy
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Gwenael Primas
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Martial Saumier
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Nadia Boubkiri
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Sandrine Martin-Saumier
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Myriam Nasroune
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Hélène Peixoto
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Arnaud Delaye
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Virginie Pinchot
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Mariam Bastucci
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Sophie Guillou
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Magali Chevillon
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Ricardo Sainz-Fuertes
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Said Meguenni
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Joan Aurich-Costa
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Dorra Cherif
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Anne Gimalac
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Cornelia Van Duijn
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Denis Gauvreau
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Gail Ouellette
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Isabel Fortier
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,John Raelson
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Tatiana Sherbatich
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Nadejda Riazanskaia
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Evgeny Rogaev
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Peter Raeymaekers
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Jeroen Aerssens
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Frank Konings
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Walter Luyten
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Fabio Macciardi
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Pak C Sham
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Richard E Straub
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Daniel R Weinberger
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Nadine Cohen
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Daniel Cohen
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,Gail Ouelette
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia,2002,John Realson
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration,2014,Yang Zhao
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration,2014,Cheng-Xin Gong
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Reiner Ulrich
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Christina Puff
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Konstantin Wewetzer
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Arno Kalkuhl
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Ulrich Deschl
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination,2014,Wolfgang Baumgärtner
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Hang Yu
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Xiaomei Huang
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Xiaosun Liu
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Hailong Jin
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Ge'er Zhang
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Qing Zhang
Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter,2012,Jiren Yu
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Marie-Jet Bekkers
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Sharon A Simpson
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Frank Dunstan
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Kerry Hood
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Monika Hare
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,John Evans
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,Christopher C Butler
Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention,2010,[Collective Name] STAR Study Team
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Thomas M Fandel
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Maarten Albersen
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Guiting Lin
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Xuefeng Qiu
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Hongxiu Ning
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Lia Banie
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Tom F Lue
Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury,2011,Ching-Shwun Lin
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Walter K Schlage
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Anita R Iskandar
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Radina Kostadinova
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Yang Xiang
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Alain Sewer
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Shoaib Majeed
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Diana Kuehn
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Stefan Frentzel
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Marja Talikka
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Marcel Geertz
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Carole Mathis
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Nikolai Ivanov
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Julia Hoeng
In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures,2014,Manuel C Peitsch
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Giovanna Calandra-Buonaura
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Nicola Toschi
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Federica Provini
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Ivan Corazza
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Francesca Bisulli
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Giorgio Barletta
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Stefano Vandi
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Pasquale Montagna
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Maria Guerrisi
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Paolo Tinuper
Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology,2012,Pietro Cortelli
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy,2013,T Hakala
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy,2013,I Kholová
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy,2013,J Sand
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy,2013,R Saaristo
A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy,2013,P Kellokumpu-Lehtinen
Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis,2014,Colin R Buchanan
Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis,2014,Lewis D Pettit
Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis,2014,Amos J Storkey
Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis,2014,Sharon Abrahams
Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis,2014,Mark E Bastin
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Xuyuan Li
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Wen Lin
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Hongbiao Wang
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Wenzhao Lin
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Suiling Lin
Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma,2013,Yingcheng Lin
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Somchit Jaruratanasirikul
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Rarong Chareonmuang
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Malai Wongcharnchailert
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Vichai Laosombat
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Pasuree Sangsupavanich
Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy,2007,Kalaya Leetanaporn
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Massimiliano Calabrese
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Francesca Rinaldi
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Dario Seppi
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Alice Favaretto
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Letizia Squarcina
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Irene Mattisi
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Paola Perini
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Alessandra Bertoldo
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study,2011,Paolo Gallo
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Christoph Skudlik
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Elke Weisshaar
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Reginald Scheidt
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Peter Elsner
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Britta Wulfhorst
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Michael Schönfeld
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Swen Malte John
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,Thomas Ludwig Diepgen
First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ),2011,[Collective Name] ROQ Study Group
Microbial dysbiosis is associated with human breast cancer,2014,Caiyun Xuan
Microbial dysbiosis is associated with human breast cancer,2014,Jaime M Shamonki
Microbial dysbiosis is associated with human breast cancer,2014,Alice Chung
Microbial dysbiosis is associated with human breast cancer,2014,Maggie L Dinome
Microbial dysbiosis is associated with human breast cancer,2014,Maureen Chung
Microbial dysbiosis is associated with human breast cancer,2014,Peter A Sieling
Microbial dysbiosis is associated with human breast cancer,2014,Delphine J Lee
High blood pressure: why prevention and control are urgent and important--a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension,2014,Norm R C Campbell
High blood pressure: why prevention and control are urgent and important--a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension,2014,Daniel T Lackland
High blood pressure: why prevention and control are urgent and important--a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension,2014,Mark L Niebylski
High blood pressure: why prevention and control are urgent and important--a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension,2014,[Collective Name] World Hypertension League Committee
High blood pressure: why prevention and control are urgent and important--a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension,2014,[Collective Name] International Society of Hypertension Executive Committee
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará,2014,Fabrício Bitu Sousa
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará,2014,Malena Regina de Freitas e Silva
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará,2014,Clarissa Pessoa Fernandes
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará,2014,Paulo Goberlânio de Barros Silva
Oral cancer from a health promotion perspective: experience of a diagnosis network in Ceará,2014,Ana Paula Negreiros Nunes Alves
Sensitivity of a subject-specific musculoskeletal model to the uncertainties on the joint axes location,2014,Saulo Martelli
Sensitivity of a subject-specific musculoskeletal model to the uncertainties on the joint axes location,2014,Giordano Valente
Sensitivity of a subject-specific musculoskeletal model to the uncertainties on the joint axes location,2014,Marco Viceconti
Sensitivity of a subject-specific musculoskeletal model to the uncertainties on the joint axes location,2014,Fulvia Taddei
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Erin T Tobin
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Heidi S Kane
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Daniel J Saleh
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Sylvie Naar-King
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Pavadee Poowuttikul
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Elizabeth Secord
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Wayne Pierantoni
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Valerie A Simon
Naturalistically Observed Conflict and Youth Asthma Symptoms,2014,Richard B Slatcher
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Laura Schneider
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Yaron Shargall
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Colin Schieman
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Andrew J Seely
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Sadeesh Srinathan
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Richard A Malthaner
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Andrew F Pierre
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Najib Safieddine
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Rosaire Vaillancourt
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Madelaine Plourde
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,James Bond
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Scott Johnson
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Shona E Smith
Design of a consensus-derived synoptic operative report for lung cancer surgery,2014,Christian J Finley
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice,2014,Maria Meyer
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice,2014,Maria Claudia Gonzalez Deniselle
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice,2014,Hazel Hunt
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice,2014,E Ronald de Kloet
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice,2014,Alejandro F De Nicola
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Bo-wei Liu
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Quiang Lu
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Chun-ming Ma
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Shu-yi Wang
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Dong-hui Lou
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Xiao-li Lou
Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes,2009,Fu-zai Yin
Patient perspectives of diagnostic delay for suspicious oral mucosal lesions,2014,Kristine Allen
Patient perspectives of diagnostic delay for suspicious oral mucosal lesions,2014,Camile S Farah
Nursing strategies to support family members of ICU patients at high risk of dying,2014,Judith A Adams
Nursing strategies to support family members of ICU patients at high risk of dying,2014,Ruth A Anderson
Nursing strategies to support family members of ICU patients at high risk of dying,2014,Sharron L Docherty
Nursing strategies to support family members of ICU patients at high risk of dying,2014,James A Tulsky
Nursing strategies to support family members of ICU patients at high risk of dying,2014,Karen E Steinhauser
Nursing strategies to support family members of ICU patients at high risk of dying,2014,Donald E Bailey
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Yen-Lin Chen
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Cheng-Yi Wang
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Chin-Chia Wu
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Moon-Sing Lee
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Shih-Kai Hung
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Wei-Chou Chen
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Chih-Yao Hsu
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Chia-Wen Hsu
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Chih-Yuan Huang
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Yu-Chieh Su
Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center,2014,Ching-Chih Lee
Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas,2014,Edward A Ratovitski
A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis,2013,Matthew S Devine
A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis,2013,Anna Farrell
A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis,2013,Helen Woodhouse
A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis,2013,Pamela A McCombe
A developmental perspective on bulbar involvement in amyotrophic lateral sclerosis,2013,Robert D Henderson
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Masayoshi Yamaguchi
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Shijun Zhu
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Shumin Zhang
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Daqing Wu
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Terry M Moore
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,James P Snyder
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis,2014,Mamoru Shoji
Doughnut sign in thyroid lymphoma],2012,José Luis Muñoz de Nova
Doughnut sign in thyroid lymphoma],2012,Ana Rodríguez Sánchez
Doughnut sign in thyroid lymphoma],2012,Joaquín Gómez Ramírez
Doughnut sign in thyroid lymphoma],2012,Eduardo Larrañaga Barrera
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Tai-shun Li
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Wen-jie Sun
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Ming-wei Wei
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Shi-hong Chen
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Peng Wang
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Xu-lin Wang
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Lian-ping He
Roc curves of obesity indicators have a predictive value for children hypertension aged 7-17 years,2014,Yu-feng Wen
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Minseon Park
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Eunsil Yoon
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Youn-Hee Lim
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Ho Kim
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Jinwook Choi
Renal Hyperfiltration as a Novel Marker of All-Cause Mortality,2014,Hyung-Jin Yoon
Imaging and histopathological features of Jacob's disease: a case study,2011,Vidya Ajila
Imaging and histopathological features of Jacob's disease: a case study,2011,Shruthi Hegde
Imaging and histopathological features of Jacob's disease: a case study,2011,R Gopakumar
Imaging and histopathological features of Jacob's disease: a case study,2011,G Subhas Babu
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Daniela Alves Fernandes
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Clarissa Lin Yasuda
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Tátila Martins Lopes
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Ghizoni Enrico
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Andréa Alessio
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Helder Tedeschi
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Evandro de Oliveira
Long-term postoperative atrophy of contralateral hippocampus and cognitive function in unilateral refractory MTLE with unilateral hippocampal sclerosis,2014,Fernando Cendes
Neuromechanical features of the cardiac baroreflex after exercise,2011,Christopher K Willie
Neuromechanical features of the cardiac baroreflex after exercise,2011,Philip N Ainslie
Neuromechanical features of the cardiac baroreflex after exercise,2011,Chloe E Taylor
Neuromechanical features of the cardiac baroreflex after exercise,2011,Helen Jones
Neuromechanical features of the cardiac baroreflex after exercise,2011,Peter Y W Sin
Neuromechanical features of the cardiac baroreflex after exercise,2011,Yu-Chieh Tzeng
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Zuowei Duan
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Wen Sun
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Wenhua Liu
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Lulu Xiao
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Zhixin Huang
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Liping Cao
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Hua Li
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Yunyun Xiong
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Dezhi Liu
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Gelin Xu
Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery,2014,Xinfeng Liu
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Lucia Mališová
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Zuzana Kováčová
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Michal Koc
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Jana Kračmerová
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Vladimír Stich
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes,2013,Lenka Rossmeislová
Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model,2013,Silvia D Stan
Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model,2013,Shivendra V Singh
Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model,2013,David C Whitcomb
Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model,2013,Randall E Brand
Valuing fire planning alternatives in forest restoration: using derived demand to integrate economics with ecological restoration,2014,Douglas B Rideout
Valuing fire planning alternatives in forest restoration: using derived demand to integrate economics with ecological restoration,2014,Pamela S Ziesler
Valuing fire planning alternatives in forest restoration: using derived demand to integrate economics with ecological restoration,2014,Nicole J Kernohan
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Lisa B Sheeber
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,John R Seeley
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Edward G Feil
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Betsy Davis
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Erik Sorensen
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Derek B Kosty
Development and pilot evaluation of an Internet-facilitated cognitive-behavioral intervention for maternal depression,2012,Peter M Lewinsohn
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,R Boushel
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,I Ara
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,E Gnaiger
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,J W Helge
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,J González-Alonso
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,T Munck-Andersen
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,H Sondergaard
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,R Damsgaard
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,G van Hall
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,B Saltin
Low-intensity training increases peak arm VO2 by enhancing both convective and diffusive O2 delivery,2014,J A L Calbet
Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors,2011,Jason Debley
Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors,2011,Sanja Stanojevic
Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors,2011,Amy G Filbrun
Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors,2011,Padmaja Subbarao
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Hirohide Yokokawa
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Aya Goto
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Hironobu Sanada
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Tsuyoshi Watanabe
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Robin A Felder
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Pedro A Jose
Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH),2013,Seiji Yasumura
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS,2013,Kathleen M Zackowski
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS,2013,Michelle Cameron
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS,2013,Joanne M Wagner
Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches,2014,Oron Levin
Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches,2014,Hakuei Fujiyama
Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches,2014,Matthieu P Boisgontier
Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches,2014,Stephan P Swinnen
Aging and motor inhibition: a converging perspective provided by brain stimulation and imaging approaches,2014,Jeffery J Summers
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Yohei Kurosaki
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Ayato Takada
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Hideki Ebihara
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Allen Grolla
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Naoki Kamo
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Heinz Feldmann
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Yoshihiro Kawaoka
Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification,2006,Jiro Yasuda
Extracorporeal ultrafiltration for heart failure: focus on organ cross talk and clinical trials,2014,Ivana Marana
Extracorporeal ultrafiltration for heart failure: focus on organ cross talk and clinical trials,2014,Giancarlo Marenzi
Extracorporeal ultrafiltration for heart failure: focus on organ cross talk and clinical trials,2014,Amir Kazory
Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers,2014,Kristen Qutub
Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers,2014,David Lacomis
Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers,2014,Stephen M Albert
Life factors affecting depression and burden in amyotrophic lateral sclerosis caregivers,2014,Eleanor Feingold
Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension,2014,K Kamide
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Katarzyna A Gromek
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Fabian P Suchy
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Hannah R Meddaugh
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Russell L Wrobel
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Loren M LaPointe
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Uyen B Chu
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,John G Primm
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Arnold E Ruoho
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Alessandro Senes
The oligomeric states of the purified sigma-1 receptor are stabilized by ligands,2014,Brian G Fox
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Elaine Kingwell
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,James J Marriott
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Nathalie Jetté
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Tamara Pringsheim
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Naila Makhani
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Sarah A Morrow
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,John D Fisk
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Charity Evans
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Sarah Gabrielle Béland
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Sophie Kulaga
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Jonathan Dykeman
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Christina Wolfson
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Marcus W Koch
Incidence and prevalence of multiple sclerosis in Europe: a systematic review,2013,Ruth Ann Marrie
Update on the management of chronic eczema: new approaches and emerging treatment options,2010,Hobart W Walling
Update on the management of chronic eczema: new approaches and emerging treatment options,2010,Brian L Swick
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Mei-Ling Luo
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Hong-Zhuan Tan
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Ri-Hua Xie
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Shu-Jin Zhou
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Ravi Retnakaran
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Graeme Smith
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Mark C Walker
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Sandra T Davidge
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Jacquetta Trasler
Maternal exposure to the production of fireworks and reduced rate of new onset hypertension in pregnancy,2014,Shi Wu Wen
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Chaim Huyser
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Odile A van den Heuvel
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Lidewij H Wolters
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Else de Haan
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Frits Boer
Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder,2012,Dick J Veltman
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Hengjun J Kim
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Sang Joon Kim
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Ho Sung Kim
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Choong Gon Choi
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Namkug Kim
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Seungbong Han
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Eun Hye Jang
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Sun J Chung
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease,2013,Chong Sik Lee
Incidence of osteoradionecrosis of the temporal bone,2011,David Morrissey
Incidence of osteoradionecrosis of the temporal bone,2011,Roger Grigg
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Fernando Carrasco
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Manuel Moreno
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Verónica Irribarra
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Lorena Rodríguez
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,María Antonieta Martin
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Alejandra Alarcón
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Claudio Mizón
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Constanza Echenique
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Víctor Saavedra
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Tito Pizarra
Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes],2008,Eduardo Atalah
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Hatim A Khoja
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Abdulmonem Almutawa
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Ali Binmahfooz
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Muhammad Aslam
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Abdullah A Ghazi
Papillary thyroid carcinoma-like tumor of the kidney: a case report,2011,Sara Almaiman
Is malnutrition a problem for multiple sclerosis patients?,2014,Mine Hayriye Sorgun
Is malnutrition a problem for multiple sclerosis patients?,2014,Canan Yucesan
Is malnutrition a problem for multiple sclerosis patients?,2014,Cuneyt Tegin
A roadmap for genetic testing in ALS,2013,Bryan J Traynor
The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise,2014,Matthew J Rossman
The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise,2014,Ryan S Garten
The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise,2014,Massimo Venturelli
The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise,2014,Markus Amann
The role of active muscle mass in determining the magnitude of peripheral fatigue during dynamic exercise,2014,Russell S Richardson
Risk factors associated with urinary albumin excretion in African Americans,2010,K E Ussai
Risk factors associated with urinary albumin excretion in African Americans,2010,S W Keith
Risk factors associated with urinary albumin excretion in African Americans,2010,E Pequignot
Risk factors associated with urinary albumin excretion in African Americans,2010,B Falkner
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Achille Tarsitano
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Simona Mazzoni
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Riccardo Cipriani
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Roberto Scotti
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Claudio Marchetti
The CAD-CAM technique for mandibular reconstruction: An 18 patients oncological case-series,2014,Leonardo Ciocca
Participation of interleukin 17A in neuroimmune interactions,2014,Derek M Moynes
Participation of interleukin 17A in neuroimmune interactions,2014,Stephen J Vanner
Participation of interleukin 17A in neuroimmune interactions,2014,Alan E Lomax
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Janneke A J Rood
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Florence J van Zuuren
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Frank Stam
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Tjeerd van der Ploeg
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Corien Eeltink
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Irma M Verdonck-de Leeuw
Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences,2014,Peter C Huijgens
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Janel O Johnson
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Erik P Pioro
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Ashley Boehringer
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Ruth Chia
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Howard Feit
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Alan E Renton
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Hannah A Pliner
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Yevgeniya Abramzon
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Giuseppe Marangi
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Brett J Winborn
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,J Raphael Gibbs
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Michael A Nalls
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Sarah Morgan
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Maryam Shoai
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,John Hardy
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Alan Pittman
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Richard W Orrell
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Andrea Malaspina
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Katie C Sidle
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Pietro Fratta
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Matthew B Harms
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Robert H Baloh
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Alan Pestronk
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Conrad C Weihl
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Ekaterina Rogaeva
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Lorne Zinman
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Vivian E Drory
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Giuseppe Borghero
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Gabriele Mora
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Andrea Calvo
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Jeffrey D Rothstein
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,[Collective Name] ITALSGEN Consortium
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Carsten Drepper
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Michael Sendtner
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Andrew B Singleton
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,J Paul Taylor
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Mark R Cookson
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Gabriella Restagno
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Mario Sabatelli
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Robert Bowser
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Adriano Chiò
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis,2014,Bryan J Traynor
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Evi Masschelein
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Ruud Van Thienen
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Gommaar D'Hulst
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Peter Hespel
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Martine Thomis
Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner,2013,Louise Deldicque
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Noelle K LoConte
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Albiruni R A Razak
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Percy Ivy
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Amye Tevaarwerk
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Rachael Leverence
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Jill Kolesar
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Lillian Siu
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Sam J Lubner
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Daniel L Mulkerin
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,William R Schelman
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Dustin A Deming
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Kyle D Holen
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Lakeesha Carmichael
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Jens Eickhoff
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors,2014,Glenn Liu
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib,2014,Mitul D Gandhi
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib,2014,Mark Agulnik
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,A Ribaud
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,I Tavares
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,E Viollet
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,M Julia
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,C Hérisson
Which physical activities and sports can be recommended to chronic low back pain patients after rehabilitation?,2013,A Dupeyron
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Camilla P Hansen
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Tina L Berentzen
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Jane N Østergaard
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Christina C Dahm
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Lars I Hellgren
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Erik B Schmidt
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Anne Tjønneland
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Thorkild I A Sørensen
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Kim Overvad
Adipose tissue trans-fatty acids and changes in body weight and waist circumference,2013,Marianne U Jakobsen
Analysis of macular OCT images using deformable registration,2014,Min Chen
Analysis of macular OCT images using deformable registration,2014,Andrew Lang
Analysis of macular OCT images using deformable registration,2014,Howard S Ying
Analysis of macular OCT images using deformable registration,2014,Peter A Calabresi
Analysis of macular OCT images using deformable registration,2014,Jerry L Prince
Analysis of macular OCT images using deformable registration,2014,Aaron Carass
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Leslie Wilson
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Jun Tang
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Lixian Zhong
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Gregory Balani
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Gregory Gipson
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Pin Xiang
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Dawn Yu
New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?,2013,Sandy Srinivas
Applications of telecounselling in spinal cord injury rehabilitation: a systematic review with effect sizes,2013,Diana Dorstyn
Applications of telecounselling in spinal cord injury rehabilitation: a systematic review with effect sizes,2013,Jane Mathias
Applications of telecounselling in spinal cord injury rehabilitation: a systematic review with effect sizes,2013,Linley Denson
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,YuJun Wang
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,LiJuan Chen
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,LiWei Tan
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,Qian Zhao
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,Feng Luo
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,YuQuan Wei
PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy,2014,ZhiYong Qian
Atherosclerosis in epilepsy: Its causes and implications,2014,Sherifa A Hamed
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,K Kan-O
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,K Matsumoto
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,H Inoue
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,S Fukuyama
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,Y Asai
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,W Watanabe
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,M Kurokawa
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,J Araya
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,K Kuwano
Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium,2012,Y Nakanishi
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Stephanie Whisnant Cash
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Huiyan Ma
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Pamela L Horn-Ross
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Peggy Reynolds
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Alison J Canchola
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Jane Sullivan-Halley
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Shirley A A Beresford
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Marian L Neuhouser
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Thomas L Vaughan
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Patrick J Heagerty
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study,2012,Leslie Bernstein
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Wings T Y Loo
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Qing Liu
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Michael C W Yip
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Min Wang
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Louis W C Chow
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Mary N B Cheung
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Adrian Y S Yip
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients,2013,Elizabeth L Y Ng
Cell cycle-regulatory cyclins and their deregulation in oral cancer,2013,Rajakishore Mishra
Novel targets in the treatment of advanced melanoma: new first-line treatment options,2013,Kathryn A Culos
Novel targets in the treatment of advanced melanoma: new first-line treatment options,2013,Sandra Cuellar
Identification of Ebola virus microRNAs and their putative pathological function,2014,HongWei Liang
Identification of Ebola virus microRNAs and their putative pathological function,2014,Zhen Zhou
Identification of Ebola virus microRNAs and their putative pathological function,2014,SuYang Zhang
Identification of Ebola virus microRNAs and their putative pathological function,2014,Ke Zen
Identification of Ebola virus microRNAs and their putative pathological function,2014,Xi Chen
Identification of Ebola virus microRNAs and their putative pathological function,2014,ChenYu Zhang
The relationship between red cell distribution width and chronic thromboembolic pulmonary hypertension,2014,Mehmet Agilli
The relationship between red cell distribution width and chronic thromboembolic pulmonary hypertension,2014,Fevzi Nuri Aydin
The relationship between red cell distribution width and chronic thromboembolic pulmonary hypertension,2014,Tuncer Cayci
The relationship between red cell distribution width and chronic thromboembolic pulmonary hypertension,2014,Yasemin Gulcan Kurt
Subjective cognitive complaints and the role of executive cognitive functioning in the working population: a case-control study,2013,Cecilia U D Stenfors
Subjective cognitive complaints and the role of executive cognitive functioning in the working population: a case-control study,2013,Petter Marklund
Subjective cognitive complaints and the role of executive cognitive functioning in the working population: a case-control study,2013,Linda L Magnusson Hanson
Subjective cognitive complaints and the role of executive cognitive functioning in the working population: a case-control study,2013,Töres Theorell
Subjective cognitive complaints and the role of executive cognitive functioning in the working population: a case-control study,2013,Lars-Göran Nilsson
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Amit Fulzele
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Siddhi A Malgundkar
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Rukmini B Govekar
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Anil K D'Cruz
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Pankaj Chaturvedi
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Asawari Patil
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Shubhada V Kane
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications,2012,Surekha M Zingde
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Thomas Bitter
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Johanna Brüderle
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Hilmar Gudziol
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Hartmut Peter Burmeister
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Christian Gaser
Gray and white matter reduction in hyposmic subjects--A voxel-based morphometry study,2010,Orlando Guntinas-Lichius
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Apostolis Papapostolou
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Kostas Spengos
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Irene Fylaktou
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Myrto Poulou
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Ilias Gountas
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Sophia Kitsiou-Tzeli
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Emmanuel Kanavakis
Are ALOX5AP gene SNPs a risk or protective factor for stroke?,2014,Maria Tzetis
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Hui-Jye Chen
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Chung-Ming Lin
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Chao-Ying Lee
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Nai-Chen Shih
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Sakae Amagaya
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Yung-Chang Lin
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling,2013,Jai-Sing Yang
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Keishiro Yajima
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Tomoko Uehira
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Hiroshi Otera
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Yusuke Koizumi
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Dai Watanabe
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Yoshinori Kodama
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Noriyoshi Kuzushita
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Yasuharu Nishida
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Eiji Mita
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Masayuki Mano
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection,2014,Takuma Shirasaka
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Alessia Caleo
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Elena Vigliar
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Mario Vitale
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Vincenzo Di Crescenzo
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Mariapia Cinelli
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Chiara Carlomagno
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Alfredo Garzi
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients,2013,Pio Zeppa
The role of autophagy in neurodegenerative disease,2013,Ralph A Nixon
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,O Laccourreye
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,D Malinvaud
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,M Ménard
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,S Consoli
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,P Giraud
Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences,2014,P Bonfils
Noninvasive measurement and clinical relevance of myocardial twist and torsion,2014,Parash Pokharel
Noninvasive measurement and clinical relevance of myocardial twist and torsion,2014,Andrew J Yoon
Noninvasive measurement and clinical relevance of myocardial twist and torsion,2014,Jonathan N Bella
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Susy Braun
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Melanie Kleynen
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Tessa van Heel
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Nena Kruithof
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Derick Wade
The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis,2013,Anna Beurskens
Risk-taking behaviours and beliefs about fertility in university students,2013,Ilkay Gungor
Risk-taking behaviours and beliefs about fertility in university students,2013,Gulay Rathfisch
Risk-taking behaviours and beliefs about fertility in university students,2013,Nezihe Kizilkaya Beji
Risk-taking behaviours and beliefs about fertility in university students,2013,Makbule Yarar
Risk-taking behaviours and beliefs about fertility in university students,2013,Fatma Karamanoglu
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Yasheng Chen
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Hongtu Zhu
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Hongyu An
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Diane Armao
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Dinggang Shen
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,John H Gilmore
More insights into early brain development through statistical analyses of eigen-structural elements of diffusion tensor imaging using multivariate adaptive regression splines,2013,Weili Lin
Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival,2012,L K Brockley
Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival,2012,M A Cooper
Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival,2012,P F Bennett
Clinical pharmacologists in pharmacoeconomics: what is their role?,2014,Michael D Rawlins
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma,2014,Jeff Johnson
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma,2014,Zonggao Shi
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma,2014,Yueying Liu
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma,2014,M Sharon Stack
Managing water quality under drought conditions in the Llobregat River Basin,2014,Andrea Momblanch
Managing water quality under drought conditions in the Llobregat River Basin,2014,Javier Paredes-Arquiola
Managing water quality under drought conditions in the Llobregat River Basin,2014,Antoni Munné
Managing water quality under drought conditions in the Llobregat River Basin,2014,Andreu Manzano
Managing water quality under drought conditions in the Llobregat River Basin,2014,Javier Arnau
Managing water quality under drought conditions in the Llobregat River Basin,2014,Joaquín Andreu
Denosumab in osteoporosis,2013,Dima L Diab
Denosumab in osteoporosis,2013,Nelson B Watts
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Nadia Barizzone
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Sara Monti
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Simona Mellone
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Michela Godi
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Maurizio Marchini
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Raffaella Scorza
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Maria G Danieli
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases,2013,Sandra D'Alfonso
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Vagner R R Silva
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Thayana O Micheletti
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Gustavo D Pimentel
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Carlos K Katashima
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Luciene Lenhare
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Joseane Morari
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Maria Carolina S Mendes
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Daniela S Razolli
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Guilherme Z Rocha
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Claudio T de Souza
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Dongryeol Ryu
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Patrícia O Prada
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Lício A Velloso
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,José B C Carvalheira
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,José Rodrigo Pauli
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Dennys E Cintra
Hypothalamic S1P/S1PR1 axis controls energy homeostasis,2014,Eduardo R Ropelle
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Li-Chun Hsieh
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,John W Chen
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Li-Ying Wang
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Yuk-Ming Tsang
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Pei-Wei Shueng
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Li-Jen Liao
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Wu-Chia Lo
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Yu-Chin Lin
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Chien-Fu Tseng
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Ying-Shiung Kuo
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Jie-Yang Jhuang
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Hui-Ju Tien
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Hsueh-Fen Juan
Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging,2014,Chen-Hsi Hsieh
Oncocytic sialolipoma of the submandibular gland,2014,Dongbin Ahn
Oncocytic sialolipoma of the submandibular gland,2014,Tae In Park
Oncocytic sialolipoma of the submandibular gland,2014,Junesik Park
Oncocytic sialolipoma of the submandibular gland,2014,Sung Jae Heo
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Michael W Drazer
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Sandip M Prasad
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Dezheng Huo
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Mara A Schonberg
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,William Dale
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Russell Z Szmulewitz
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making,2014,Scott E Eggener
Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy,2013,Li Li
Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy,2013,Manabu Fukumoto
Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy,2013,Duo Liu
The many meanings of evidence: implications for the translational science agenda in healthcare,2013,Gill Harvey
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project,2014,Christina Westerdahl
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project,2014,Bengt Zöller
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project,2014,Eren Arslan
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project,2014,Serap Erdine
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project,2014,Peter M Nilsson
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients,2012,Elena Goleva
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients,2012,Leisa P Jackson
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients,2012,Melanie Gleason
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients,2012,Donald Y M Leung
A method for fuzzy soft sets in decision making based on grey relational analysis and d-s theory of evidence: application to medical diagnosis,2014,Ningxin Xie
A method for fuzzy soft sets in decision making based on grey relational analysis and d-s theory of evidence: application to medical diagnosis,2014,Guoqiu Wen
A method for fuzzy soft sets in decision making based on grey relational analysis and d-s theory of evidence: application to medical diagnosis,2014,Zhaowen Li
Clinico-epidemiologic study of cutaneous leishmaniasis in Diyarbakir Turkey,2006,S Aytekin
Clinico-epidemiologic study of cutaneous leishmaniasis in Diyarbakir Turkey,2006,M Ertem
Clinico-epidemiologic study of cutaneous leishmaniasis in Diyarbakir Turkey,2006,O Yağdiran
Clinico-epidemiologic study of cutaneous leishmaniasis in Diyarbakir Turkey,2006,N Aytekin
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Ndongala M Lubaki
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Philipp Ilinykh
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Colette Pietzsch
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Bersabeh Tigabu
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Alexander N Freiberg
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Richard A Koup
The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains,2013,Alexander Bukreyev
Kidney: polycystic kidney disease,2014,Binu M Paul
Kidney: polycystic kidney disease,2014,Gregory B Vanden Heuvel
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Alfredo Gamboa
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Luis E Okamoto
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Amy C Arnold
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Rocio A Figueroa
Autonomic blockade improves insulin sensitivity in obese subjects,2014,André Diedrich
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Satish R Raj
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Sachin Y Paranjape
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Ginnie Farley
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Naji Abumrad
Autonomic blockade improves insulin sensitivity in obese subjects,2014,Italo Biaggioni
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Hamid Javadi
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Sara Jallalat
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Shokrollah Farrokhi
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Shahriar Semnani
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Mehdi Mogharrabi
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Ahmad Riazi
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Iraj Nabipour
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Darab Moshtaghi
Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report,2012,Majid Assadi
Metastases to the thyroid: a review of the literature from the last decade,2012,Alice Y Chung
Metastases to the thyroid: a review of the literature from the last decade,2012,Thuy B Tran
Metastases to the thyroid: a review of the literature from the last decade,2012,Kevin T Brumund
Metastases to the thyroid: a review of the literature from the last decade,2012,Robert A Weisman
Metastases to the thyroid: a review of the literature from the last decade,2012,Michael Bouvet
Robotically assisted selective neck dissection in parotid gland cancer: preliminary report,2012,Chul-Ho Kim
Robotically assisted selective neck dissection in parotid gland cancer: preliminary report,2012,Jae Won Chang
Robotically assisted selective neck dissection in parotid gland cancer: preliminary report,2012,Eun Chang Choi
Robotically assisted selective neck dissection in parotid gland cancer: preliminary report,2012,Yoo Seob Shin
Robotically assisted selective neck dissection in parotid gland cancer: preliminary report,2012,Yoon Woo Koh
Workloads in Australian emergency departments a descriptive study,2008,Joy Lyneham
Workloads in Australian emergency departments a descriptive study,2008,Liz Cloughessy
Workloads in Australian emergency departments a descriptive study,2008,Valmai Martin
Neonatal portal vein thrombosis: diagnosis and management,2011,Suzan Williams
Neonatal portal vein thrombosis: diagnosis and management,2011,Anthony K C Chan
Thrombolysis of an acute stroke presentation with an incidental unruptured aneurysm,2013,J Ganesalingam
Thrombolysis of an acute stroke presentation with an incidental unruptured aneurysm,2013,R Redwood
Thrombolysis of an acute stroke presentation with an incidental unruptured aneurysm,2013,Ih Jenkins
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Hanane Chenna
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Hanane Berhil
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Karima Nouni
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Hanane Kabbaj
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Hanane Zaidi
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Ahmedou Toulba
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Hanan El Kacemi
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Khalid Hassouni
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Tayeb Kebdani
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Brahim Khalil El Gueddari
Primitive non-Hodgkin lymphoma of the thyroid: about seven cases],2012,Noureddine Benjaafar
Low back pain: atypical presentation of multiple sclerosis],2013,I Miguéns Blanco
Low back pain: atypical presentation of multiple sclerosis],2013,E Rego Sieira
Low back pain: atypical presentation of multiple sclerosis],2013,L García Méndez
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Sung Yong Oh
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Won Seog Kim
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Jin Seok Kim
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Seok Jin Kim
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Suee Lee
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Dae Ho Lee
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Hye Jin Kang
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Moo Kon Song
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Hyo Jung Kim
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Jung Hye Kwon
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Jae-Yong Kwak
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Byeong-Bae Park
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Young-Rok Do
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Seong Hyun Jeong
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study,2011,Cheolwon Suh
Transoral Robotic Surgery in the HPV Era,2014,Irit Duek
Transoral Robotic Surgery in the HPV Era,2014,Salem Billan
Transoral Robotic Surgery in the HPV Era,2014,Moran Amit
Transoral Robotic Surgery in the HPV Era,2014,Ziv Gil
Immunohistochemical studies of the kynurenine pathway in morphea,2013,Rowland Noakes
Immunohistochemical studies of the kynurenine pathway in morphea,2013,Nick Mellick
Knowledge of Dutch GPs in caring for cancer patients using oral anticancer therapy at home,2013,Sanne L C van Roosmalen
Knowledge of Dutch GPs in caring for cancer patients using oral anticancer therapy at home,2013,A Jeannette Pols
Knowledge of Dutch GPs in caring for cancer patients using oral anticancer therapy at home,2013,Dick L Willems
Identifying behavioral circuits in Drosophila melanogaster: moving targets in a flying insect,2012,Leslie C Griffith
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Francesco Patti
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Angelo Pappalardo
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Enrico Montanari
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Ilaria Pesci
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Valeria Barletta
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study,2013,Carlo Pozzilli
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,David Conde-Estévez
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,Esther Salas
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain,2013,Joan Albanell
Indication and Technical Aspects of Adrenal Blood Sampling,2014,D Blondin
Indication and Technical Aspects of Adrenal Blood Sampling,2014,I Quack
Indication and Technical Aspects of Adrenal Blood Sampling,2014,M Haase
Indication and Technical Aspects of Adrenal Blood Sampling,2014,S Kücükköylü
Indication and Technical Aspects of Adrenal Blood Sampling,2014,H S Willenberg
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy,2014,Consuelo Pérez-Rico
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy,2014,Esperanza Gutiérrez-Díaz
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy,2014,Enrique Mencía-Gutiérrez
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy,2014,María Josefa Díaz-de-Atauri
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy,2014,Román Blanco
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Ye-Ming Lee
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Chiu-Yun Chang
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Ting-Lin Yen
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Pitchairaj Geraldine
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Chang-Chou Lan
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Joen-Rong Sheu
Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence,2014,Jie-Jen Lee
Psychological morbidity and health-related quality of life in patients with differing awareness of cancer diagnosis: a cross-sectional study,2014,Dian Can Wang
Psychological morbidity and health-related quality of life in patients with differing awareness of cancer diagnosis: a cross-sectional study,2014,Chuan Bin Guo
Psychological morbidity and health-related quality of life in patients with differing awareness of cancer diagnosis: a cross-sectional study,2014,Xin Peng
Psychological morbidity and health-related quality of life in patients with differing awareness of cancer diagnosis: a cross-sectional study,2014,Yan Jie Su
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Tomaso Bottio
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Jonida Bejko
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Alvise Guariento
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Vincenzo Tarzia
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Demetrio Pittarello
Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia,2014,Gino Gerosa
Forest and funnel plots illustrated the calibration of a prognostic model: a descriptive study,2007,Kwok Ming Ho
Intraoperative Laser-Assisted Indocyanine Green Imaging for Objective Measurement of the Vascular Delay Technique in Locoregional Head and Neck Flaps,2014,Linda N Lee
Intraoperative Laser-Assisted Indocyanine Green Imaging for Objective Measurement of the Vascular Delay Technique in Locoregional Head and Neck Flaps,2014,David F Smith
Intraoperative Laser-Assisted Indocyanine Green Imaging for Objective Measurement of the Vascular Delay Technique in Locoregional Head and Neck Flaps,2014,Kofi D Boahene
Intraoperative Laser-Assisted Indocyanine Green Imaging for Objective Measurement of the Vascular Delay Technique in Locoregional Head and Neck Flaps,2014,Patrick J Byrne
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Luke Ambrose
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Robert D Cooper
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Tanya L Russell
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Thomas R Burkot
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Neil F Lobo
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Frank H Collins
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Jeffrey Hii
Microsatellite and mitochondrial markers reveal strong gene flow barriers for Anopheles farauti in the Solomon Archipelago: implications for malaria vector control,2014,Nigel W Beebe
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Ellen B Fung
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Paul R Harmatz
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Meredith Milet
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Thomas D Coates
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Alexis A Thompson
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Mark Ranalli
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Robert Mignaca
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Charles Scher
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Patricia Giardina
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Shanda Robertson
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Lynne Neumayr
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,Elliott P Vichinsky
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia,2008,[Collective Name] Multi-Center Iron Overload Study Group
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Cailing Yang
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Jianguo Yan
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Guoyan Yuan
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Yinghua Zhang
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Derong Lu
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Mingxin Ren
Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression,2014,Weigang Cui
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Alessandro Antonelli
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Silvia Martina Ferrari
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Poupak Fallahi
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Simona Piaggi
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Andrea Di Domenicantonio
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,David Galleri
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Libero Santarpia
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Fulvio Basolo
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Ele Ferrannini
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer,2012,Paolo Miccoli
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Takaki Yoshikawa
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Kazuaki Tanabe
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Kazuhiro Nishikawa
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Yuichi Ito
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Takanori Matsui
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Yutaka Kimura
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Shinichi Hasegawa
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Toru Aoyama
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Tsutomu Hayashi
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Satoshi Morita
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Yumi Miyashita
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Akira Tsuburaya
Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study,2014,Junichi Sakamoto
Female obesity and assisted reproductive technologies,2012,Banu Kumbak
Female obesity and assisted reproductive technologies,2012,Engin Oral
Female obesity and assisted reproductive technologies,2012,Orhan Bukulmez
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Michael Hutchinson
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Robert J Fox
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Eva Havrdova
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Nuwan C Kurukulasuriya
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Sujata P Sarda
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Sonalee Agarwal
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Mohd Kashif Siddiqui
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Ankush Taneja
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison,2013,Baris Deniz
Case study: Correction of angular deformity post-trans-tibial amputation to improve prosthesis fit and comfort,2014,Beth Lineham
Case study: Correction of angular deformity post-trans-tibial amputation to improve prosthesis fit and comfort,2014,Paul Harwood
Case study: Correction of angular deformity post-trans-tibial amputation to improve prosthesis fit and comfort,2014,Peter Giannoudis
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Carmela Foti
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Cristina Florean
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Antonio Pezzutto
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Paola Roncaglia
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Andrea Tomasella
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Stefano Gustincich
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system,2009,Claudio Brancolini
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Almudena Gómez-Hernández
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Liliana Perdomo
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Natalia de Las Heras
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Nuria Beneit
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Oscar Escribano
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Yolanda F Otero
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Carlos Guillén
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Sabela Díaz-Castroverde
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Beatriz Gozalbo-López
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Victoria Cachofeiro
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Vicente Lahera
Antagonistic effect of TNF-¿ and insulin on UCP-2 expression and vascular damage,2014,Manuel Benito
Factors Associated with Length of Stay for Pediatric Asthma Hospitalizations,2014,Leticia A Shanley
Factors Associated with Length of Stay for Pediatric Asthma Hospitalizations,2014,Hua Lin
Factors Associated with Length of Stay for Pediatric Asthma Hospitalizations,2014,Glenn Flores
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Amy K Walker
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,René L Jacobs
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Jennifer L Watts
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Veerle Rottiers
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Karen Jiang
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Deirdre M Finnegan
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Toshi Shioda
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Malene Hansen
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Fajun Yang
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Lorissa J Niebergall
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Dennis E Vance
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Monika Tzoneva
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Anne C Hart
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans,2011,Anders M Näär
A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions,2013,N B Nayak
A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions,2013,R Salah
A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions,2013,J C Huang
A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions,2013,G M Hathout
Association of Mortality Risk with Various Definitions of Intradialytic Hypotension,2014,Jennifer E Flythe
Association of Mortality Risk with Various Definitions of Intradialytic Hypotension,2014,Hui Xue
Association of Mortality Risk with Various Definitions of Intradialytic Hypotension,2014,Katherine E Lynch
Association of Mortality Risk with Various Definitions of Intradialytic Hypotension,2014,Gary C Curhan
Association of Mortality Risk with Various Definitions of Intradialytic Hypotension,2014,Steven M Brunelli
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Cheng Ean Chee
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Smitha Krishnamurthi
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Charles J Nock
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Neal J Meropol
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Joseph Gibbons
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Pingfu Fu
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Joseph Bokar
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Lois Teston
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Timothy O'Brien
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Vinay Gudena
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Amy Reese
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Mark Bergman
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Joel Saltzman
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,John J Wright
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Afshin Dowlati
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas,2013,Joanna Brell
Acidic Polysaccharide Extracts from Gastrodia Rhizomes Suppress the Atherosclerosis Risk Index through Inhibition of the Serum Cholesterol Composition in Sprague Dawley Rats Fed a High-Fat Diet,2012,Kui-Jin Kim
Acidic Polysaccharide Extracts from Gastrodia Rhizomes Suppress the Atherosclerosis Risk Index through Inhibition of the Serum Cholesterol Composition in Sprague Dawley Rats Fed a High-Fat Diet,2012,Ok-Hwan Lee
Acidic Polysaccharide Extracts from Gastrodia Rhizomes Suppress the Atherosclerosis Risk Index through Inhibition of the Serum Cholesterol Composition in Sprague Dawley Rats Fed a High-Fat Diet,2012,Chan-Kyu Han
Acidic Polysaccharide Extracts from Gastrodia Rhizomes Suppress the Atherosclerosis Risk Index through Inhibition of the Serum Cholesterol Composition in Sprague Dawley Rats Fed a High-Fat Diet,2012,Young-Chan Kim
Acidic Polysaccharide Extracts from Gastrodia Rhizomes Suppress the Atherosclerosis Risk Index through Inhibition of the Serum Cholesterol Composition in Sprague Dawley Rats Fed a High-Fat Diet,2012,Hee-Do Hong
Tumoral calcinosis in systemic sclerosis associated with multicentric Castleman's disease,2013,Sei-ichiro Motegi
Tumoral calcinosis in systemic sclerosis associated with multicentric Castleman's disease,2013,Kazuya Yamada
Tumoral calcinosis in systemic sclerosis associated with multicentric Castleman's disease,2013,Akira Shimizu
Tumoral calcinosis in systemic sclerosis associated with multicentric Castleman's disease,2013,Osamu Ishikawa
Long-term prognosis of patients presenting first-ever vestibular symptoms in a community-based study,2014,Rui Felgueiras
Long-term prognosis of patients presenting first-ever vestibular symptoms in a community-based study,2014,Rui Magalhães
Long-term prognosis of patients presenting first-ever vestibular symptoms in a community-based study,2014,Manuel Correia
Long-term prognosis of patients presenting first-ever vestibular symptoms in a community-based study,2014,Maria Carolina Silva
Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori,2014,M M Walker
Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori,2014,N J Talley
Eczematous dermatitis from heparin],2006,S Emilie
Eczematous dermatitis from heparin],2006,C Bachmeyer
Eczematous dermatitis from heparin],2006,P Moguelet
Eczematous dermatitis from heparin],2006,C Pecquet
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Emanuela Locci
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Samuela Laconi
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Raffaello Pompei
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Paola Scano
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Adolfo Lai
Wheat bran biodegradation by Pleurotus ostreatus: a solid-state carbon-13 NMR study,2007,Flaminia Cesare Marincola
Occult Progressive Pulmonary Arterial Occlusion Associated with Right Ventricular Hypertension in Patients with Systemic Arteriopathy,2014,Brian H Morray
Occult Progressive Pulmonary Arterial Occlusion Associated with Right Ventricular Hypertension in Patients with Systemic Arteriopathy,2014,Lisa Bergersen
Occult Progressive Pulmonary Arterial Occlusion Associated with Right Ventricular Hypertension in Patients with Systemic Arteriopathy,2014,James E Lock
Occult Progressive Pulmonary Arterial Occlusion Associated with Right Ventricular Hypertension in Patients with Systemic Arteriopathy,2014,Audrey C Marshall
Clinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease,2014,Shu-Ping Liu
Clinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease,2014,Jie Ding
Clinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease,2014,Fang Wang
Clinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease,2014,Yan-Qin Zhang
Clinical characteristics and mutation analysis of three Chinese children with autosomal recessive polycystic kidney disease,2014,Jin-Tang Ye
The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema,2007,Michael Meurer
The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema,2007,Jann Lubbe
The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema,2007,Alexander Kapp
The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema,2007,Dirk Schneider
Bullied by peers in childhood and borderline personality symptoms at 11 years of age: a prospective study,2012,Dieter Wolke
Bullied by peers in childhood and borderline personality symptoms at 11 years of age: a prospective study,2012,Andrea Schreier
Bullied by peers in childhood and borderline personality symptoms at 11 years of age: a prospective study,2012,Mary C Zanarini
Bullied by peers in childhood and borderline personality symptoms at 11 years of age: a prospective study,2012,Catherine Winsper
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis,2014,Anthony M Harrison
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis,2014,Angeliki Bogosian
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis,2014,Eli Silber
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis,2014,Lance M McCracken
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis,2014,Rona Moss-Morris
Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study,2014,Peter Dieringer
Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study,2014,Evan M Klass
Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study,2014,Brenna Caine
Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study,2014,Julie Smith-Gagen
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Hongjian Liu
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Xiumin Zhang
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Xiaoli Feng
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Jinghua Li
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Ming Hu
Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese,2010,Tomoyuki Yambe
Alleviating mucositis: are we on track for a novel therapeutic?,2014,Rajesh V Lalla
Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study,2012,Raj Govind Sharma
Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study,2012,Bhavesh Bang
Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study,2012,Hemlata Verma
Profile of oral squamous cell cancer in a tertiary level medical college hospital: a 10 yr study,2012,J M Mehta
The Effect of Rubber Dam Usage on the Survival Rate of Teeth Receiving Initial Root Canal Treatment: A Nationwide Population-based Study,2014,Po-Yen Lin
The Effect of Rubber Dam Usage on the Survival Rate of Teeth Receiving Initial Root Canal Treatment: A Nationwide Population-based Study,2014,Shih-Hao Huang
The Effect of Rubber Dam Usage on the Survival Rate of Teeth Receiving Initial Root Canal Treatment: A Nationwide Population-based Study,2014,Hong-Ji Chang
The Effect of Rubber Dam Usage on the Survival Rate of Teeth Receiving Initial Root Canal Treatment: A Nationwide Population-based Study,2014,Lin-Yang Chi
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls,2014,Susan Coote
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls,2014,Catriona O'Dwyer
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Hua Li
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Mingjia Tan
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Lijun Jia
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Dongping Wei
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Yongchao Zhao
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Guoan Chen
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Jie Xu
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Lili Zhao
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Dafydd Thomas
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,David G Beer
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis,2014,Yi Sun
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Eric Weinlander
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Yash Somnay
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,April D Harrison
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Cheng Wang
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Yi-Qiang Cheng
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Renata Jaskula-Sztul
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Xiao-Min Yu
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth,2014,Herbert Chen
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Terence Dwyer
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Costan G Magnussen
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Michael D Schmidt
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Obioha C Ukoumunne
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Anne-Louise Ponsonby
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Olli T Raitakari
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Paul Z Zimmet
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Steven N Blair
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Russell Thomson
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Verity J Cleland
Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults,2008,Alison Venn
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Agnes E Nystad
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Stig Wergeland
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Lage Aksnes
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Kjell-Morten Myhr
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Lars Bø
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model,2014,Oivind Torkildsen
Childhood obesity,2012,Anju Seth
Childhood obesity,2012,Rajni Sharma
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Volker Ziller
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Ioannis Kyvernitakis
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Dana Knöll
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Astrid Storch
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Olaf Hars
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study,2013,Peyman Hadji
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery,2014,Chaturbhuj Rathore
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery,2014,John C Dickson
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery,2014,Rute Teotónio
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery,2014,Peter Ell
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery,2014,John S Duncan
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Blanca Rojas
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Beatriz I Gallego
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Ana I Ramírez
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Juan J Salazar
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Rosa de Hoz
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Francisco J Valiente-Soriano
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Marcelino Avilés-Trigueros
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Maria P Villegas-Perez
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Manuel Vidal-Sanz
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,Alberto Triviño
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers,2014,José M Ramírez
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Kushal Wijesundara
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Carlton Zdanski
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Julia Kimbell
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Hillel Price
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Nicusor Iftimia
Quantitative upper airway endoscopy with swept-source anatomical optical coherence tomography,2014,Amy L Oldenburg
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,I Bahce
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,C G Vos
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,C Dickhoff
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,K J Hartemink
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,M Dahele
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,E F Smit
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,R Boellaard
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,O S Hoekstra
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC,2014,E Thunnissen
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Gregorio Paolo Milani
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Alberto Edefonti
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Giacomo Tardini
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Elisa Arturi
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Claudia Maria Cinnante
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Emanuela Anna Laicini
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Ernesto Leva
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Alberto Maria Cappellari
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Carlo Agostoni
Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome,2014,Emilio Filippo Fossali
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,R Dummer
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,M Duvic
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,J Scarisbrick
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,E A Olsen
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,S Rozati
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,N Eggmann
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,S M Goldinger
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,K Hutchinson
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,L Geskin
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,T M Illidge
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,E Giuliano
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,J Elder
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome),2014,Y H Kim
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,S Barollo
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,R Pezzani
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,A Cristiani
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,L Bertazza
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,B Rubin
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,A Bulfone
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,M R Pelizzo
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,F Torresan
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,F Mantero
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,G Pennelli
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,S Moro
Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer,2013,C Mian
Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis,2007,Yoshiki Kuroda
Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis,2007,Hiroyuki Nakao
Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis,2007,Kunio Ikemura
Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis,2007,Takahiko Katoh
Primary sclerosing cholangitis,2014,Kate D Williamson
Primary sclerosing cholangitis,2014,Roger W Chapman
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Vito Cantisani
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Vito D'Andrea
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Fausto Biancari
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Olena Medvedyeva
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Mattia Di Segni
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Matteo Olive
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Gregorio Patrizi
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Adriano Redler
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Enrico De Antoni E
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Raffaele Masciangelo
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Francesca Frezzotti
Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience,2012,Paolo Ricci
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Nidhi Bansal
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Jade Mims
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Jeffrey G Kuremsky
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Amy L Olex
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Weiling Zhao
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Leimiao Yin
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Revati Wani
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Jiang Qian
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Brian Center
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Glen S Marrs
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Mercedes Porosnicu
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Jacquelyn S Fetrow
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Allen W Tsang
Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer,2014,Cristina M Furdui
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares,2013,Vincent Bryan Salvador
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares,2013,Sharmaine Habib
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares,2013,Alanna Nattis
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares,2013,Susan Sanelli-Russo
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares,2013,Vincent Rizzo
Primary mucosal melanomas: a comprehensive review,2012,Marija Mihajlovic
Primary mucosal melanomas: a comprehensive review,2012,Slobodan Vlajkovic
Primary mucosal melanomas: a comprehensive review,2012,Predrag Jovanovic
Primary mucosal melanomas: a comprehensive review,2012,Vladisav Stefanovic
High expression of microRNA‑127 is involved in cell cycle arrest in MC‑3 mucoepidermoid carcinoma cells,2012,Ji-Ae Shin
High expression of microRNA‑127 is involved in cell cycle arrest in MC‑3 mucoepidermoid carcinoma cells,2012,Chengming Li
High expression of microRNA‑127 is involved in cell cycle arrest in MC‑3 mucoepidermoid carcinoma cells,2012,Eun-Sun Choi
High expression of microRNA‑127 is involved in cell cycle arrest in MC‑3 mucoepidermoid carcinoma cells,2012,Sung-Dae Cho
High expression of microRNA‑127 is involved in cell cycle arrest in MC‑3 mucoepidermoid carcinoma cells,2012,Nam-Pyo Cho
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Seyed Mansoor Rayegani
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Hadi Shojaee
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Leyla Sedighipour
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Mohammad Reza Soroush
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Mohammad Baghbani
The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury,2011,Omm'ol Banin Amirani
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Bahareh Rasouli
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Tomas Andersson
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Per-Ola Carlsson
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Mozhgan Dorkhan
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Valdemar Grill
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Leif Groop
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Mats Martinell
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Tiinamaja Tuomi
Alcohol and the risk for latent autoimmune diabetes in adults: results based on Swedish ESTRID study,2014,Sofia Carlsson
A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules,2013,David Nigel Poller
A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules,2013,Prashanth Kandaswamy
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Herbert Deppe
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Thomas Mücke
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Bettina Hohlweg-Majert
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Wolfgang Hauck
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Stefan Wagenpfeil
Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up,2011,Frank Hölzle
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,Magali Saint Martin
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,Emilia Sforza
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,Frédéric Roche
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,Jean Claude Barthélémy
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,Catherine Thomas-Anterion
Sleep Breathing Disorders and Cognitive Function in the Elderly: An 8-Year Follow-up Study. The Proof-Synapse Cohort,2014,[Collective Name] on behalf of the PROOF study group
The Dutch Health Care Performance Report: seven years of health care performance assessment in the Netherlands,2014,Michael J van den Berg
The Dutch Health Care Performance Report: seven years of health care performance assessment in the Netherlands,2014,Dionne S Kringos
The Dutch Health Care Performance Report: seven years of health care performance assessment in the Netherlands,2014,Lisanne K Marks
The Dutch Health Care Performance Report: seven years of health care performance assessment in the Netherlands,2014,Niek S Klazinga
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Andréa Simone Siqueira de Queirós
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Simone Cristina Soares Brandão
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Ana Lúcia Coutinho Domingues
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Liana Gonçalves Macedo
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Maira Souto Ourem
Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis,2014,Edmundo Pessoa Almeida Lopes
Two-player partnered exergame for obesity prevention: using discrepancy in players' abilities as a strategy to motivate physical activity,2012,Deborah L Feltz
Two-player partnered exergame for obesity prevention: using discrepancy in players' abilities as a strategy to motivate physical activity,2012,Brandon Irwin
Two-player partnered exergame for obesity prevention: using discrepancy in players' abilities as a strategy to motivate physical activity,2012,Norbert Kerr
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Christiana M Leonard
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Stephen Towler
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Suzanne Welcome
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Laura K Halderman
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Ron Otto
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Mark A Eckert
Size matters: cerebral volume influences sex differences in neuroanatomy,2008,Christine Chiarello
Efficacy of a Behavioral Intervention for Reducing Sedentary Behavior in Persons with Multiple Sclerosis: A Pilot Examination,2014,Rachel E Klaren
Efficacy of a Behavioral Intervention for Reducing Sedentary Behavior in Persons with Multiple Sclerosis: A Pilot Examination,2014,Elizabeth A Hubbard
Efficacy of a Behavioral Intervention for Reducing Sedentary Behavior in Persons with Multiple Sclerosis: A Pilot Examination,2014,Robert W Motl
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Emanuele Cereda
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Veronica Codullo
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Catherine Klersy
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Silvia Breda
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Anna Crippa
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Maria Luisa Rava
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Margherita Orlandi
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Chiara Bonardi
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Maria Lina Fiorentini
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Roberto Caporali
Disease-related nutritional risk and mortality in systemic sclerosis,2013,Riccardo Caccialanza
Intractable hiccups: a rare presentation of phrenic nerve schwannoma,2012,S M Gilani
Intractable hiccups: a rare presentation of phrenic nerve schwannoma,2012,R D Danforth
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases,2013,Robert I Richards
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases,2013,Saumya E Samaraweera
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases,2013,Clare L van Eyk
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases,2013,Louise V O'Keefe
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases,2013,Catherine M Suter
Liver complications in inflammatory bowel diseases,2013,V Wieser
Liver complications in inflammatory bowel diseases,2013,R Gerner
Liver complications in inflammatory bowel diseases,2013,A R Moschen
Liver complications in inflammatory bowel diseases,2013,H Tilg
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,V M Pachón-Garrudo
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,J I Cuenca-Cuenca
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,J Ruiz-Franco-Baux
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,I Borrego-Dorado
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,J L Tirado-Hospital
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,E Navarro-González
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels,2012,R Vázquez-Albertino
"Tailored"" submaximal step test for VO2max prediction in healthy older adults",2013,Silvia Pogliaghi
"Tailored"" submaximal step test for VO2max prediction in healthy older adults",2013,Cecilia Bellotti
"Tailored"" submaximal step test for VO2max prediction in healthy older adults",2013,Donald H Paterson
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Yoshinori Nishimoto
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Shinichi Nakagawa
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Tetsuro Hirose
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Hirotaka James Okano
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Masaki Takao
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Shinsuke Shibata
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Satoshi Suyama
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Ken-Ichiro Kuwako
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Takao Imai
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Shigeo Murayama
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Norihiro Suzuki
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis,2013,Hideyuki Okano
Osteoporosis in primary biliary cirrhosis of the liver,2014,Joanna Raszeja-Wyszomirska
Osteoporosis in primary biliary cirrhosis of the liver,2014,Tomasz Miazgowski
Metabolic syndrome and lifestyle modification,2014,Mitsuyoshi Takahara
Metabolic syndrome and lifestyle modification,2014,Iichiro Shimomura
Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?,2013,Jong Sil Lee
Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?,2013,Oh Jin Kwon
Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?,2013,Jung Je Park
Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?,2013,Ji Hyun Seo
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features,2013,Pilar Toledano
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features,2013,Nicolae Sarbu
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features,2013,Gerard Espinosa
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features,2013,Núria Bargalló
Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features,2013,Ricard Cervera
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis,2014,Bradley S Quon
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis,2014,David A Ngan
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis,2014,Pearce G Wilcox
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis,2014,S F Paul Man
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis,2014,Don D Sin
Gastric cancer drug trials - are women second class citizens?,2014,Lishi Wang
Gastric cancer drug trials - are women second class citizens?,2014,Yan Jiao
Gastric cancer drug trials - are women second class citizens?,2014,Yun Jiao
Gastric cancer drug trials - are women second class citizens?,2014,Yanhong Cao
Gastric cancer drug trials - are women second class citizens?,2014,Weikuan Gu
Congenital atrichia and hypotrichosis,2011,Antoni Bennàssar
Congenital atrichia and hypotrichosis,2011,Juan Ferrando
Congenital atrichia and hypotrichosis,2011,Ramon Grimalt
Management of calcium channel blocker overdoses,2014,Sundeep Shenoy
Management of calcium channel blocker overdoses,2014,Shilpa Lankala
Management of calcium channel blocker overdoses,2014,Sasikanth Adigopula
Neutrophil-tumor cell cannibalism in oral squamous cell carcinoma,2014,Sachin C Sarode
Neutrophil-tumor cell cannibalism in oral squamous cell carcinoma,2014,Gargi S Sarode
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Claire L Gordon
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Stephanie Pouch
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Lindsay G Cowell
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Mary Regina Boland
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Heather L Platt
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Albert Goldfain
Design and evaluation of a bacterial clinical infectious diseases ontology,2013,Chunhua Weng
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Louise Brunkwall
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Ulrika Ericson
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Sophie Hellstrand
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Bo Gullberg
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Marju Orho-Melander
Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults,2013,Emily Sonestedt
Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A,2014,Kun-Long Tang
Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A,2014,Yi Lin
Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A,2014,Li-Ming Li
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,R R Rosas
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,K A Cole
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,L Darrah
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,M D Rohrer
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,N L Rhodus
A comparison of screening methods in two early phase oral leukoplakia clinical trials,2012,F G Ondrey
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Yn Li
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Fl Hu
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Yj Dai
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,R Li
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Xx Ma
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Y Du
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,M Feng
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Y Jia
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Cf Zhang
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,L Zhu
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Dp Ascherman
Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus,2014,Zg Li
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Andrea Mike
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Erzsebet Strammer
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Mihaly Aradi
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Gergely Orsi
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Gabor Perlaki
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Andras Hajnal
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Janos Sandor
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Miklos Banati
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Eniko Illes
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Alexander Zaitsev
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Robert Herold
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Charles R G Guttmann
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study,2013,Zsolt Illes
Anatomical connectivity changes in the bilingual brain,2013,Lorna García-Pentón
Anatomical connectivity changes in the bilingual brain,2013,Alejandro Pérez Fernández
Anatomical connectivity changes in the bilingual brain,2013,Yasser Iturria-Medina
Anatomical connectivity changes in the bilingual brain,2013,Margaret Gillon-Dowens
Anatomical connectivity changes in the bilingual brain,2013,Manuel Carreiras
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm,2014,Rathan M Subramaniam
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm,2014,Krishna C Alluri
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm,2014,Abdel K Tahari
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm,2014,Nafi Aygun
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm,2014,Harry Quon
Modeling the connectome of a simple spinal cord,2011,Roman Borisyuk
Modeling the connectome of a simple spinal cord,2011,Abul Kalam Al Azad
Modeling the connectome of a simple spinal cord,2011,Deborah Conte
Modeling the connectome of a simple spinal cord,2011,Alan Roberts
Modeling the connectome of a simple spinal cord,2011,Stephen R Soffe
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Annalisa Palmieri
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Francesco Carinci
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Marcella Martinelli
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Furio Pezzetti
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Ambra Girardi
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Francesca Cura
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Corrado Rubini
Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma,2014,Luca Scapoli
Are extrinsic black stains of teeth iron-saturated bovine lactoferrin and a sign of iron deficient anemia or iron overload?,2012,Ilir Mesonjesi
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Gaetana Lanzi
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Daniele Moratto
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Donatella Vairo
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Stefania Masneri
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Ottavia Delmonte
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Tiziana Paganini
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Silvia Parolini
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Giovanna Tabellini
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Cinzia Mazza
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Gianfranco Savoldi
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Davide Montin
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Silvana Martino
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Pierangelo Tovo
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Itai M Pessach
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Michel J Massaad
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Narayanaswamy Ramesh
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Fulvio Porta
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Alessandro Plebani
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Luigi D Notarangelo
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Raif S Geha
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP,2012,Silvia Giliani
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Jane M Cramm
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Apostolos Tsiachristas
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Bethany H Walters
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Samantha A Adams
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Roland Bal
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Robbert Huijsman
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Maureen P M H Rutten-Van Mölken
The management of cardiovascular disease in the Netherlands: analysis of different programmes,2013,Anna P Nieboer
White matter changes on magnetic resonance imaging: a risk factor for stroke in an African population?,2013,Godwin I Ogbole
White matter changes on magnetic resonance imaging: a risk factor for stroke in an African population?,2013,Mayowa O Owolabi
White matter changes on magnetic resonance imaging: a risk factor for stroke in an African population?,2013,Bolutife P Yusuf
Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study,2013,Martin Vessey
Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study,2013,David Yeates
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Christian Sina
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Simone Lipinski
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Olga Gavrilova
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Konrad Aden
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Ateequr Rehman
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Andreas Till
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Andrea Rittger
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Rainer Podschun
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Ulf Meyer-Hoffert
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Robert Haesler
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Emilie Midtling
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Katrin Pütsep
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Michael A McGuckin
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Stefan Schreiber
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Paul Saftig
Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice,2012,Philip Rosenstiel
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Edward J Kim
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Vaibhav Sahai
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Ethan V Abel
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Kent A Griffith
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Joel K Greenson
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Naoko Takebe
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Gazala N Khan
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,John L Blau
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Ulysses G Balis
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Ronald Craig
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Mark M Zalupski
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma,2014,Diane M Simeone
Neuroimaging findings in a case of fluoxetine overdose,2011,Miklós Szólics
Neuroimaging findings in a case of fluoxetine overdose,2011,Muhammad Chaudhry
Neuroimaging findings in a case of fluoxetine overdose,2011,Milos Ljubisavljevic
Neuroimaging findings in a case of fluoxetine overdose,2011,Peter Corr
Neuroimaging findings in a case of fluoxetine overdose,2011,Hashim A Samir
Neuroimaging findings in a case of fluoxetine overdose,2011,Klaus Neidl van Gorkom
Image analysis of food particles can discriminate deficient mastication of mixed foodstuffs simulating daily meal,2014,K Sugimoto
Image analysis of food particles can discriminate deficient mastication of mixed foodstuffs simulating daily meal,2014,Y Hashimoto
Image analysis of food particles can discriminate deficient mastication of mixed foodstuffs simulating daily meal,2014,C Fukuike
Image analysis of food particles can discriminate deficient mastication of mixed foodstuffs simulating daily meal,2014,N Kodama
Image analysis of food particles can discriminate deficient mastication of mixed foodstuffs simulating daily meal,2014,S Minagi
Obesity and colorectal cancer risk: the role of oxidative stress,2013,Alphons J M Vermorken
Obesity and colorectal cancer risk: the role of oxidative stress,2013,Jingjing Zhu
Obesity and colorectal cancer risk: the role of oxidative stress,2013,Emmanuel Andrès
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,A Lammert
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,H J Schneider
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,T Bergmann
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,U Benck
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,B K Krämer
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,R Gärtner
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,C Metzner
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,C Schöfl
Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy,2013,C Berking
Decision-related pupil dilation reflects upcoming choice and individual bias,2014,Jan Willem de Gee
Decision-related pupil dilation reflects upcoming choice and individual bias,2014,Tomas Knapen
Decision-related pupil dilation reflects upcoming choice and individual bias,2014,Tobias H Donner
Angiographic suppression of the artery of Adamkiewicz by venous hypertension resolving after embolization in a case of spinal epidural arteriovenous fistula,2014,Danielle Eckart Sorte
Angiographic suppression of the artery of Adamkiewicz by venous hypertension resolving after embolization in a case of spinal epidural arteriovenous fistula,2014,Carlos A Pardo
Angiographic suppression of the artery of Adamkiewicz by venous hypertension resolving after embolization in a case of spinal epidural arteriovenous fistula,2014,Philippe Gailloud
Fasudil reduces GFAP expression after hypoxic injury,2014,Varun Kesherwani
Fasudil reduces GFAP expression after hypoxic injury,2014,Shikha Tarang
Fasudil reduces GFAP expression after hypoxic injury,2014,Robert Barnes
Fasudil reduces GFAP expression after hypoxic injury,2014,Sandeep K Agrawal
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,S Numao
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,Y Hayashi
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,Y Katayama
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,T Matsuo
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,T Tomita
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,K Ohkawara
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,Y Nakata
Effects of obesity phenotype on fat metabolism in obese men during endurance exercise,2006,K Tanaka
The many generations of sequencing technology,2014,Neeraj Sethi
The many generations of sequencing technology,2014,Henry Wood
The many generations of sequencing technology,2014,Pamela Rabbitts
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Lyne Chahine
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Bassel Abou-Khalil
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Auli Siren
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Frederick Andermann
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Peter Hedera
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Qing Ge
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Eva Andermann
A new locus for familial temporal lobe epilepsy on chromosome 3q,2013,Massimo Pandolfo
Soluble extract from Moringa oleifera leaves with a new anticancer activity,2014,Il Lae Jung
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,R Rokyta
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,M Matejovic
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,I Novak
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,V Zeman
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,A Krouzecky
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,J Novak
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,L Trefil
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,K Linhartova
Submaximal exercise in healthy volunteers: the relationship between gastric mucosal and systemic energy status,2001,V Sramek
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Giulia Barletta
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Carlo Genova
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Erika Rijavec
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Giovanni Burrafato
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Federica Biello
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Claudio Sini
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Maria Giovanna Dal Bello
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Simona Coco
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Anna Truini
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Irene Vanni
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Angela Alama
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Sabrina Beltramini
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Maria Attilia Grassi
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Francesco Boccardo
Oral vinorelbine in the treatment of non-small-cell lung cancer,2014,Francesco Grossi
Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities,2014,Maria L Mancini
Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities,2014,Stephen T Sonis
Causes for hospitalization and death in Iranian patients with β-thalassemia major,2010,Masood Bazrgar
Causes for hospitalization and death in Iranian patients with β-thalassemia major,2010,Farah Peiravian
Causes for hospitalization and death in Iranian patients with β-thalassemia major,2010,Fatemeh Abedpour
Causes for hospitalization and death in Iranian patients with β-thalassemia major,2010,Mehran Karimi
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Sharon P Fowler
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Sobha Puppala
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Rector Arya
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Geetha Chittoor
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Vidya S Farook
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Jennifer Schneider
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Roy G Resendez
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Ram Prasad Upadhayay
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Jane Vandeberg
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Kelly J Hunt
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Benjamin Bradshaw
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Eugenio Cersosimo
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,John L Vandeberg
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Laura Almasy
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Joanne E Curran
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Anthony G Comuzzie
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Donna M Lehman
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Christopher P Jenkinson
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Jane L Lynch
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Ralph A Defronzo
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,John Blangero
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Daniel E Hale
Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study,2013,Ravindranath Duggirala
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Nikolaos Bonaros
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,David Vill
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Dominik Wiedemann
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Klaus Fischler
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Guy Friedrich
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Otmar Pachinger
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Michael Grimm
Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention,2011,Thomas Schachner
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature,2014,Matteo Sacchi
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature,2014,Edoardo Villani
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature,2014,Francesca Gilardoni
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature,2014,Paolo Nucci
How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case,2012,Vikneswary Batumalai
How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case,2012,Michael G Jameson
How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case,2012,Dion F Forstner
How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case,2012,Philip Vial
How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case,2012,Lois C Holloway
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences,2013,Friedemann Paul
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences,2013,Dennis Bourdette
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,[Collective Name] The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Ardalan Ebrahimi
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Ziv Gil
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Moran Amit
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Tzu-Chen Yen
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Chun-Ta Liao
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Pankaj Chaturvedi
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Jai Prakash Agarwal
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Luiz P Kowalski
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Matthias Kreppel
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Claudio R Cernea
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Jose Brandao
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Gideon Bachar
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Andrea Bolzoni Villaret
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Dan Fliss
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Eran Fridman
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,K Thomas Robbins
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Jatin P Shah
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Snehal G Patel
Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Depth of Invasion: An International Multicenter Retrospective Study,2014,Jonathan R Clark
Fine needle aspiration biopsy: in the diagnosis of salivary gland neoplasms compared with histopathology,2012,Hasan Mete Inançlı
Fine needle aspiration biopsy: in the diagnosis of salivary gland neoplasms compared with histopathology,2012,Mahmut Alper Kanmaz
Fine needle aspiration biopsy: in the diagnosis of salivary gland neoplasms compared with histopathology,2012,Ahmet Ural
Fine needle aspiration biopsy: in the diagnosis of salivary gland neoplasms compared with histopathology,2012,Gulay Bilir Dilek
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Eriko Takatori
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Tadahiro Shoji
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Yuki Miura
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Anna Takada
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Satoshi Takeuchi
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report,2014,Toru Sugiyama
Promoting person-centeredness in long-term care: an exploratory study,2013,David Edvardsson
Promoting person-centeredness in long-term care: an exploratory study,2013,Pia Varrailhon
Promoting person-centeredness in long-term care: an exploratory study,2013,Kristina Edvardsson
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Raya Leibowitz-Amit
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Nimira Alimohamed
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Francisco E Vera-Badillo
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Jo-An Seah
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Arnoud J Templeton
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Jennifer J Knox
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Ian F Tannock
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Srikala S Sridhar
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone,2014,Anthony M Joshua
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,M L King
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,M E Lindberg
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,G R Stodden
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,H Okuda
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,S D Ebers
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,A Johnson
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,A Montag
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,E Lengyel
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,J A MacLean Ii
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer,2014,K Hayashi
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Brandy A Wicklow
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Kristy D M Wittmeier
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Andrea C MacIntosh
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Elizabeth A C Sellers
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Lawrence Ryner
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Hacene Serrai
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Heather J Dean
Metabolic consequences of hepatic steatosis in overweight and obese adolescents,2012,Jonathan M McGavock
Caspase cleavage of HER-2 releases a Bad-like cell death effector,2008,Anne M Strohecker
Caspase cleavage of HER-2 releases a Bad-like cell death effector,2008,Fruma Yehiely
Caspase cleavage of HER-2 releases a Bad-like cell death effector,2008,Feng Chen
Caspase cleavage of HER-2 releases a Bad-like cell death effector,2008,Vincent L Cryns
